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 Summary 
This report is embedded in the larger research project ‘Towards a Holistic 
Conception of Life? Epistemic Presumptions and Socio-Cultural Implications 
of Systems Biology’, conducted jointly by the Institute of Technology As-
sessment at the Austrian Academy of Sciences and the Research Centre for 
Biotechnology, Society, and the Environment (FSP BIOGUM) at the Univer-
sity of Hamburg. 
It gives a first overview of the state of establishment and institutionalisation 
of systems biology in Austria in 2011. It is based upon a methodical investi-
gation of scientists, institutions, research projects, university courses and pub-
lications making use of the term ‘systems biology’ in this national context 
and puts an emphasis on the completeness and reproducibility of the reported 
results. The most relevant institutions are enlisted along three categories and 
shortly characterised.  
Overall, the state of establishment of systems biology is much less advanced 
than in Germany, the United Kingdom or Switzerland. It takes place on a 
smaller scale and is driven by a more cautious attitude. Also, it takes place in 
a more diverse and fragmented mode. Only a few, small institutes carry the 
label in their name and systems biology is (at least as a label) almost absent 
in university curricula. 
The rightful attribution or meaning of the label ‘systems biology’ is not ques-
tioned at this point; rather, different configurations of doing systems biology 
are addressed tentatively by co-authorship analyses, discipline-based catego-
risations, historical timelines and geographical analyses. Moreover, general 
problems relating to such an early onwards assessment of the state of a new 
scientific field are discussed in the introduction.  
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 1 Introduction: systems biology as a new label 
Around the turn of the last century, systems biology has established itself as a 
new and prominent research label within the life sciences. The number of 
publications featuring ‘systems biology’ as a keyword has increased steadily 
from four in the year 2000 to 1.362 in the year 2011 (Web of KnowledgeTM 
database1, Figure 1). The relative frequency of such papers shows the same 
steady increase with a stabilising trend since 2011.2  
 
Figure 1: Papers in Web of KnowledgeTM database with topic ‘biotechnology’, 
‘systems biology’, ‘genetic engineering’ or ‘synthetic biology’  
(as of March 5th, 2012) 
The increased use of the term in scientific publication databases has been ac-
companied by the promotion of systems biology research via specific funding 
programmes and its institutionalisation via new research centres. Hot spots of 
such systems biology funding and founding activities include the USA, Great 
Britain and Germany. 
The US National Institutes of Health (NIH) currently support thirteen National 
Centers for Systems Biology, including the Center for Systems Biology (*2006) 
at the Institute of Systems Biology in Seattle, Washington (*2000), the Center 
for Systems and Synthetic Biology at the University of California San Francisco 
(*2010), the Center for Complex Biological Systems at the University of Cali-
fornia (*2001), Irvine, the Chicago Center for Systems Biology, the Duke Cen-
                                                           
1 http://apps.webofknowledge.com, search for topics, March 13th, 2012. 
2 One methodological caveat has to be considered here: although absolute (papers 
with keyword per year) and relative (papers with keyword divided by total number 
of papers per year) frequency curves do not differ fundamentally in their shape, the 
observable general tendency of such curves to show upward trends could be the re-
sult of rising numbers of keywords per paper over time. Still, counter-examples can 
be found, like for instance for the topics ‘chromosome’ or ‘transduction’. 
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ter for Systems Biology (*2007), the San Diego Center for Systems Biology 
(*2010) and the Systems Biology Center New York.3 
In a joint effort, the Biotechnology and Biological Sciences Research Council 
(BBSRC) and the Engineering and Physical Sciences Research Council 
(EPSRC) funded six Centres for Integrative Systems Biology (CISBs) in the 
United Kingdom in two rounds in 2005/6: the Centre for Integrated Systems 
Biology of Ageing and Nutrition (CISBAN) at Newcastle University, the Centre 
for Integrative Systems Biology at Imperial College (CISBIC) at Imperial Col-
lege London, the Manchester Centre for Integrative Systems Biology (MCISB) 
at the University of Manchester, the Centre for Systems Biology at Edinburgh 
(CSBE) at the University of Edinburgh, the Centre for Plant Integrative Biol-
ogy (CPIB) at the University of Nottingham and the Oxford Centre for Integra-
tive Systems Biology (OCISB) at the University of Oxford.4 A 2007 report by 
the Academy of Medical Sciences and The Royal Academy of Engineering 
(Academy of Medical Sciences and The Royal Academy of Engineering 2007: 
34) lists a total of sixteen systems biology centres in the UK. 
In Germany, the Federal Ministry of Education and Research (BMBF) launched 
a call for proposals entitled ‘Systems of Life – Systems Biology’ in 2001 and 
initiated the pilot project HepatoSys, that was followed up by the Virtual Liver 
Network and has “since developed into an internationally recognized network 
of expertise on the ‘liver system model’”5. In 2007, four FORSYS centres 
were established, the Freiburg Initiative for Systems Biology (FRISYS), Go-
FORSYS in Potsdam-Golm, VIROQUANT (systems biology of virus-cell in-
teractions) and the Magdeburg Centre for Systems Biology (MaCS). Further 
funding has been targeted at a systems biological research focus on ageing 
(GerontoSys), at medical systems biology (MedSys, Berlin-Institute for Medi-
cal Systems Biology, Medical Systems Biology Charité) and a few further ini-
tiatives (cp. Brüninghaus and Kastenhofer 2012). 
Compared to these substantive and pronounced efforts, the situation in Austria 
is much more modest. Mission-oriented funding targeting systems biology was 
restricted to the FFG-initiative GEN-AU (Austrian Research Promotion Agen-
cy, 2001-2012),6 in which systems biology played an increasing but not a 
central role and which will end in 2012, most likely without replacement. The 
Austrian Science Fund (FWF), dedicated to bottom-up funding of fundamental 
research, mentions only one transnational and three national research projects 
with ‘systems biology’ as a key word.7 Major research networks or institutes 
do not feature under this label. Moreover, scientists seem to be more reluc-
tant to take up the new term when characterising their research and depicting 
their own affiliation. Currently, one research centre – although not advertising 
it in its name – is perceived as a systems biology research institution within 
the national and international scientific community (CeMM – Centre for Mo-
lecular Medicine). Additionally, two chairs at the University of Vienna (for 
Computational Systems Biology and Molecular Systems Biology) and a few 
research groups run under the label of ‘systems biology’ (see the detailed list 
in chapters 5, 6 and 7).  
                                                           
3 http://www.systemscenters.org/, accessed March 5th, 2012. 
4 http://www.bbsrc.ac.uk/organisation/institutes/systems-biology-centres.aspx,  
accessed March 5th, 2012. 
5 http://www.systembiologie.de/en/information.html, accessed March 5th, 2012. 
6 The Vienna Science and Technology Fund (WWTF) also funded one ‘Life Science 
Chair’ in 2004, devoted to bioinformatics and systems biology research. 
7 http://www.fwf.ac.at/de/projects/projekt_suche.html, as of March 5th, 2012. 
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Austria also participates in systems biology projects funded within the EU 
framework programmes 6 and 78 and in EU ERA-NET activities, the SysMO 
initiative on the ‘Systems Biology of Microorganisms’9 and the ERASysBio 
initiative, “a consortium of funding bodies, ministries and project management 
agencies” with the mission “to carry out fundamental and strategic collabora-
tion in the funding of systems approaches to biological research.”10 Here again, 
the relatively low level of participation mirrors a currently low level of insti-
tutionalisation of systems biology in Austria.  
A search in the EU research framework database11 results in 72 FP-612 and 259 
FP-713 projects mentioning ‘systems biology’ in title, abstract or keyword.14 Of 
the 67 projects funded within FP-6, none is coordinated and seven are con-
tributed to by Austrian research groups; of the 29 projects funded within FP-7, 
two are coordinated and one is contributed to by Austrian research groups. 
An overview is presented in Figure 2. 
 
Figure 2: Number of FP-6 and FP-7 projects coordinated and participated in per country  
(multiple participation per country is not noted) 
                                                           
  8 Earlier programmes did not include research projects mentioning systems biology, 
with one exception in FP 5: ‘Open Reading Frames for the European Union Scien-
tists’ (ORFEUS), a LIFE QUALITY project coordinated by the Dpt. of Plant Sys-
tems Biology at the Flanders Interuniversity Institute for Biotechnology (VZW). 
  9 http://www.sysmo.net/, accessed April 2nd, 2012. 
10 http://www.erasysbio.net/index.php?index=311, accessed March 5th, 2012. 
11 http://cordis.europa.eu/search/index.cfm?fuseaction=proj.advSearch,  
accessed March 13th, 2012. 
12 The acronyms of these projects are listed in the annex. 
13 The acronyms of these projects are listed in the annex. 
14 This kind of search does not discern mere mentioning of systems biology from a 
fundamental orientation towards systems biology. Hence, the overall number of sys-
tems biology projects has to be taken with caution. 
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Of the 20 ERASysBio+ projects15, Austria participates in only one project. The 
ERASysBio+ initiative “brings together funding agencies from 13 countries 
including Israel and Russia.” Luxembourg and Switzerland joined later as af-
filiated partners.16 An overview of all countries participating in ERASysBio+ 
projects is given in Figure 3. 
 
Figure 3: Number of ERASysBio+ projects coordinated and participated in per country  
(multiple participation by more than one research group per country is not noted) 
Of the 19 projects funded within the SysMO programme, Austria participates 
in only two (see Figure 4). This is especially remarkable because Austria was 
one of only six countries co-funding this initiative (besides Germany, the 
Netherlands, Norway, the United Kingdom and Spain). Austria also ‘inher-
ited’ one coordinator position when the principal investigator of SulfoSYS 
moved from Norway to Austria around 2007 (not depicted in Figure 4). 
 
Figure 4: Number of SysMO projects coordinated and participated in per country 
                                                           
15 The acronyms of these projects are: FRIM, LINCONET, BioModUE PTL, Zebrain, 
Synergy, SynProt, LymphoSys, SHIPREC, ModHeart, C5Sys, iSAM, livSYSiPS, 
EpiGenSys, GRAPPLE, ApoNET, TB-HOST-NET. 
16 http://www.erasysbio.net/Summary, accessed April 4th, 2012. 
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Austrian policy documents and plans to institutionalise systems biology in 
Austria show that the interest in systems biology has already been more pro-
nounced than it is now.  
Already in 2000, the Research Center for Molecular Medicine (CeMM) of the 
Austrian Academy of Sciences was established. Although it is widely per-
ceived as contributing to systems biology research and has gained high inter-
national recognition, it does not feature systems biology in its title. 
The Austrian Council for Research and Technology Development (Rat für 
Forschung und Technologieentwicklung, “consulting the Austrian Federal Gov-
ernment in all issues of research, technology and innovation policy”17) in its 
2005 strategy for the development of the life sciences in Austria mentions 
“systems biology/quantitative and computational bio-medicine” and the then 
planned Institute for Medical Genome Research and Systems Biology (IMGuS) 
as an example for how new, national fields of competence can be established 
successfully. Systems biology is also mentioned as a field of research where a 
need for catching up is attested (Rat für Forschung und Technologieentwick-
lung 2005a). In its ‘Strategy 2010’ (Rat für Forschung und Technologieent-
wicklung 2005b) the envisioned IMGuS is mentioned as one of three leading 
biotechnology research institutes worldwide (ibid: 24). The plan to establish 
IMGuS as a major Austrian research centre was later abandoned due to a lack 
of funding resources – a sudden lack of already assigned money explained by 
the necessity to spend it for the establishment of IST Austria (Ungerböck 
2006a, 2006b). This also coincides with a general stagnation in science fund-
ing during this period and a related lack of uncommitted funds for new initia-
tives. 
The Austrian Science Board (Österreichischer Wissenschaftsrat, the “main 
advisory body to the Federal Minister of Science and Research”18) in its state-
ment on the ‘Austrian science’s excellence formation’ (Österreichischer Wis-
senschaftsrat 2007), mentions systems biology as one promising focus for the 
then newly planned Institute for Science and Technology Austria (IST Aus-
tria, inaugurated in 2009), because it links to existing research in Austria, but 
also complements it in important aspects with a view to international devel-
opments (ibid: 3). Two years later (Österreichischer Wissenschaftsrat 2009), 
the board’s recommendations for the Austrian higher education and science 
system mention the establishment of theoretical systems biology at an extra-
university institute in the first half of the 20th century (one of the scarce refer-
ences to systems biology’s Austrian forerunners in policy documents and 
media) as well as the present-day computational and molecular systems biol-
ogy institutes and the Center for Organismal Systems Biology (COSB) at the 
University of Vienna. They criticise the structural heterogeneity and dispersion 
of life science research in Vienna and recommend further integration, but do 
not promote any specific line of research (like for instance systems biology). 
In 2010, the Austrian Federal Ministries of Science and Research (BMWF), 
for Transport, Innovation and Technology (BMVIT) and of Economy, Family 
and Youth (BMWFJ) commissioned an Austrian Research and Technology 
Report (Schibany et al. 2010). This report mentions systems biology as a life 
science research field in which Austria participates in an ERA-NET and in 
transnational initiatives (medical systems biology and ELSA-GEN). The es-
tablishment and further integration of systems biology in Austria are also men-
tioned as goals for the second and third phase of GEN-AU (ibid: 157-158). 
However, the label ‘systems biology’ did not gain a very prominent role in 
                                                           
17 http://www.rat-fte.at/home_en.html, accessed April 11th, 2012. 
18 http://www.era.gv.at/space/11442/directory/11818.html, accessed April 11th, 2012. 
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the later phases of GEN-AU. Neither the web presentation nor project titles 
feature systems biology prominently, although some of the activities funded 
by GEN-AU are viewed as systems biology research or as contributions to 
establishing such an approach by relevant experts (like, for instance, the Bio-
informatics Integration Network, see chapter 6). The GEN-AU initiative itself 
will end in 2012 without (foreseeable) replacement, thereby abandoning this 
line of ‘label-oriented’ (here: genomics-oriented) research funding. 
The rapid establishment of the new label in the international scene, its great 
success in attracting funding and scientific interest in some countries and the 
observable national differences alone warrant a closer examination from a 
science studies point of view. Moreover, systems biology is often invested 
with the ability to revolutionise the life sciences19 and our understanding of 
nature, as well as to enable the precise modelling, simulation and engineering 
of living systems (the latter under the label of ‘synthetic biology’) and thereby 
to revolutionise societal contexts (in reference to the ‘Industrial Revolution’ 
or the ‘Green Revolution’20). From a critical point of view (the perspectives 
of science and technology assessment or ‘ethical, legal and social aspects of 
science and technology’ research), it is a lack of terminological clarity (of the 
term ‘systems biology’ itself as well as of terms like ‘system’), the challenges 
raised by the prerequisite interdisciplinary collaboration (especially between 
in vitro and in silico sciences) as well as by other needs of integration (e.g., 
multi-level integration of genomics, proteomics, metabolomics, interactomics, 
etc.), standardisation issues, the quality of its output (proof of principle, re-
affirmation of existing knowledge or fundamentally new insights), the feasi-
bility of the envisaged approaches (like, for instance, whole-cell-modelling), 
their applicability in industry and medicine and the overall ‘Big Science’ ap-
proach pushed by some systems biology research initiatives (Krohs and Calle-
baut 2007, O’Malley and Dupré 2005, Vermeulen 2011). From a socioethics 
point of view, O’Malley et al. (2007) add a more detailed discussion of criti-
cal aspects of systems biology associated with in silico testing, cultural un-
derstandings of life, biological modification and commercialisation.  
From the perspective of technology assessment, several potential applications 
of systems biology merit closer attention. Among these range  
1. in silico models developed for pharmaceutical drug development and 
toxicological tests: such in silico models are the product of close collabo-
rations between experimental life science research and in silico computa-
tion and modelling with a view to specific contexts of application. They 
raise critical questions about the kind, quality and applicability of knowl-
edge produced via such in silico models. It is still under debate inhowfar 
in silico tests can replace tests run via test animals, in which ways they 
might be even more apt to draw conclusions concerning the toxicity of 
specific substances or treatments to humans and in which ways they might 
be less reliable or necessitate an adaption of the overall risk management 
regime in this context. 
2. A further expansion of in silico research in the life sciences also exac-
erbates unsolved questions about property regimes at the intersection of 
biology and informatics. Biotechnology favoured patenting in the past, 
while computation and informatics feature a long-standing open source 
tradition. The combination of both precipitates decisions about where to 
apply which regulatory approach. 
                                                           
19 ERASysBio (2007) depicts systems biology as ‘biology’s Big Bang’. 
20 For instance in GEN-AU (2010: 5). 
epistemic and socio-
cultural implications of 
systems biology 
1   Introduction: systems biology as a new label __________________________________________________________________  7 
3. Systems biology’s close (if unclear) connection to synthetic biology and 
the latter’s ambition to ‘create life from scratch’ raises questions about the 
feasibility, desirability, safety, security, cultural meaning and acceptability 
of such claims and their realisation. The construction of living systems 
also blurs the boundary between what has so far been labelled as either na-
ture or artefact and thereby raises questions about regulatory regimes.  
4. Systems biology’s central role in the (projected) development of per-
sonalised medicine triggers questions about the feasibility of such a per-
sonalised approach, the related organisational changes in the health system 
it necessitates, its cost efficiency, social justice, data handling and privacy. 
Currently, most of these practical approaches are still in their infancy. A sound 
discussion of their feasibility, related best practices of innovation and possi-
ble concerns about unwanted side-effects is only possible if the current estab-
lishment and approaches of systems biology are understood in more depth. 
Moreover, systems biology – even if leading to no relevant applications in 
the near future – will leave its mark on the life science research landscape. A 
better understanding of its character and pattern of institutionalisation will 
help to reflect upon current shifts in academia and industrial research in na-
tional and international contexts. 
The following report aims at contributing to these discussions by 
• providing a detailed list of current systems biology research groups, in-
stitutes, centres and university courses in Austria, so as to render a more 
refined picture of its institutionalisation in this country, allow for a more 
informed observation of its further development in the national context and 
a more detailed comparison with other countries (chapters 5, 6, 7 and 8), 
• providing a list of systems biology experts in Austria, so as to prepare for 
expert participation in future science and technology assessment initiatives, 
• addressing the interdisciplinary and collaborative character of systems 
biology research by depicting the disciplinary affiliations of systems bi-
ologists in Austria and their positions in co-authorship networks (chapters 
3 and 4), 
• putting the current stage of establishment of systems biology into context 
by addressing relevant issues of investigating the establishment of emerg-
ing research fields (chapters 1 and 2). 
The report presented here is based upon research conducted within the project 
‘Towards a Holistic Conception of Life? Epistemic Presumptions and Socio-
Cultural Implications of Systems Biology’ (THCL), performed by the Research 
Centre for Biotechnology, Society, and the Environment (FSP BIOGUM) at 
the University of Hamburg (coordinator) and the Institute of Technology As-
sessment (ITA) at the Austrian Academy of Sciences. It is co-funded by the 
German Federal Ministry of Education and Research (BMBF) and the Aus-
trian Ministry for Science and Research (BMWF) within the transnational 
ELSA-GEN initiative (embedded in the Austrian FFG funding programme 
GEN-AU). Its Austrian sub-project ended in December 2011, whereas the 
German sub-project will last until April 2013, allowing for further empirical 
as well analytical work. 
Empirical data are based upon a thorough web-based investigation of re-
searchers, research projects, research institutes and research centres making 
use of the term ‘systems biology’. These results were followed up by 38 semi-
structured interviews and eleven informal conversations with experts in 2010 
and 2011 (predominantly systems biology researchers in Austria, comple-
mented by Austrian scientists from adjacent fields of research, Austrian sci-
general aims of 
investigating the 
establishment of systems 
biology in Austria 
the project ‘Towards  
a Holistic Conception  
of Life?’ (THCL) 
8 __________________________________________________________________  1   Introduction: systems biology as a new label 
ence policy experts and systems biology researchers in the UK).21 Addition-
ally, six systems biology symposia and conferences in Germany, the UK and 
Austria and two university courses were attended between September 2010 
and February 2012.  
While the main findings concerning the current state of systems biology in 
Austria are presented in this report, further analyses concerning more specific 
issues like interdisciplinary collaboration (cp. also Torgersen 2009) and com-
munity building within systems biology (Kastenhofer 2011, 2012), the rela-
tion of systems biology to science and engineering as well as to fundamental 
and applied research (Kastenhofer and Schmidt 2011a, 2011b), social aspects 
(Kollek et al. 2011, cp. also Kastenhofer 2010) and the governance of sys-
tems biology (Brüninghaus and Kastenhofer 2012) are (and will be) addressed 
in individual, peer reviewed journal papers. Ultimately, the transnational char-
acter of the underlying research project will allow for a more detailed com-
parison between systems biology in Austria and Germany. 
Besides the authors Karen Kastenhofer, Helge Togersen, Friederike Klein and 
Lea-Luise Klement, this report benefits from collaboration and exchange with 
Regine Kollek, Martin Döring, Anne Brüninghaus and Imme Petersen (FSP 
BIOGUM, University of Hamburg) and from all the expertise provided by our 
interview partners.  
 
 
 
                                                           
21 In this report, interview material is referred to in an anonymised mode, indicating 
the interview number (I 1, I 2, etc.). 
 2 General issues concerning systems biology 
and its establishment as a scientific field in 
a national context 
The analysis of the establishment of systems biology in Austria has to face 
some challenges that come with its research object, systems biology. These 
shall be addressed here, referring to expert interviews, primary and secondary 
literature. 
 
 
2.1 Investigating the establishment of a field early onwards 
As mentioned above, the term ‘systems biology’ has begun to spread widely 
within the scientific community only about a decade ago. The current use of 
the term goes with a definition of systems biology as “applying systems the-
ory to biology in the postgenomic era“ (Wolkenhauer et al. 2003: 39). Only if 
the latter part of this definition is ignored, one can start to delineate a longer 
history which “involved eminent researchers including Wiener, Kalman, Ber-
talanffy, Rosen and Mesarovic in the 1960’s” (ibid.). Although former theo-
retical approaches are partly incorporated in recent research, it is the combi-
nation of systems theory, computational models and –omics approaches that 
defines current systems biology. It is not seen as a necessary starting point for 
present day and future systems biologists to be familiar with the work of Nor-
bert Wiener, Ludwig von Bertalanffy or Robert Rosen. 
Hence, one can safely say that the ‘new’ systems biology is rather young and 
cannot yet count as an established scientific field. Systems biology institutes 
have had – at most – ten years to establish their own organisational and col-
laborative routines, their modes of research and training. Systems biologists 
can still be differentiated along different ‘generations’: a first generation still 
embedded in one discipline, acknowledging that there might be something of 
interest at the intersection of disciplines and exchanging ideas with scientists 
from other disciplines; a second generation with a multidisciplinary career 
track and the ability to apply all the various disciplinary tools and knowledge 
themselves; and a third generation that has already followed a curriculum in 
systems biology.22 Moreover, some prefer to call themselves systems biolo-
gists while others prefer to label themselves along more traditional catego-
ries, but tag part of their work as ‘systems biology’; still others avoid the 
term altogether while admitting that their research could also be labelled as 
‘systems biology’ and/or are seen as systems biologists by others (Kasten-
hofer 2012). 
As a result, there are multiple ‘ways of being’ within systems biology, of do-
ing systems biology and of setting up a systems biology institute. This multi-
plicity can be explained by the early stage of the ‘new’ systems biology’s de-
velopment as a research field. For Austria, it is safe to say that the new sys-
tems biology is in still earlier stages of institutionalisation than in other coun-
tries like the UK, Germany or Switzerland. During the years 2010 and 2011,  
 
                                                           
22 This differentiation was presented by one interviewed systems biologist (I 20). 
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when the empirical research for this project was conducted, the national insti-
tutional and collaborative landscape of systems biology changed a lot and – 
given the international success of the field – it is very likely that this develop-
ment has not yet come to a halt. Therefore, the current report can only offer a 
preliminary account of the state of systems biology in Austria. 
 
 
2.2 Investigating the establishment 
of a heterogeneous and interdisciplinary field 
Besides change over time, it is the heterogeneity of a field at a given time in 
history that challenges the analysis of its establishment. Systems biology is 
said to have different strands or sub-fields (like top-down, bottom-up and mid-
dle-out systems biology), it is defined in different ways by different scholars 
or schools (and discerned more or less rigorously from research that is not 
systems biology) and it is enacted in different ways by scientists stemming 
from different disciplines.  
Within the expert interviews, heterogeneity is partly attributed to different lo-
cal approaches. Specific research laboratories or institutes are seen as sites of 
specific schools, that then spread geographically. Heterogeneity is also 
connected to different research visions, research interests, research objects, 
research methods and to different (multi-)disciplinary arrangements.  
This heterogeneity results in systems biology not so much resembling one 
highly integrated scientific community, but rather a differentiated field that 
meets at annual conferences and publishes in systems biology journals, but 
also meets at more specialised symposia and workshops and publishes in sub-
group specific journals. The differentiation along different research traditions 
or schools also explains why systems biologists would mention very different 
names when asked about the most prominent colleagues within systems biol-
ogy or about a list of every systems biologist they would be aware of in Aus-
tria.23 
In all cases, multi- or interdisciplinarity is seen as a defining feature of sys-
tems biology research; the minimum requirement being the combination of 
‘wet’/‘experimental’ (biological, biochemical) and ‘dry’/‘theoretical’ (mathe-
matical, computational) sciences. An important role is also attributed to in-
formatics and (theoretical) physics. Finally, scientists trained in engineering 
fields – although not mentioned in the list of the most relevant disciplines – 
play a visible role within systems biology. Concerning the integration of ‘ex-
perimental’ and ‘theoretical’ sciences, systems biologists unequivocally ad-
vocate a symmetric relationship, void of hierarchically structured divisions of 
labour.  
 
 
                                                           
23 Besides, most interviewees also stress that they lack an overview of systems biology 
in Austria. 
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2.3 Investigating the establishment … of what? 
Systems biologists often remark on the lack of a clear definition of systems 
biology. Other than 19th century subject matter definitions like ‘botany’ or ‘zo-
ology’, or definitions that originated later onwards and determine the organ-
isational level of interest like ‘molecular biology’, ‘cell biology’, ‘population 
biology’ or ‘ecosystem research’, systems biology is understood as research 
that makes use of a specific kind of data (namely -omics data) by specific 
means (quantitative modelling), drawing on experimental approaches (every-
thing from medicine, to genetics, molecular biology and biochemistry) as well 
as theoretical approaches (mathematics, informatics) in a collaborative, inter-
disciplinary and iterative mode. Thereby, the definition of systems biology is 
far less specific concerning its subject matter (every biological entity can be 
represented as a system which would render ‘systems biology’ a tautology) but 
far more rigorous concerning its paradigms and research culture. 
Hence, to define systems biology is not trivial, but possible if one refers to its 
various disciplinary backgrounds, its historical emergence (linking it to spe-
cific theoretical and technological breakthroughs), its concrete research prac-
tices and its general vision. Differences between existing definitions can be ex-
plained by different (sub)disciplinary audiences (the aim to explain systems 
biology to molecular biologists results in different emphases than the aim to 
explain systems biology to physiologists, mathematicians or computer scien-
tists) and by different rigour.  
Different rigour results in wider or narrower definitions. An example for a 
definition that can be understood as a very wide approach (that is, if the ref-
erence to time and space is not interpreted as a reference to very specific re-
search methods) reads as follows: “Systems biology is a groundbreaking sci-
entific approach that seeks to understand how all the individual components 
of a biological system interact in time and space to determine the functioning 
of the system.” (Academy of Medical Sciences and The Royal Academy of 
Engineering 2007: 5); whereas an example of a somewhat narrower definition 
has already been quoted above as “applying systems theory to biology in the 
postgenomic era“ (Wolkenhauer et al. 2003: 39). The definition given by the 
Academy of Medical Sciences and The Royal Academy of Engineering (2007: 
5) also narrows down when adding that systems biology “allows insight into 
the large amount of data from molecular biology and genomic research, inte-
grated with an understanding of physiology, to model the complex function of 
cells, organs and whole organisms, bringing with it the potential to improve 
our knowledge of health and disease.” Overall, the more dimensions are in-
troduced in the definition, the more precise the boundary drawing becomes. 
Definitions also differ in the importance they attribute to modelling as a sine 
qua non of systems biology research (cp. also Wolkenhauer and Klingmüller 
2004). Within a call for project proposals issued by the EU funding initiative 
ERASysBio, the definition holds that “[s]ystems biology is an approach by 
which biological questions are addressed through integrating experiments in 
iterative cycles with computational modelling, simulation and theory. Model-
ling is not the final goal, but is a tool to increase understanding of the system, 
to develop more directed experiments and finally allow predictions.” (ERA-
SysBio 2008: 1-2) The Austrian annex to this call on the other hand does not 
mention modelling as a prerequisite component. Moreover, the Austrian GEN-
AU funding initiative put more emphasis on bioinformatics in more general 
terms than on modelling in a stricter sense when targeting systems biology 
research. 
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Much more complicated than defining systems biology is the task of under-
standing what kind of category ‘systems biology’ really represents. Is it a dis-
cipline, a sub-discipline, an inter-discipline, an approach, a vision, a paradigm 
or a way of doing science? All of these categories were mentioned in expert 
interviews; all of them would go with their own modes of definition, patterns 
of establishment and indicators of institutionalisation. Unfortunately, there ex-
ists no general agreement concerning this question in- or outside the scientific 
community. ‘Research area’ (Wolkenhauer et al. 2003) or ‘field of research’ 
(Wolkenhauer 2001) are just two terms that are broad enough to leave this 
question open. 
To understand what kind of category systems biology represents, it is also 
helpful to discern different contexts in which definitions of scientific fields 
are developed and made use of. Classical categories like ‘botany’ or ‘zoology’ 
were established in an academic context to demarcate general topics various 
scientists worked on. Hence, these labels offer orientation via categorisation 
to scientists, lay-men looking for experts and students choosing their univer-
sity curriculum. Outside universities and university curricula, such an absolute 
categorisation is less relevant.24 Extra-mural research institutions can invent 
any new label to point at their innovative character and build upon multi- or 
interdisciplinary approaches as they think useful. This also pertains to the con-
text of science funding.  
To better understand labelling practices in research funding that become in-
fluential in the use of terms like ‘systems biology’, general trends within this 
context have to be kept in mind (cp. also Blümel 2011). Science funding or, 
more broadly, research and development initiatives, follow one of at least three 
different models:25 bottom-up basic research funding agencies (research coun-
cils) like the Austrian FWF base their funding decisions on peer-review and 
individual quality assessment of each proposal; disciplinary categories play 
only an indirect role (e.g., the quality, availability or rigidity of reviewers may 
differ according to their disciplinary identity, thereby favouring some fields 
over others; multi- or interdisciplinary approaches may be discriminated due 
to a lack of reviewers who value interdisciplinary add-ons) as does the label-
ling of a research approach. Mission-oriented funding bodies and programmes 
(mission agencies) often define a general problem that should be solved or at 
least addressed by the funded research. Such missions link to Big Science con-
texts like the Manhattan project or the Human Genome Project, where specific 
outcomes like the building of the atom bomb or the deciphering of the humane 
genome were targeted. Mission oriented research is funded by national minis-
tries within national and international funding initiatives (like some FFG ini-
tiatives in Austria or the EU frame work programmes) with an aim to encour-
age research that is otherwise neglected and promises to contribute to the 
common good (national competitiveness or societal sustainability). A third fund-
ing strategy seems to be a blend between the former two: funding initiatives 
target specific research fields or approaches with a more implicit or indirect 
link to a concrete mission. Such initiatives seem to be mostly label-oriented 
at first sight. This tradition is well illustrated by the U.S. based National Nano-
technology Initiative of the National Science Fund, but also by initiatives tar-
                                                           
24 Hence the saying “society has problems, universities have departments”. 
25 The first and second model mentioned here represent the ‘classical models’; the third 
model is newly introduced by the authors. Alternatively, one could also think of even 
more refined models or subsume ‘label-oriented funding’ under ‘mission-oriented 
funding’. Interestingly, the third funding model stands for a targeted policy that is 
pursued by research councils or ministries. This combination runs counter to the 
twofold classification, along which research councils and ministries follow a bottom-
up funding policy while targeted programmes are initiated by mission agencies. 
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geting systems biology or synthetic biology. The Austrian GEN-AU funding 
initiative by the FFG could be assigned to this category, targeting genomics.26 
The Gernan BMBF initiatives targeting systems biology research also fall un-
der this category. Earlier initiatives in Germany targeted fields like bionics, 
cybernetics and artificial intelligence (Aumann 2011).  
It is against the background of a growing importance and impact of such label-
oriented funding approaches that the emergence of terms like ‘systems’ or 
‘synthetic biology’ can be better understood as will become even clearer in the 
following section. The use of terms like ‘systems biology’ not only points at 
a specific research approach, but also at a specific – namely a strategic fund-
ing – discourse; just like the use of the term ‘biotechnology’ not only invokes 
the idea of a specific research field but also a connection to technology-based 
innovation and industrial revolutions. 
 
 
2.4 Discussing the establishment of an actual research field, 
a label or a hype? 
Besides the fuzziness of the category ‘systems biology’, that challenges its 
epistemic value, there exists a general unease within the scientific community 
about its use. The general unease, with which the term ‘systems biology’ is 
sometimes met, is also directed to other terms like ‘synthetic biology’ (Nature 
Biotechnology 2009), ‘nanotechnology’ (Wullweber 2008) or ‘converging tech-
nologies’ (Coenen 2008).27 Historians of science have also detected it for ‘cy-
bernetics’ and ‘bionics’ (Aumann 2011). This unease is mirrored in accusa-
tions that systems biology was a mere ‘buzzword’ or, along the terminology 
of discourse theory, an ‘empty signifier’ (Wullweber 2008). Such accusations 
brand a strategic use of the term with political motives combined with a lack 
of meaning in a scientific context. They also refer to the power of hype-cycles 
within industrial and public funding policies. Hype-cycles are thought to be 
spurred by new terms that go with a revolutionary vision, while promising to 
solve the already established list of major societal problems (cancer, hunger, 
climate change and economic competitiveness). 
It is the threefold reference to a lack of epistemic value, to political instrumen-
talisation and to an ever growing over-hyping within research and development 
fields that can render the use of the term ‘systems biology’ suspect. If the 
term is seen as a buzzword or at least as a label that only makes sense in the 
political, but not the epistemic sphere, than those who use the label to describe 
their research or their scientific affiliation are suspect; that is, under the as-
sumption that science is a solely epistemic undertaking that has to be protected 
from social or political influences.  
Wolkenhauer and Klingmüller (2004: 22) highlight a second cause why ‘sys-
tems biology’ might be criticised of buzzword-ism. “For any emerging area 
of research there is a risk that at some point in future it is looked at as a buzz-
word with all its negative connotations. There are two main causes for this to 
happen: individuals (mis)use the new term as a means to attract research fund-
                                                           
26 In Austria, label-oriented research funding seems not to be very popular among 
politicians as well as scientists. 
27 Terms like ‘molecular biology’ or ‘biochemistry’ also had to struggle with critique 
in the beginning, but are established labels now. Other terms like ‘cybernetics’ were 
controversially discussed and have never been fully embraced in academia. 
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ing through relabeling old ideas and without actually embracing new ap-
proaches. Secondly, an area can simply fail for scientific reasons to realise the 
promises it made.” 
This second cause is linked to the hype-patterns of the R&D sphere when 
scientists in systems and synthetic biology articulate the fear that ‘the bubble 
may burst’.28 Over-hyping leads to the formulation of audacious promises con-
cerning the scientific as well as technological potentials of new approaches. 
These promises include the kind of innovation, the time horizon of its realisa-
tion and its potential to solve societal problems. Currently, the need to formu-
late promises of all kinds to attract funding is perceived as still rising, where-
as the failure to fulfil these promises is seldom sanctioned with direct meas-
ures. All actors involved seem to be well aware that scientific breakthroughs 
cannot be guaranteed for or predicted with precision. At the same time, there 
is a fair chance that money spent for scientific research will lead to some kind 
of innovation, be it in the form of new data, technologies, insights or applica-
tions. 
Critique of buzzword-ism comes not as much from the public or from critical 
science studies (the latter in fear of ‘jumping on the bandwagon’ themselves, 
when contributing to the over-hyping of a field with their research on ‘ethi-
cal, legal and social implications’ of fields that do not really exist yet, cp. 
Nordmann 2007, Williams 2008), but from the scientific community. Scien-
tists engaged in systems biology feel that they take the term very seriously and 
therefore invest a lot of effort in realising its claims (like a very elaborate in-
terdisciplinary collaboration, the development of complex models, the produc-
tion of sound and useful data, etc.) and thereby lose out on colleagues who use 
the term more lightly. Scientists who follow different research approaches and 
avoid using the new label fear to lose money and reputation for their own re-
search approaches that are being hyped to a lesser degree. Both groups com-
plain about a general decline of terminological precision and ‘anything goes’-
attitudes. Their critique can be seen as a struggle for limited resources as well 
as a defence of scientific and terminological soundness.  
Use of language also has a cultural component and national context. Most of 
present day research labels have been launched in the USA,29 including ‘syn-
thetic biology’, ‘systems biology’, ‘nanotechnology’ and ‘converging technol-
ogies’ or funding slogans like ‘Atoms for Peace’, ‘War against Cancer’ or 
‘Human Enhancement’. This national contextualisation might not be as much 
of a bone of contention for scientists who perceive themselves already as 
global players and it is certainly not regarded as a disadvantage in the eyes of 
politicians who aim at ‘narrowing a trans-continental innovation gap’ and safe-
guarding national competitiveness by following the US example. Nevertheless, 
it does have some potential to raise public unease given a rather ambivalent 
opinion about US American culture and industry.  
As for systems biology, the critique of buzzword-ism and the reluctance to 
make use of the new label seem to be significantly more pronounced among 
Austrian scientists than in other countries. With the available data, this situa-
tion becomes evident, but is difficult to explain. Some scientists refer to a 
rather conservative attitude within the Austrian research landscape that would 
also have led to a relatively late establishment of molecular biology some 30 
years ago; others mention a lack of expertise in contributing fields like bioin-
formatics at the time when systems biology was introduced. One might also 
                                                           
28 A formulation put forward by a British systems biology researcher (I 1). 
29 Although the first uses and definitions of these terms are sometimes of European 
origin. 
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explain the cautious attitude by more general effects of scale concerning both, 
the scale of the existing scientific community (and hence its ability to cover 
all specialities) and the scale of science funding (which was especially re-
stricted during the period of interest). Hence, the establishment of national re-
search networks, the funding of new, multidisciplinary centres and the par-
ticipation in large EU funded projects are more challenging. The historical fact 
that one prominent forerunner of systems biology, Ludwig von Bertalanffy, 
stems from Austria and initiated the reading of a ‘theoretical biology’ at the 
University of Vienna already in the 1940ies does not really seem to affect this 
situation.30 
 
 
2.5 Why then investigate the establishment of a new research field? 
The arguments made above all highlight the difficulty of investigating the es-
tablishment of a new research field. They also highlight the danger of contrib-
uting to science governance in a negative way, by ‘jumping on a bandwagon’ 
that is fuelled by a buzzword; a risk that is almost unavoidable as each use of 
a term conveys the message that the denoted field really existed and carried 
some relevance. Why, then, should one be interested at all? 
General arguments for investigating the establishment of new research fields 
hold that  
• an engagement with research fields early onwards in their development 
leave more room for constructive interaction between the dominant con-
ception of the new research field, alternative standpoints, societal interests 
and R&D policies, 
• processes of R&D formation, institutionalisation and routinisation are 
per se interesting subjects of investigation, allowing for further insights in 
the then prevalent general patterns and logics of change 
• during transitional phases, general aspects of R&D become more evident 
and are voiced more explicitly by all actors involved than during more stable 
phases, hence allowing for a better understanding of general patterns and 
logics at work in R&D, 
• in its early phase, the development of research fields seems to be influenced 
more strongly by their national contexts than later onwards when stable in-
ternational research communities exist; investigating these early, to some 
extent formative phases, allows for insights into the specificities of national 
innovation regimes. 
It has to be added here that all these promising goals are somewhat challenged 
by a lack of validated models of how innovation in science and technology 
really comes about. Societal ideas about such innovation seem to have gone 
through at least three paradigmatic stages, all of which still influence our cur-
rent perception: a first stage where science and technology were really seen as 
two distinct fields and scientific research was more closely affiliated to scien-
tific education than to technological application (illustrated by the Humbold-
tian university model); a second stage (with Vannevar Bush as its most promi-
nent promoter) where science and technology were seen as interlinked by a 
linear, unidirectional process; and a third stage (sometimes associated with 
                                                           
30 Von Bertalanffy’s membership in the NSDAP cannot be left unmentioned here, al-
though it is not widely known of and therefore is unlikely to have affected the re-
cent take-up of his work (or lack thereof).  
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the term ‘technoscience’) where scientific and technological innovation are 
seen as so closely interwoven that any kind of funding will result in all kinds 
of innovation. All three models co-exist simultaneously today and shape cur-
rent science and science policy discourse.31 Basic research, applied research 
and product development are sometimes distinguished (to argue for the auton-
omy of basic research, the public funding of applied research or the regula-
tion of product development), sometimes they are depicted as causally related 
(to advertise the economic and societal benefits of basic research funding), 
sometimes they are conflated (for instance when promoting label-oriented 
funding initiatives or different levels of private-public partnerhip). Overall, 
the eclectic reference to one of the three models invokes the impression that 
scientific breakthroughs and technological innovation are linked by more or 
less simple cause-effect relations and hence can be predicted and planned for.  
For systems biology research, the media as well as funding policy documents 
advertise the foreseeable production of revolutionary “new ideas, new tools 
and new data”, a radical change in our views “about how cells self-regulate, 
how life becomes more complex, how diseases develop and how evolution 
operates.” (ERASysBio 2007: 6) These are accredited with the potential to 
revolutionise the (bio)pharmaceutical sector, estimating “that cell-based sys-
tems biology in the USA could reduce drug discovery costs by € 330M and 
reduce development times by three years for each drug released to the mar-
ket.” (ibid.: 13) Overall, systems biology is said to promise “enormous eco-
nomic and social impact, probably comparable to that in the 20th century from 
advances in physics, which provided electrification, radio communication, 
electronics, telephony, internal combustion engines, atomic energy and the 
internet.” (ibid: 15) Individual scientists support such hopes, promising a com-
plete model of the brain in 10 years (ibid.: 16) or the completion of “a detailed 
and comprehensive simulation model of the human cell at an estimated error 
margin of 20 percent by the year 2020” and the identification “of the system 
profile for all genetic variations, drug responses, and environmental stimuli by 
the year 2030.” (Kitano, 2001: 25) 
Scientists, when directly asked in interviews, point at the fact that they cannot 
really predict breakthroughs. They feel confident to predict incremental change 
to some extent and to envisage which new insight or technology could revo-
lutionise their field of research. But when this new insight or technological 
innovation is going to be achieved, by whom and by what means, is mostly 
left open. Also, they admit that innovation might go into totally different, un-
foreseen directions and that predicted (epistemic or technological) revolutions 
might not happen at all. As for time spans, the interviewed scientists mention 
two different time horizons: one of about three to five years, equalling an av-
erage project length (or length of a PhD project); and one of about 20 years, 
which seems to refer to a time horizon that cannot really be overseen. Such 
uncertainties about the logics of innovation, its direction and time-scales per-
sist among theoreticians of science as well as scientists and contribute to the 
problem of ‘bursting bubbles’ mentioned above. Their explication still helps 
to get a better grasp of innovation potentials in science and technology in the 
sense that prevalent uncertainties, ambiguities and gaps of evidence are ad-
dressed and specified. The hope is that their explicit description helps to take 
some steam out of the current over-hyping that is seen as detrimental by all 
interviewed scientists unequivocally. 
 
                                                           
31 The very idea that the three stages followed one after the other in history is con-
tested by some experts as is the announcement of a technoscience era (cp. Forman 
2007), their current parallel existence seldom is. 
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2.6 Investigating the establishment of 
a transnational research network from a national perspective 
Scientific progress is commonly perceived to take place in a global sphere. 
The empirical investigation of systems biology in Austria also shows that in-
ternational networks are far more important in the formation of research pro-
jects and in co-authorship selection than national networks. Still, the quality, 
speed and dimension of the establishment of systems biology in academia 
and industry differ considerably between the various national contexts. This 
situation is clearly linked to varying funding contexts and varying traditions 
of institutionalising science and research.  
Moreover, the heterogeneity of systems biology approaches and its differen-
tiation into schools seem to have a geographical component. The explanation 
of this pattern can draw upon the fact that epistemic approaches are some-
times developed in a very local context, closely linked to specific research 
laboratories and individual promoters of a specific approach; and it can also 
draw on the idea that – even though science is a transnational undertaking – a 
kind of national science culture exists.  
The presented study opted for a national perspective, focusing on the Austrian 
context. Thanks to some additional research undertaken in the UK and the 
close collaboration with the German sub-project its results can also be com-
pared to the British and the German context. Based on this national approach 
and the transnational comparison, it is possible to describe national specifici-
ties in more detail and to ask about their possible causes and consequences. 
Thereby, the close link between funding initiatives, institutional settings and 
the establishment of systems biology in Austria becomes more visible. Addi-
tionally, the specific challenges and opportunities an innovative, interdisci-
plinary and collaborative research approach faces in a small country with re-
stricted resources can be highlighted. As noted by Marcus (2008), “the chal-
lenge is to find the ‘right-size’ science level for each problem”, somewhere 
between “the ‘small-science’ doctoral student looking at one DNA sequence 
to large international ‘big-science’ teams trying to develop computer models 
of mulitilevel physiological systems”. (ibid: 14) 
 

 3 Academic societies, research institutions, 
research groups and individual researchers 
dedicated to systems biology in Austria 
3.1 Method of inquiry 
This chapter presents an overview of academic societies, networks, institutions 
and individual researchers dedicated to systems biology in Austria (as of De-
cember 2011). Shortcomings of such an overview result from a difficulty to 
discern systems biology activities from non-systems biology activities (due to 
the heterogeneity of approaches and boundary drawings mentioned above) and 
a lack of quality, completeness, homogeneity and up-dating of web based data 
sources that formed the main bases of this investigation. Moreover, this sur-
vey does not necessarily allow conclusions concerning the importance of the 
individual institutions and researchers enlisted within the international systems 
biology community. 
Systems biology networks, research institutions and researchers are enlisted 
based upon 
• an internet search for systems biology research in Austria,  
• a search for systems biology projects in the databases of funding institu-
tions, namely the Vienna Science and Technology Fund (WWTF)32, the Aus-
trian Science Fund (FWF)33, and the Austrian Research Promotion Agency’s 
(FFG) programme Genome Research in Austria (GEN-AU)34 
• a search for publications since 2000 with ‘systems biology’ in title, topic or 
keywords in the Web of Science35. 
The list of research actors also allows for drawing a map of systems biology 
research in Austria. The list of publications was further used for a co-author-
ship analysis. Furthermore, this report includes a list of the main funding in-
stitutions for systems biology research in Austria and gives an overview of 
how systems biology is embedded in the Austrian higher education system by 
enlisting past and current courses in systems biology. 
In order to further categorise the prevalent research actors, three different cate-
gories were developed. These categories help to give an overview by indicat-
ing the individual actor’s centrality within a national systems biology land-
scape. Here, again, we had to rely on the prominence of the label ‘systems 
biology’ in given profiles, combined with types of institutionalisation. For the 
full list of institutions and their descriptions, see chapters 6, 7 and 8. 
 
                                                           
32 Source: http://www.wwtf.at/, accessed June 12th, 2011. 
33 Source: http://www.fwf.ac.at/index.asp, accessed June 12th, 2011. 
34 Source: http://www.gen-au.at/index.jsp?lang=de, accessed June 12th, 2011. Unfor-
tunately, the FFG does not provide a publicly accessible data bank storing infor-
mation about all funded projects. Therefore, the search was restricted to the GEN-
AU web site. Using its search option and the keywords ‘systems biology’ and 
‘Systembiologie’, all projects resulting from this search were registered. 
35 Source: http://wokinfo.com/, accessed June 19th, 2011. 
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Category I includes all societies, networks and institutions with ‘systems bi-
ology’ in the title, in their main goal definition or/and the disciplinary affilia-
tion of the director or head. The category is divided into academic societies & 
networks, institutions and research groups, depending on whether the whole 
institution/society/network or only one or more research groups work are dedi-
cated to systems biology. 
Characterisations presented for category I institutions in chapter 6 consist of 
following data (depending on data availability): a short profile (including type 
of institution, address, founding year, head, disciplinary profile, beginning of 
systems biology research and researchers involved in systems biology) and a 
more detailed account (delineating approach, staff, research groups, research 
projects, cooperation partners, teaching and publications). 
Category II includes all academic societies, networks and institutions with 
‘systems biology’ mentioned in projects or texts. 
Characterisations presented for Category II institutions in chapter 7 offer (de-
pending on data availability) short profiles and a short account (including all 
available information on staff, research groups, research projects, cooperation 
partners, teaching and publications). 
Category III enlists all institutions that published one or more papers in the 
field of systems biology (‘systems biology’ in title and/or among keywords) 
and do research on the latter to an unknown degree. 
Characterisations presented for Category III institutions in chapter 8 give the 
address, systems biology relevant experts, systems biology projects and sys-
tems biology publications published and researchers involved in systems bi-
ology. Sometimes, short descriptions are added. 
 
 
3.2 Overview of systems biology in Austria 
As noted above, the list of institutions and scientists dedicated to systems bi-
ology can be depicted geographically. This map provides a first overview of 
systems biology in Austria, including an attribution of institutions to catego-
ries I to III (Figure 5). 
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Figure 5: Map of systems biology research in Austria with attribution to categories I to III 
VIENNA 
z Austrian Society of Systems Biology (ÖGSB)  
z Center for Organismal Systems Biology (COSB)/Univ. of Vienna 
z Research Center for Molecular Medicine (CeMM)/ÖAW 
z Department of Computational Systems Biology/Univ. of Vienna 
z Department of Molecular Systems Biology/Univ. of Vienna  
z Institute for Medical Genome Research and Systems Biology (IMGuS) 
z Research Institute of Molecular Pathology (IMP)  
z Department of Biotechnology/BOKU 
z Department of Pathophys. and Allergy Research/Med. Univ. of Vienna 
z Department of Medicinal Chemistry/Univ. of Vienna  
z Department of Genetics in Ecology/Univ. of Vienna  
z Department of Theoretical Biology/Univ. of Vienna  
z Institute for Theoretical Chemistry/Univ. of Vienna 
z Max F. Perutz Laboratories/Univ. of Vienna & Medical Univ. of Vienna 
z Institute of Technology Assessment (ITA)/ÖAW 
z Emergentec Biodevelopment GmbH 
z Viscovery Software GmbH 
z + 30 x Category III (see section 7) 
ALTENBERG 
z Konrad Lorenz Institute (KLI) 
KLOSTERNEUBURG 
z Institute of Science and 
Technology Austria (IST Austria) 
HAGENBERG 
z Software Competence Center 
Hagenberg (SCCH) 
LINZ 
z Johann Radon Institute for 
Computational and Applied 
Mathematics (RICAM)/ÖAW 
z Biophysics Inst./ 
Johannes Kepler Univ. Linz 
z Research Institute for  
Symbolic Computation/ 
Johannes Kepler Univ. Linz 
INNSBRUCK 
z Oncotyrol – Center for Personalized Cancer Medicine 
z Biocrates Life Sciences AG 
z Inst. for Bioinformatics and Translational Research/UMIT 
z Department of Pharmacognosy/Univ. of Innsbruck 
z Inst. of Analytical Chemistry and Radiochem.  
(Horvath Laboratory for Bioseperation Sciences)/ 
Univ. of Innsbruck 
z Division of Bioinformatics/Innsbruck Med. Univ. 
z Division of Cell Biology/Innsbruck Med. Univ. 
z Division of Physiology/Innsbruck Med. Univ. 
z Division of Human Genetics/Innsbruck Med. Univ. 
z Urology / Innsbruck Med. Univ. 
z Cardiac Surgery/Innsbruck Medical University 
z Nephrology and Hypertension/Innsbruck Med. Univ. 
z Institute for Biomedical Aging Research (IMB)/ÖAW 
GRAZ 
z Dpt. of Pharmaceutical Chemistry/Univ. of Graz 
z Institute of Molecular Biosciences/Univ. of Graz 
z Institute of Pathology/Med. Univ. Graz 
z Div. of Endocrinology and Metab./Med. Univ. Graz 
z Christian Doppler Laboratory for Genomics and 
Bioinformatics/Technical Univ. Graz 
Colour key: Category I
Category II
Category III
Acronyms: 
BOKU … University of Natural Resources and Life Sciences, Vienna 
ÖAW … Austrian Academy of Sciences
UMIT … Health and Life Sciences University Hall/Tirol
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3.3 Disciplinary orientation and background of category 
I and II academic societies, networks and research institutions 
Systems biology research is by definition an interdisciplinary undertaking. All 
definitions of systems biology emphasise this central feature and highlight 
the importance of a symmetrical relationship between experimental and theo-
retical approaches. Mostly, this symmetrical relationship is depicted by itera-
tive circles that link experimental and theoretical phases of research over time. 
Nevertheless, systems biology research also takes place in given institutional 
contexts. This leads to specific research approaches and accounts to some ex-
tent for the heterogeneity of the current international systems biology land-
scape. In most cases in Austria, systems biology research is embedded in in-
stitutions with a more specific disciplinary or thematic focus. This may or may 
not result in systems biology research approaches that have a disciplinary or 
thematic focus point. To get an idea about the possible disciplinary focus 
points or strengths of Austrian systems biology research, an attempt was made 
to categorise institutions and scientists along disciplinary affiliations (Table 1). 
Again, such a categorization can only provide a tentative picture. 
The categorisation of institutions follows their self-portraits.36 Institutions are 
characterized along their affiliation to biomedicine, biology, bioinformatics & 
mathematics, chemistry and/or philosophy of science. The category ‘biology’ 
mostly relates to molecular biology, genetics and microbiology. Only in the 
cases of the Institute of Theoretical Biology and the Center of Organismal 
Systems Biology (COSB), both at the University of Vienna, ‘biology’ has a 
different scope, focusing on evolutionary and developmental biology and on 
the organismic level within zoology and human biology.  
The categorisation of scientists is based upon their training, degrees and re-
search, with an emphasis on PhD and habilitation topics. Data were retrieved 
from curricula vitae available on the Internet. Scientists are characterised 
along their affiliation to biomedicine, clinical medicine, biology, bioinformat-
ics, mathematics, physics, chemistry and/or science & technology studies. 
The clustering of institutes with similar disciplinary foci in Table 1 (left side) 
shows a relative dominance of institutes with a primary focus on biomedicine 
or (molecular or micro-) biology. Only a handful of institutions with systems 
biology research groups feature a primary focus on bioinformatics & mathe-
matics (most notably: RICAM) or on chemistry (most notably: the Institute 
for Theoretical Chemistry). A dual focus on biomedicine AND bioinformat-
ics & mathematics or on biology AND bioinformatics & mathematics is rare 
at the institutional level, although examples exist (Oncotyrol, Dpt. of Compu-
tational Systems Biology, IST Austria).  
 
 
                                                           
36 The Institute of Technology Assessment (ÖAW) and the Department of Theoreti-
cal Biology (Univ. of Vienna) were not included in this analysis, because these in-
stitutions concentrate on meta-level questions relating to systems biology. Therefore, 
their contribution to systems biology research is of a different kind. Still, Manfred 
Drack from the Department of Theoretical Biology is mentioned as a researcher em-
bedded in COSB, as the Department of Theoretical Biology is a member of COSB 
and his publications are currently the only COSB-affiliated publications explicitly 
addressing systems biology. 
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A dual focus bridging in silico and in vitro research is nevertheless present 
within Austrian systems biology research. This becomes more evident when 
depicting the (sub-)disciplinary affiliations of individual scientists (Table 1, 
right side). At this level, physics and chemistry are much more present and 
bioinformatics and mathematics are slightly more present. 
The extent to which in silico and in vitro (or in vivo) research are combined 
within research could be further delineated when including (sub-)disciplinary 
affiliations at an organisational level below the one chosen here (divisions, 
departments, research groups). One could also include all members of a re-
search group additionally to their principal investigators and give more credit 
to multi-disciplinary careers of individual researchers, thereby featuring all 
(sub-) disciplinary resources available within the research process. These two 
aspects are not presented here, to the effect that it is only the (probable) pri-
mary disciplinary focus and not the overall interdisciplinary width that is de-
picted.  
Table 1: Primary disciplinary affiliations for category I and II research institutions  
(in alphabetical order, secondary affiliations hatched) and systems biology researchers 
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CeMM (Research Center for 
Molecular Medicine)/ÖAW 
          Superti-Furga, G.                 
 
Institute of Pathology/ 
Medical University Graz 
          Zatloukal, K.                 
 
Dpt. of Pathophysiology and 
Allergy Research/MUW 
          Mechtcheriakova, 
D. 
                
 
Oncotyrol – Center for 
Personalized Cancer Medicine  
          Graber, A.                 
 
          Deigner, H.-P.                 
      Enot, D. P.                 
      Koal, T.                 
      Osprian, I.                 
Biocrates Life Sciences AG 
          Weinberger, K.                  
 
Institute for Medical Genome 
Research and Systems Biology 
(IMGuS) 
          Zacherl, N.                 
 
     Grabherr, R.                 Dpt. of Biotechnology/BOKU 
     Kreil, D. P.                 
 
          Weckwerth, W.                 Dpt. of Molecular Systems 
Biology/Univ. of Vienna           Wienkoop, S.                 
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Dpt. of Genetics in 
Ecology/Univ. of Vienna 
          Schleper, C.                 
 
          Hirt, H.                 Max F. Perutz Laboratories  
          Kuchler, K.                 
 
          Mechtler, K.                 Research Institute of 
Molecular Pathology (IMP)            Stark, A.                 
 
          Mayer, B.                 
      Mühlberger, I.                 
      Perco, P.                 
Emergentec Biodevelopment 
GmbH  
          Wiesinger, M.                 
 
Center for Organismal 
Systems Biology (COSB) 
     Drack, M.         
 
          Rattei, T.                 Dpt. of Computational Systems 
Biology/Univ. of Vienna           Widder, S.                 
 
          Bollenbach, T.                 
       Guet, C.                 
The Institute of Science and 
Technology Austria  
(IST Austria)  
          Henzinger, T.                 
 
          Engl, H. W.                 
      Kugler, P.                 
      Lu, J.                 
Johann Radon Institute for 
Computational and Applied 
Mathematics (RICAM)/ÖAW  
          Schmeiser, C.                 
 
     Graber, A.                 Institute for Bioinformatics 
and Translational 
Research/UMIT  
     Dehmer, M.                 
 
          Flamm, C.                 
      Hofacker, I. L.                 
Institute for Theoretical 
Chemistry/Univ. of Vienna  
          Schuster, P.                 
 
Dpt. of Medicinal Chemistry/ 
Univ. of Vienna 
          Noe, C.                 
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3.4 The geography of Austrian systems biologists 
Besides their disciplinary and institutional affiliation, one can also ask about 
the past national affiliations of systems biologists currently working in Aus-
tria. Such an analysis of the ‘geographic past’ of key players within Austrian 
systems biology allows for a more detailed analysis of the current state of 
globalisation within this community.  
Searching through data on individual career tracks available on the internet, 
three different data sets were prepared (as of March 20th, 2012):  
• the country in which systems biologists currently active in Austria 
completed their PhD 
• the country they stayed in before moving to Austria 
• the length of time they have already spent in Austria without cease until 
now. 
Again, the reliability of these data is limited by the reliability of the on-line 
data sources and, in a few cases, the attribution to a specific category was not 
unequivocal. Still, the overall results are likely to be fairly robust. 
Of 31 systems biologists currently working in Austria (of the 40 systems bi-
ologists identified earlier onwards, those nine that work in companies were 
ignored because their national affiliations were difficult to ascertain and their 
influence on the academic field is likely to be less strong), 58 % completed 
their PhD in Austria. Another 23 % completed their PhD in Germany; 10 % 
in the US and 3 % (i.e., one person) each in the UK, Russia and Switzerland 
(Figure 6). 
 
Figure 6: Country in which the PhD was completed 
Of these same 31 scientists, 49 % held their last position in Austria, while 26 % 
moved to Austria from Germany, 13 % from the US and 3 % (one person) each 
from the UK, Switzerland, Spain and Norway (Figure 7). 
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Figure 7: Country in which the last position was held taking into account the 
past 12 years. 
As for the length of time these 31 scientists have been staying in Austria 
without major interruptions, 26 % only have moved to Austria in or after 
2009; 26 % have moved to Austria in or after 2000; and 35 % have been stay-
ing in Austria at least for the past twenty years (Figure 8). 
 
Figure 8: Length of time spent in Austria without interruption before 2011 
Overall, these results show that of 31 academic systems biology researchers 
currently working in Austria, around three quarters have spent most of their 
scientific career in Austria or Germany, the only other geographic context more 
than one scientists stems from being the US. Some scientists moved to Ger-
many or the US (or Spain or Norway) for a longer time period37 after complet-
ing their PhD in Austria and returned back to Austria afterwards. 
 
                                                           
37 Stays shorter than one year were not taken into account. 
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Moreover, one quarter of the 31 systems biologists currently active in Austria 
has only moved to Austria during the past years, when systems biology al-
ready represented an internationally recognized focus of life science research. 
Another quarter has moved to Austria between 2000 and 2009, a phase of es-
tablishment of systems biology in the international context and of a genera-
tional turn-over at Austrian universities. Another one third has been staying 
in Austria all along, showing a geographical stability not atypical for earlier 
generations of scientists but less common nowadays.38  
 
 
3.5 Timeline of systems biology in Austria 
Besides the ‘early school of systems biology’ in Vienna, represented by the 
scientists Hans Leo Przibram, Paul A. Weiss and Ludwig von Bertalanffy 
(Drack et al. 2007) and situated at the ‘Biologische Versuchsanstalt’ in the Vi-
ennese Prater (1902-1947) as well as at the University of Vienna (until Berta-
lanffy’s suspension in 1945 and his permanent leave in 1947), current ‘new’ 
systems biology research centres, institutes, departments, groups and compa-
nies have not been established before 2000 (see Figure 9). The Research Center 
for Molecular Medicine (CeMM) at the Austrian Academy of Sciences is one 
of the first of such foundations; it represents until now the only big research 
centre dedicated to systems biology and situated in its own building (offi-
cially opened in 2010) in Austria. The establishment of CeMM was followed 
by the creation of an Austrian Society of Systems Biology and of two small, 
systems biology affiliated companies, Biocrates Life Sciences AG and Emer-
gentec Biodevelopment GmbH around 2002. A major milestone regarding 
broader capacity building for systems biology research in Austria was set in 
2003 with the start of the Bioinformatics Integration Network and the Aus-
trian Proteomics Platform funded by the GEN-AU programme of the FFG.  
In the following years, a few individual research groups strengthened their fo-
cus on systems biology or were newly established with an explicit focus on sys-
tems biology. This includes research groups at the department of biotechnology 
at the BOKU, at the departments of medicinal chemistry and of theoretical 
biology as well as at the institute for theoretical chemistry at the University of 
Vienna, at the department of pathophysiology and allergy research at the Medi-
cal University of Vienna, at the Institute of Molecular Pathology (IMP), at the 
newly established RICAM of the Austrian Academy of Sciences, at the newly 
established Max F. Perutz Laboratories, at the newly established Center for Per-
sonalised Cancer Medicine (Oncotyrol), at the newly established institute for 
bioinformatics and translational research at the UMIT, at the Software Com-
petence Center Hagenberg (SCCH) and at the newly established IST Austria.  
The long envisioned Institute of Medical Genome Research and Systems Biol-
ogy (IMGuS) came to life around 2006 in the form of a coordinatory platform 
for two systems biology research projects. Around 2009, another company, Vis-
covery Software GmbH, started contributing to a systems biology project. And 
in 2009 and 2010, two new institutes dedicated explicitly to molecular and 
computational systems biology opened their doors at the University of Vienna. 
 
                                                           
38 A methodical investigation of such more general patterns would allow for a better 
validation of this conclusion we mostly derived from expert interviews. Unfortu-
nately, it is currently not available for the Austrian context. 
‘old’ and ‘new’  
systems biology 
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 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
CeMM/ÖAW       Cen                         
RICAM/ÖAW          Inst.         SB research group 
Dpt. of Molecular Systems Biology/Univ. Vienna                Dpt.       
Dpt. of Computational Systems Biology/Univ. Vienna                          Dpt.     
Center for Organismal Systems Biology (COSB)               
Dpt. of Pathophys. & Allergy Res./Med. Univ. Vienna: Mol. Syst. Biology & Pathoph.    Dpt.             SB research group 
Inst. for Medical Genome Research and Systems Biology (IMGuS)                     Inst.             
Res. Inst. of Mol. Pathology (IMP) 1985 Inst.                             SB research groups 
Austrian Society of Systems Biology (ÖGSB)/BOKU                    Soc.                   
Dpt. of Biotech./BOKU: Sys. Bio. Gr. Dpt.            SB research group 
Dpt. of Biotech./BOKU: Bioinf. Chair 1968                         Bioinformatics and SB chair 
IST Austria: Design and Analysis of Concurrent and Embedded Systems               Inst.       
IST Austria: Biophysics and Systems Biology               Inst. SB research group 
IST Austria: Systems and Synthetic Biology of Genetic Networks               Inst. SB research group 
Oncotyrol – Center for Personalized Cancer Medicine: Bioinformatics & Systems Biology              Cent.       
Austrian Proteomics Platform                    Pf.                   
Bioinformatics Integration Network        Nw.          
Inst. for Theor. Chem./Univ. Vienna 1945 Inst.                         SB research & teaching group 
Dpt. of Genetics in Ecology/Univ. Vienna             Dpt. SB projects 
Dpt. of Med. Chemistry/Univ. Vienna          Dpt.               
Dpt. of Theoretical Biology/Univ. Vienna          Dpt           SB proj 
Max F. Perutz Laboratories (MPL)             L               
Inst. for Bioinformatics and Transl. Research/UMIT                                   Inst.   
Institute of Technology Assessment (ITA)/ÖAW   Inst.                             SB projects 
Software Competence Center Hagenberg (SCCH)       Cent.                   SB projects 
Biocrates Life Sciences AG          AG                     
Emergentec Biodevelopment GmbH              G.               SB projects  
Viscovery Software GmbH  G.                             SB projects 
Figure 9: Beginning of systems biology focus at Austrian universities, extra-university research institutes and companies. Dark green colouring: explicit systems biology focus 
(hatched: unclear level of activity); light green colouring: systems biology relevant activities; grey colouring: philosophy and sociology of science activities; dark frames 
indicate the establishment of the entity the systems biology activities are situated at (centres, institutes, departments, platforms, networks and companies)
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3.6 Co-authorship networks of 
Austrian and international systems biology researchers 
The analysis of co-authorship networks allows for delineating scientific col-
laboration among researchers.39 Thereby, it is important to keep in mind that 
a cluster of connected authors doesn’t necessarily mean that they represent a 
coherent group. For example, author A co-authored a paper with author B and 
another paper with author C. Although authors B and C are connected by au-
thor A, authors A, B and C do not necessarily represent a coherent group or 
school. 
To get a first impression, two small scale co-authorship analyses of Austrian 
systems biology researchers and international systems biology researchers were 
conducted.  
Austrian systems biology researchers were selected by the criteria of being 
part of an institution of Category I or II, and having publications since 2000 
with ‘systems biology’ in title, topic or keywords (based on Web of Science 
database40). This led to a result of 40 ‘Austrian’ systems biology researchers 
(for a list and full names see annex). ‘Austrian’ is thereby defined as ‘based at 
an Austrian institution in the year 2011’. It has to be noted here, that many of 
these scientists have moved to an Austrian research institute only a few years 
ago.41 All publications by these 40 authors since 2000 were included in the 
network analysis. 
International systems biology researchers were selected by the criterion of 
having publications with ‘systems biology’ in title, topic or keywords in the 
Web of Science database since 2000 (7092 publications match this character-
istic). The 100 authors with the highest number of systems biology publica-
tions were then selected (based upon the Web of Science list, corrected for 
inconsistencies). See annex for a full list. 
The network analyses were performed with the programme Pajek42 and re-
sulted in two co-authorship networks: 
1. Co-authorship network of 40 Austrian systems biology researchers  
(all publications since 2000 in Web of Science) 
2. Co-authorship network of Top-100 systems biology researchers and Aus-
trian systems biology researchers (systems biology publications since 2000 
in Web of Science)  
All visualisations depict authors as nodes and co-authored papers as lines (with 
distance, thickness of lines and/or values indicating the number of papers).  
                                                           
39 Due to restricted resources, a more detailed analysis, including co-citation analy-
ses, could not be performed within this project.  
40 http://apps.webofknowledge.com/, accessed Sept. 14th, 2011. 
41 In addition to the high geographical mobility of scientists, Austrian universities face 
somewhat of a generation change at the moment, with many (Austrian) professors 
retiring at the same time and their positions being filled with new (international) 
candidates or being transformed into new chairs which are then also filled with 
new (international) candidates. The former mode of ‘Hausberufung’ (filling a posi-
tion with a candidate stemming from the same institution and hence also the same 
country) is thereby abandoned. Due to language constraints, most of the international 
candidates stem from Germany. A more detailed analysis and reliable description of 
this observable generation change would necessitate a methodological investigation. 
42 Source: V. Batagelj, A. Mrvar: Pajek – Program for Large Network Analysis, 
http://vlado.fmf.uni-lj.si/pub/networks/pajek/, accessed Sept. 14th, 2011. 
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3.6.1 Co-authorship network of Austrian systems biologists 
In Figure 10, the co-authorship network of Austrian systems biology research-
ers is arranged in a circle. Small circles indicate authors belonging to the same 
institution; circle colours indicate the main disciplinary focus of this institution.  
Co-authorship is realised preferably within a single institution, whereas inter-
institutional collaboration seems to be more common in medical fields. Very 
little co-authoring takes place in the areas of biology, physics/chemistry, bio-
informatics and technology assessment. Interdisciplinary co-authoring occurs 
between medicine and biology, biology and bioinformatics, and bioinformat-
ics and physics/chemistry. 
 
3.6.2 Co-authorship networks of Austrian systems biologists  
and top-100 international systems biologists 
Figure 11 depicts a co-authorship network for the top-100 international sys-
tems biology researchers (most papers with ‘systems biology’ in title, topic or 
keywords) and all Austria-based systems biologists. Top-100 systems biology 
authors are represented by red nodes (among them Wolfram Weckwerth as 
the only Austrian representative), all other Austrian systems biologists are re-
presented by blue nodes. Only publications with ‘systems biology’ in title, 
topic or keywords are considered for co-authorship links.  
The network is visualized based upon automatic layout generation (algorithm 
Kamada-Kawai in Pajek); components were optimized separately (a few man-
ual adjustments enhance visibility of nodes and edges). Authors who did not 
co-author papers with the top-100 international systems biology researchers 
are listed on the right side of Figure 9.  
Besides the international network, there are two separate conceivable Austrian 
networks: the Biocrates Life Sciences AG (Koal, Deigner, Enot) and a second 
cluster consisting of the Institute for Theoretical Chemistry at the University 
of Vienna (Schuster, Flamm), the Johann Radon Institute for Computational 
and Applied Mathematics at the Austrian Academy of Sciences (Engl, Kügler, 
Lu) and the Department of Computational Systems Biology at the University 
of Vienna (Widder).  
The authors Noe (Department of Medicinal Chemistry, University of Vienna), 
Schleper (Department of Genetics in Ecology, University of Vienna) and Drack 
(Department of Theoretical Biology, University of Vienna) are linked to the 
international systems biology network via individual publications with Wester-
hoff. Wienkoop and Weckwerth (Department of Molecular Systems Biology, 
University of Vienna) show even stronger links to the international network. 
Graber co-authored papers with Westerhoff and Holmes and therefore links the 
Institute for Bioinformatics and Translational Research to the big network 
component. This institute is also linked to the Biocrates Life Sciences AG 
(Osprian, Weinberger) and Emergentec Biodevelopment GmbH (Mayer, Perco, 
Wiesinger, Mühlberger). Superti-Furga (CeMM, Austrian Academy of Sci-
ences) shows the strongest co-authorship activity with international systems 
biologists. 
intra- and inter-
institutional, intra- and 
interdsiciplinary  
co-authorship networks 
national and 
international  
co-authorship networks 
3.6   Co-authorship networks of Austrian and international systems biology researchers ____________________________________  31 
 
 F
ig
ur
e 
10
:  
Co
-a
ut
ho
rs
hi
p 
ne
tw
or
k 
of
 A
us
tri
an
 sy
ste
m
s b
io
lo
gy
 re
se
ar
ch
er
s (
W
eb
 o
f K
no
wl
ed
ge
TM
 d
at
ab
as
e,
 J
an
 1
st
, 2
00
0 
– 
Se
pt
. 1
4t
h , 
20
11
) 
32 _______  3   Academic societies, research institutions, research groups and individual researchers dedicated to systems biology in Austria 
 F
ig
ur
e 
11
: 
Co
-a
ut
ho
rs
hi
p 
ne
tw
or
k 
of
 A
us
tri
an
 sy
ste
m
s b
io
lo
gi
sts
 a
nd
 to
p-
10
0 
sy
ste
m
s b
io
lo
gi
sts
 b
as
ed
 u
po
n 
sy
ste
m
s b
io
lo
gy
 p
ub
lic
at
io
ns
  
(W
eb
 o
f K
no
wl
ed
ge
TM
 d
at
ab
as
e,
 J
an
 1
st
, 2
00
0 
– 
Se
pt
. 1
4t
h , 
20
11
) 
3.6   Co-authorship networks of Austrian and international systems biology researchers ____________________________________  33 
 
Overall, Austrian scientists do not publish extensively under the label of ‘sys-
tems biology’. Austrian systems biologists seem to either concentrate on col-
laborating with other Austrian systems biologists or to concentrate on collabo-
rating with systems biologists based in other countries (Graber, Wienkoop 
and Weckwerth being the only authors with national as well as international 
systems biology co-authorships). The general level of Austrian systems bi-
ologists’ international integration is rather low. Moreover, networking between 
Austrian systems biology research groups is still scarce – presumably in its 
beginnings.43 
 
                                                           
43 Recent networking activities like the ‘Workshop at the Interface of {Molecular Bi-
ology U Medicine} and {Computational U Applied Mathematics}’ organised jointly 
by RICAM and CeMM on February 16th, 2012 point at a possibly stronger trans-
institutional integration in the near future.  

 4 University courses in systems biology 
In order to get an overview of how systems biology is embedded in Austrian 
university curricula, all online university teaching databases were searched for 
lectures with ‘systems biology’ or ‘Systembiologie’ in their title (as of June 6th, 
2011). The results were summarized in historical order.44 Additionally, all 
universities of applied sciences’ (‘Fachhochschulen’) databases were searched 
for courses featuring ‘systems biology’ or ‘Systembiologie’ in their title (as of 
October 1st, 2011). For these, only the current curricula are taken into account 
(due to a lack of data about previous courses). 
In total, 18 courses targeting ‘systems biology’ or ‘Systembiologie’ were found, 
with the first course starting in 2004 (see Table 2). The results show that most 
of the courses are being or have been held at the University Vienna (ten 
courses), followed by the Technical University of Graz (two courses) and the 
University of Natural Resources and Life Sciences (Universität für Boden-
kultur, BOKU), the Health and Life Sciences University (Private Universität 
für Gesundheitswissenschaften, medizinische Informatik und Technik, Hall 
in Tirol, UMIT), the University of Salzburg and the FH Joanneum – Univer-
sity of Applied Sciences, the FH Campus Vienna – University of Applied Sci-
ences and the FH Hagenberg – University of Applied Sciences Upper Austria 
with one course each. This leaves many research institutions that are doing 
systems biology research without any teaching addressing this topic as a ma-
jor theme, although the total number of courses has been increasing during the 
last years. Furthermore, courses in systems biology are not held each semester 
at each site. They are predominantly held as lectures, with only a few interac-
tive seminars and hands-on practical courses.  
Systems biology courses include: 
• Grundlagen der Systembiologie [Fundamentals of systems biology]  
(Univ. of Vienna, Institute for Theoretical Chemistry) 
• Aktuelle Technologien in der Systembiologie [Current technologies in 
systems biology] (Univ. of Vienna, Center for Molecular Biology,  
Dpt. for Biochemistry and Cellbiology) 
• Einführung in die Anwendung der Systembiologie in den pharmazeutischen 
Wissenschaften [Introduction into the application of systems biology in the 
pharmaceutical sciences] (University of Vienna, external lecturer in 
pharmacy) 
• Evolution und Systembiologie [Evolution and systems biology] 
(University of Vienna, external lecturer in pharmacy) 
• Bioinformatik und Systembiologie [Bioinformatics and systems biology] 
(University of Vienna, Dpt. of Computational Systems Biology) 
• Grundlagenpraktikum Systembiologie [Practical course in systems 
biology] (Univ. of Vienna, Dpt. of Computational Systems Biology) 
• Current Topics in Computional and Systems Biology – Literature seminar 
(University of Vienna, Dpt. of Computational Systems Biology) 
• Ausgewählte Kapitel aus Biomathematik/Mathematische Methoden der 
Systembiologie [Selected chapters from biomathematics/mathematical 
methods in systems biology] (Univ. of Vienna, Institute of Mathematics) 
                                                           
44 Not all on-line databases go back to the same year; therefore the information pro-
vided for courses in distant years is incomplete to varying degrees. 
marginal role of systems 
biology in university 
curricula 
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• Plant Metabolism – Plant Systems Biology: modern methods in Systems 
Biology, metabolomics, proteomics (University of Vienna, Dpt. of Molecular 
Systems Biology) 
• Analytical Methods in Systems Biology (University of Vienna,  
Dpt. of Molecular Systems Biology) 
• Systembiologie [Systems biology] (BOKU, Institute of Applied 
Microbiology) 
• Systembiologie [Systems biology] (TU Graz, Institute of Molecular 
Biotechnology) 
• Formal Methods for Systems and Synthetic Biology  
(TU Graz, Signal Processing and Speech Communication Lab) 
• Systembiologie [Systems biology] (UMIT) 
• Systems Biology of Human Diseases (Univ. of Salzburg,  
Dpt. of Cell Biology) 
• Einführung in die Systembiologie [Introduction to systems biology]  
(FH Joanneum – University of Applied Sciences) 
• Systembiologie [Systems biology] (FH Campus Vienna – University of 
Applied Sciences) 
• Ausgewählte Kapitel der Systembiologie [Selected chapters of systems 
biology] (FH Hagenberg – Univ. of Applied Sciences Upper Austria). 
Whether systems biology represents a constitutive part of lectures and semi-
nars with a broader thematic scope (not mentioning it in the title), is more 
difficult to assess. A few unsystematic conversations with students do not hint 
into such a direction; rather, explicit reference to systems biology seems to be 
restricted to a few courses.  
Also, systems biology seems to elicit much lower interest among students than, 
for instance, at some British or German universities with established systems 
biology curricula. This lack of enthusiasm resonates with the dominant (criti-
cal) opinion among university teachers, a scattered teaching programme and a 
lack of visible career opportunities in Austria. Whole curricula, PhD or mas-
ter programmes in systems biology do not exist in Austria at the moment. 
At the extra-curricular level, it is noteworthy to mention the biannual, inter-
national FEBS (Federation of the European Biochemical Societies) “Advanced 
Lecture Course on Systems Biology”. It was first held in 2005 in Gosau (Up-
per Austria), then again in 2007, 2009 (in Alpbach, Tyrol) and 2011 (in Inns-
bruck, Tyrol). It is steered by Hans Westerhoff (The Netherlands, UK), Karl 
Kuchler (AT), Edda Klipp and Ursula Kummer (DE), Frank Bruggeman and 
Anneke Koster (NL), Uwe Sauer (CH) and Jacky Snoep (RSA). 
The situation of higher education in systems biology in Austria also has to be 
assessed against a broader (although not very fiercely held) international de-
bate about how systems biology can and should be taught. Especially, at which 
point systems biology teaching should set in during higher education curric-
ula (at pre-graduate, post-graduate, PhD or masters level), and how it should 
introduce interdisciplinarity (teaching each required discipline additively or 
teaching transdisciplinary contents and skills). With new generations of scien-
tists, systems biology could either become a (trans)discipline in its own right or 
stay an inter- or even multi-discipline that builds upon previous, (sub-)dis-
ciplinary specialisations.  
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Table 2: Systems biology courses at Austrian universities (including ‘Fachhochschulen’). Courses are ordered along universities  
and these according to the first introduction of such courses. Lectures are coloured in green, practical courses and seminars in pink. 
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Systembiologie BOKU Biotechnology Grabherr, Rüker, 
Bayer, Striedner  
3 VO X  X  X  X  X  X  X    X 
Aktuelle Technologien in der Systembiologie Univ. of 
Vienna 
Molecular 
Biology 
Schüller, Köcher 2 VO  X  X  X  X  X  X      
Grundlagen der Systembiologie Univ. of 
Vienna 
Molecular 
Biology 
Flamm 3 VO      X  X  X  X  X  X  
Einführung in die Anwendung der 
Systembiologie in den pharmazeutischen 
Wissenschaften 
Univ. of 
Vienna 
Pharmacy Aszódi (2) VO     X             
Evolution und Systembiologie Univ. of 
Vienna 
Pharmacy Aszódi 2 VO       X           
Bioinformatik und Systembiologie Univ. of 
Vienna 
Computer 
Science 
Aszódi; Rattei 
since WS 10 
3 VU        X  X  X  X  X  
Ausgewählte Kapitel aus Biomathematik 
(Mathematische Methoden der 
Systembiologie) 
Univ. of 
Vienna 
Mathematics Hofbauer 5 VO         X         
Analytical Methods in Systems Biology Univ. of 
Vienna 
Biology Weckwerth, 
Tanaka 
1 VO           X       
Plant Metabolism – Plant systems biology: 
modern methods in systems biology, 
metabolomics, proteomics 
Univ. of 
Vienna 
Biology Weckwerth, 
Wienkoop, 
Hadacek 
3 VO             X  X  X 
Grundlagenpraktikum Systembiologie Univ. of 
Vienna 
Biology Widder, Ekker 5 SE               X  X 
Current Topics in Computional and Systems 
Biology – Literature seminar 
Univ. of 
Vienna 
Biology Widder, Rattei 2 SE               X  X 
Introduction in the Evolutionary Systems 
Biology – What do ‘Big-Data-Approaches’  
add to our understanding of systems? 
Univ. of 
Vienna 
Biology Pavlicev 3 VO                 X 
Systems Biology of Human Diseases Univ. of 
Salzburg 
Molecular 
Biology 
Mewes  2 VO       X  X  X  X  X  X 
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Systembiologie TU Graz Botanics, 
Biotechnology 
Blank, Glieder, 
Schneideler, 
Hartner 
(5) VO         X  X  X  X  X 
Formal Methods for Systems and Synthetic 
Biology 
TU Graz n/a Köppl (3) VO           X  X  X  ? 
Systembiologie UMIT n/a Baumgartner n/a VO            X      
Einführung in die Systembiologie FH 
Joanneum  
Applied 
Bioanalytical 
Sciences 
n/a 2 VO                X  
Systembiologie FH Campus 
Vienna 
Molecular 
Biotechnology 
(Master) 
n/a 1 VO                X  
Ausgewählte Kapitel der Systembiologie FH 
Hagenberg 
Biomedical 
Informatics 
(Master) 
n/a 5 UE+V
O 
                X 
 
 
 5 Category I institutions 
For each institution, short descriptions and profiles are presented. Uncertain 
data are indicated by an asterisk (*). Source of information is the official web-
site of the institution unless otherwise stated.  
The category ‘systems biology projects’ mentions projects funded within the 
6th and 7th Framework Programme of the EU45, within the two European 
ERANET funding initiatives ERASysBio46 and SysMO47, within the national 
GEN-AU funding initiative of the FFG48 or by the national funding agency 
FWF49.  
The category ‘systems biology publications’ refers to publications published 
between 1/2000 and 7/2011 with ‘systems biology’ in title, topic or keywords 
found in Web of Science50. 
 
 
5.1 Academic societies & networks 
5.1.1 Austrian Society of Systems Biology (ÖGSB) 
Short description51: Reingard Grabherr is chairwoman of the society since 
2003, which is also assumed to be its founding year. Another member of the 
ÖGSB is Wolfgang Ernst52. 
Address: n/a 
Website: n/a 
Founded: 2003* 
Systems biology since: 2003* 
Chairwoman: Reingard Grabherr 
Further members: Wolfgang Ernst 
Type: academic society 
Disciplinary profile: n/a (food science and biotechnology) 
Systems biology projects: n/a 
Courses in systems biology: n/a 
Systems biology publications: n/a 
                                                           
45 http://cordis.europa.eu/search/index.cfm?fuseaction=proj.advSearch,  
accessed March 13th, 2012. 
46 http://www.erasysbio.net/index.php?index=311, accessed March 5th, 2012. 
47 http://www.sysmo.net/, accessed April 2nd, 2012. 
48 As mentioned earlier, the FFG unfortunately does not provide a publicly accessible da-
tabank storing information about all funded projects. Therefore, the search was re-
stricted to the GEN-AU web site. Using its search option and the keywords ‘systems 
biology’ and ‘Systembiologie’, all projects resulting from this search were registered. 
49 http://www.fwf.ac.at/index.asp, accessed June 12th, 2011. 
50 http://apps.webofknowledge.com/, accessed July 19th, 2011. 
51 https://forschung.boku.ac.at/fis/suchen.person_uebersicht?sprache_in= 
de&menue_id_in=101&id_in=4804, accessed June 25th, 2011. 
52 Source: http://www.systemsbiology.at/team/show/id/15, accessed June 30th, 2011. 
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5.1.2 Center for Organismal Systems Biology (COSB)/ 
University of Vienna 
Short description: “The center unites eight departments devoted to research 
in organismal biology through the shared interest in understanding organisms 
as complex systems. This common scientific goal is approached through the 
integrated study of temporal and structural organization, of the dynamics of 
physiological, developmental, and evolutionary processes, and of the neuronal, 
mental, social, and environmental information flows in organismal systems.”  
The foundation of COSB can be seen as an effect of a university reform that 
was realised around 2005 and encouraged the establishment of multi-depart-
mental centres and as a reaction to the establishment of two new chairs under 
the labels of ‘molecular systems biology’ and ‘computational systems biology’ 
at the same campus (i.e., the ‘Biozentrum Althanstraße’). 
Address: A-1090 Vienna 
Website: http://www.univie.ac.at/Lebenswissenschaften/OrgSysBiol/osbiol.html 
Founded: 2009* 
Systems biology since: n/a 
Speaker: Gerd B. Müller, Department of Theoretical Biology 
Members: Dpt. of Anthropology, Dpt. of Behavioural Biology, Dpt. of 
Cognition Research, Dpt. of Evolutionary Biology, Dpt. of Integrative 
Zoology, Dpt. of Molecular Evolution and Development, Dpt. of 
Neurobiology, Dpt. of Theoretical Biology 
Type: association of eight university departments 
Disciplinary profile: diverse (organismal biology) 
Systems biology projects: n/a 
Courses in systems biology: n/a 
Systems biology publications: n/a 
 
 
5.2 Research institutions 
(centers, departments, institutes, companies) 
5.2.1 Research Center for Molecular Medicine (CeMM)/ 
Austrian Academy of Sciences 
Short description53: The Research Center for Molecular Medicine GmbH 
(CeMM) of the Austrian Academy of Sciences is a research institution in the 
area of molecular medicine (cancer, inflammation, immune disorders), chemi-
cal biology and bioinformatics. Founded in 2000 – which is also the estimated 
start of systems biology research – it has about 109 scientific staff members, 
working in 10 laboratories. Since 2005, Giulio Superti-Furga functions as 
scientific director.  
Address: Lazarettgasse 14, AKH BT 25.3, A-1090 Vienna 
                                                           
53 Source of information is the official website of the institution, unless otherwise stated: 
http://de.wikipedia.org/wiki/Forschungszentrum_f%C3%BCr_Molekulare_Medizin, 
accessed July 22nd, 2011. 
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Website: http://www.cemm.oeaw.ac.at/  
Founded: 2000 
Systems biology since: 2000* 
Head: Giulio Superti-Furga 
Other systems biology researchers: Denise P. Barlow, Andreas Bergthaler, 
Christoph J. Binder, Kaan Boztug, Sylvia Knapp, Robert Kralovics, 
Sebastian Nijman, Joanna Loizou,Thijn Brummelkamp, Keiryn L. Bennett, 
Jacques Colinge, Stefan Kubicek 
Type: research centre of the Austrian Academy of Sciences, GmbH 
Disciplinary profile: (systems biology): molecular medicine, chemical 
biology, bioinformatics 
Courses in systems biology: n/a 
Systems biology projects:  
I-FIVE (FP7-IDEAS)  
ASSET (FP7-HEALTH) 
Austrian Proteomics Platform II (FFG) 
Austrian Proteomics Platform III (FFG) 
Systems biology publications: 3 
Superti-Furga, G., 2005, Proteomics, systems biology and molecular medicine, 
Febs Journal 272, 433-434. 
Rix, U. and Superti-Furga, G., 2009, Target profiling of small molecules by 
chemical proteomics, Nature Chemical Biology 5(9), 616-624. 
Kocher, T. and Superti-Furga, G., 2007, Mass spectrometry-based functional 
proteomics: from molecular machines to protein networks, Nature Methods 
4(10), 807-815. 
 
5.2.2 Department of Computational Systems Biology/ 
University Vienna 
Short description54: The Department of Computational Systems Biology at 
the University of Vienna was founded in spring 201055. Currently, the depart-
ment has six staff members – with Thomas Rattei (Head) and Stefanie Widder 
as key systems biology researchers.  
Address: Althanstraße 14, A-1090 Vienna 
Website: http://compsysbio.univie.ac.at/ 
Founded: Spring 2010 
Systems biology since: Spring 2010 
Head: Thomas Rattei 
Other systems biology researchers: Stefanie Widder 
Type: university department – research & education 
Disciplinary profile (systems biology): (genome-orientated) bioinformatics, 
genomics 
                                                           
54 Source of information is the official website of the institution given below, unless 
otherwise stated. 
55 Source: http://ecology.univie.ac.at/fce-news/einzelansicht/article/department-
opening-on-june-25th-2010-department-of-computational-systems-biology/ 
?tx_ttnews%5BbackPid%5D=69894&cHash=557024b846e044440c26694902b8cb03, 
accessed June 20th, 2011. 
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Systems biology research projects: n/a 
Courses in systems biology56: 
SE Grundlagenpraktikum Systembiologie (English: practical course on 
systems biology), 5 ECTS (3h) 
SE Current Topics in Computional and systems biology – Literature seminar, 
2 ECTS, (2h) 
VU Bioinformatik und Systembiologie (English: Bioinformatics and systems 
biology), 3 ECTS (2h) 
Systems biology publications: 0 
 
5.2.3 Department of Molecular Systems Biology (MoSys)/ 
University Vienna 
Short description: The Department of Molecular Systems Biology was founded 
in 2009. Main systems biology researchers are Wolfram Weckwerth, Stefanie 
Wienkoop, Markus Teige and Volker Egelhofer.  
Address: Althanstraße 14, A-1090 Vienna 
Website: http://www.univie.ac.at/mosys/  
Founded: 2009 
Systems biology since: 2009 
Head: Wolfram Weckwerth 
Other systems biology researchers: Stefanie Wienkoop, Markus Teige, 
Volker Egelhofer 
Type: university department – research, education 
Disciplinary profile (systems biology): molecular plant physiology 
Systems biology research projects:  
EPISYSBIOL (FP7-PEOPLE) 
‘Leguminosen: Multilevelanalyse hin zur Trockenresistenz’ (FWF Eintelprojekt) 
‚PathoNet – Das Pflanzenimmunsystem’ (FFG, GEN-AU) 
Courses in systems biology57: 
PP Proteomics in systems biology (Wienkoop, Egelhofer, Weckwerth),  
10 ECTS (6h)  
VO Plant Metabolism – Plant systems biology: modern methods in systems 
biology, metabolomics, proteomics (Weckwerth, Hadacek, Wienkoop),  
3 ECTS (2h) 
PP Bioinformatics in Mass Spectrometry (Egelhofer, Weckwerth), 10 ECTS (6h) 
PP Metabolomics (Wienkoop, Weckwerth), 10 ECTS (6h) 
Systems biology publications: 9 
Agrawal, G. K., Job, D., Zivy, M., Agrawal, V. P., Bradshaw, R. A., Dunn, M. 
J., Haynes, P. A., van Wijk, K. J., Kikuchi, S., Renaut, J., Weckwerth, W. and 
Rakwal, R., 2011, Time to articulate a vision for the future of plant proteomics 
– A global perspective: An initiative for establishing the International Plant 
Proteomics Organization (INPPO), Proteomics 11(9), 1559-1568. 
                                                           
56 Source: http://online.univie.ac.at/vlvz?extended=Y, accessed June 30th, 2011. 
57 Source: http://online.univie.ac.at/vlvz?extended=Y, accessed June 20th, 2011. 
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Weckwerth, W., 2011, Unpredictability of metabolism-the key role of 
metabolomics science in combination with next-generation genome 
sequencing, Analytical and Bioanalytical Chemistry 400(7), 1967-1978. 
Wienkoop, S., Baginsky, S. and Weckwerth, W., 2010, Arabidopsis thaliana as 
a model organism for plant proteome research, Journal of Proteomics 73(11), 
2239-2248. 
Weckwerth W., 2010, Metabolomics: an integral technique in systems 
biology, Bioanalysis 2(4), 829-36. 
Kempa, S., Hummel, J., Schwemmer, T., Pietzke, M., Strehmel, N., Wienkoop, 
S., Kopka, J. and Weckwerth, W., 2009, An automated GCxGC-TOF-MS 
protocol for batch-wise extraction and alignment of mass isotopomer matrixes 
from differential (13)C-labelling experiments: a case study for photoauto-
trophic-mixotrophic grown Chlamydomonas reinhardtii cells, Journal of 
Basic Microbiology 49(1), 82-91. 
Lehmann, U., Wienkoop, S., Tschoep, H. and Weckwerth, W., 2008, If the 
antibody fails – a mass Western approach, Plant Journal 55(6), 1039-1046. 
Hoehenwarter, W., van Dongen, J. T., Wienkoop, S., Steinfath, M., Humme, J., 
Erban, A., Sulpice, R., Regierer, B., Kopka, J., Geigenberger, P. and Weck-
werth, W., 2008, A rapid approach for phenotype-screening and database 
independent detection of cSNP/protein polymorphism using mass accuracy 
precursor alignment, Proteomics 8(20), 4214-4225. 
Weckwerth, W., Baginsky, S., van Wijk, K., Heazlewood, J. L. and Millar, 
H., 2008, The Multinational Arabidopsis Steering Subcommittee for 
Proteomics assembles the largest proteome database resource for plant 
systems biology, Journal of Proteome Research 7(10), 4209-4210. 
Wienkoop, S., Morgenthal, K., Wolschin, F., Scholz, M., Selbig, J. and 
Weckwerth, W., 2008, Integration of metabolomic and proteomic phenotypes, 
Molecular & Cellular Proteomics 7(9), 1725-1736. 
 
5.2.4 Institute for Medical Genome Research and Systems Biology 
(IMGuS) 
Short description: The Institute for Medical Genome Research and Systems 
Biology (IMGuS) is headed by Nikolaus Zacherl. It has only been realised in 
a reduced form. The website lists one project, namely ‘Systems Biology of 
Steatohepatitits’ (see also below).  
Address: n/a 
Website: http://imgus.at/index.php?cat=02_Welcome 
Founded: n/a 
Systems biology since: 2006* 
Head: Nikolaus Zacherl 
Systems biology researchers: n/a 
Type: n/a 
Disciplinary profile: medical genome research, systems biology 
Systems biology research projects: 
‘Systems Biology of Steatohepatitis’: funding n/a 
‚Systems Biology of Prostate Cancer’: Nationalstiftung für Forschung,  
Technologie & Entwicklung and Austria Wirtschaftsservice (AWS) 
Courses in systems biology: n/a 
Systems biology publications: 0 
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5.3 Research groups 
5.3.1 @ Research Institute of Molecular Pathology (IMP) 
Short description: The Research Institute of Molecular Pathology (IMP) was 
founded in 1985 and is sponsored by the pharmaceutical company Boehringer 
Ingelheim GmbH & Co KG – but independent in research and governance. 
Together with Max F. Perutz Laboratories (MFPL), the Institute of Molecular 
Biotechnology (IMBA), the Gregor Mendel Institute (GMI) and several Bio-
tech companies, the IMP is part of the Campus Vienna Biocenter. Furthermore 
the IMP shares several so called ‘core facilities’ with other research institutes 
at the campus.  
More than 200 people work at the IMP (including scientific, administrative 
and technical staff). Managing directors are Barry Dickson and Harald Ise-
mann. Systems biology research probably started in 2008, when the Alexan-
der Stark – research group was first mentioned in the annual reports. Further-
more, Karl Mechtler (Head of the Mass Spectrometry & Protein Chemistry) 
published a paper in the field of systems biology. In total, 20 research groups 
work at the IMP. 
Address: Dr. Bohr-Gasse 7, A-1030 Vienna 
Website: http://www.imp.ac.at/  
Founded: 1985 
Systems biology since: 2008* 
Heads: Barry Dickson, Harald Isemann (Managing Directors) 
Systems biology researchers: Alexander Stark, Karl Mechtler 
Type: independent research institute mainly funded by Boehringer Ingelheim 
Disciplinary profile (systems biology): molecular biology, bioinformatics 
Systems biology research groups: 
Stark group 
Mechtler group 
Systems biology research projects: 
MEIOSYS (FP7-KBBE) 
REGULATORY GENOMICS (FP7-IDEAS) 
APO-SYS (FP7-HEALTH) 
MITOSYS (FP7-HEALTH) 
GENCODYS (FP7-HEALTH) 
EPIGENESYS (FP7-HEALTH) 
Austrian Proteomics Platform II (FFG, GEN-AU) 
Austrian Proteomics Platform III (FFG, GEN-AU) 
Austrian Network for Functional Mouse Genomics II (FFG, GEN-AU) 
Courses in systems biology: n/a 
Systems biology publications: 1 
Kocher, T., Pichler, P., Swart, R. and Mechtler, K., 2011, Quality control in 
LC-MS/MS, Proteomics 11(6), 1026-1030 
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5.3.2 @ Department of Biotechnology/ 
University of Natural Resources and Life Sciences (BOKU) 
Short description: The Department of Biotechnology was established with 
the Institute of Applied Microbiology in 1945 and focuses on research in the 
field of Biotechnology. Karola Vorauer Uhl is the current head of the Insti-
tute of Applied Microbiology. The institute consists of several working groups, 
one of them called ‘Systems Biology’ led by Reingard Grabherr. Since 2005, 
the Department has a WWTF endowment, establishing the Chair of Bioin-
formatics (BI). 
Address: Muthgasse 11,A-1190 Vienna 
Website: http://www.systemsbiology.at, 
http://www.biotec.boku.ac.at/333.html?&L=1  
Founded: 1945 
Systems biology since: 2003* 
Head: Karola Vorauer-Uhl  
Systems biology researchers: Reingard Grabherr, Wolfgang Ernst,  
David P. Kreil 
Type: university department – research, education 
Disciplinary profile: biotechnology; applied microbiology and virology 
Systems biology research groups: 
Systems Biology Group 
Chair in Bioinformatics (and Systems Biology) 
Systems biology research projects funded by the EU, ERASysBio,  
FWF or FFG:  
‘Stiftungsprofessur’/working group ‘bioninformatics/systems biology’ (WWTF) 
Courses in systems biology: 
VO Systembiologie (Reingard Grabherr) 3 ECTS (2h) 
Publications: 1 
Auburn, R.P., Kreil, D.P., Meadows, L.A., Fischer, B., Matilla, S.S., Russell, 
S., 2005, Robotic spotting of cDNA and oligonucleotide microarrays, Trends 
in Biotechnology 23 (7), 374-379. 
 
5.3.3 @ The Institute of Science and Technology Austria  
(IST Austria) 
Short description: The Institute of Science and Technology Austria (IST Aus-
tria) is a Ph.D. granting research and educational institution. Research at IST 
Austria is located in the field of basic natural and mathematical sciences (up 
to now mainly in the fields of evolutionary biology, cell biology and biophys-
ics, neuroscience, computer science). The current president is Thomas A. Hen-
zinger. The institute is not organised in departments but in independent re-
search groups with the goal of enhancing inter- and multidisciplinary research. 
At the moment, 17 research groups exist, of which two explicitly perform re-
search in the area of systems biology, namely the Bollenbach and Guet Group. 
Furthermore, the Henzinger Group published a paper in the field of systems 
biology.  
Address: Am Campus 1,A-3400 Klosterneuburg 
Website: http://www.ist.ac.at/ 
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Founded: 2009 
Systems biology since: 2009 
Head: Thomas A. Henzinger (president) 
System biology researchers: Calin C. Guet, Tobias Bollenbach 
Type: research & education institution (funded by the federal government 
Austrian & third-party funds) 
Disciplinary profile (systems biology): molecular (cell) biology, biophysics 
Systems biology research groups: 
Bollenbach Group: Biophysics and Systems Biology 
Guet Group: Systems and Synthetic Biology of Genetic Networks 
Henzinger Group: Design and Analysis of Concurrent and Embedded Systems 
Systems biology research projects: 
QUAREM (ERC Advanced Grant) 
Courses in systems biology: n/a 
Publications: 1 
Mateescu, M., Wolf, V., Didier, F. and Henzinger, T. A., 2010, Fast adaptive 
uniformisation of the chemical master equation, Iet Systems Biology 4(6), 
441-452. 
 
5.3.4 @ Johann Radon Institute for Computational and Applied 
Mathematics (RICAM)/Austrian Academy of Sciences 
Short description: RICAM (Johann Radon Institute for Computational and 
Applied Mathematics) was founded in 2003 at the Austrian Academy of Sci-
ences. It has several research groups and about 66 staff members. The research 
group ‘Mathematical Methods in Molecular and Systems Biology’ has seven 
staff members and first publications root back to 2008. Research group lead-
ers are Christian Schmeiser and Philipp Kügler. 
Address: Altenbergerstraße 69, A-4040 Linz, Austria 
Website: http://www.ricam.oeaw.ac.at/ 
Founded: 2003 
Systems biology since: 2008* 
Head: Heinz W. Engl 
Systems biology researchers: Christian Schmeiser, Philipp Kügler, James Lu 
Type: research institute 
Disciplinary profile: mathematics (systems biology modelling) 
Systems biology research groups: 
‘Mathematical Methods in Molecular and Systems Biology’ 
Systems biology research projects: 
Elucidating spatio-temporal coherence of cellular processes by data-driven 
inverse analysis: redox rhythmicity in yeast and diffusion controlled hormone 
feedback cycles (WWTF) 
Courses in systems biology: 
In 2007/2008 the RICAM institute held a special semester on quantitative 
Biology analyzed by Mathematical Methods. Biologists, physicists and 
mathematicians have been invited to discuss on problems in quantitative 
biology with a focus on bioimaging, biomechanics and chemotaxis, ion 
channels, pattern formation – and functional morphology and systems 
biology. Please see the Annex for more details. 
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Publications: 4 
Lu, James (2009) Inverse eigenvalue problems for exploring the dynamics of 
systems biology models. Advances in Applied Mathematics and Mechanics, 
Bd. 1 (6). 
Heinz W. Engl, Christoph Flamm, James Lu, Philipp Kügler, Stefan Müller, 
Peter Schuster (2009) Inverse problems in systems biology. Inverse Problems, 
Bd. 25 (12), S. 123014. 
H.W. Engl, S. Müller, J. Lu, P. Kügler (2008) Parameter identification in 
systems biology: solving ill-posed inverse problems using regularization. 
RICAM Report 2008-25. 
Flamm, C., Endler, L., Muller, S., Widder, S. and Schuster, P., 2007, A 
minimal and self-consistent in silico cell model based on macromolecular 
interactions, Philosophical Transactions of the Royal Society B-Biological 
Sciences 362(1486), 1831-1839. 
 
5.3.5 @ Oncotyrol – Center for Personalized Cancer Medicine 
Short description: Oncotyrol Center for Personalized Cancer Medicine is a 
private limited liability company with following shareholders: Medical Uni-
versity of Innsbruck, Leopold-Franzens University of Innsbruck, Tyrolean 
Health Insurance Fund (TILAK GmbH), Province of Tyrol (represented by: 
Tiroler Zukunftsstiftung/Location Agency for Business and Science and UMIT 
– University for Health Sciences, Medical Informatics and Technology) and 
CEMIT – Center of Excellence in Medicine and IT GmbH. It was founded in 
October 2010 with a duration time of four years (for the time being). In total, 
85 people work at Oncotyrol. There is no information available how many of 
them are involved in Area 5 (Bioinformatics & Systems Biology). The fol-
lowing (research) goal is stated by the company: “ONCOTYROL is an inter-
national partnership between academia and industry set up to accelerate the 
development and evaluation of individualized cancer therapies, along with di-
agnostic, prognostic and preventative tools.“58 Scientific head is Lukas Huber 
(Director of the Division of Cell biology at the Biocenter Innsbruck, Austria) 
and key people in systems biology research are Zlatko Trajanoski, Armin 
Graber, Matthias Dehmer and Reinhard Kofler.  
Address: Karl-Kapferer-Straße 5, A-6020 Innsbruck 
Website: www.oncotyrol.at  
Founded: 2008 
Systems biology since: 2008 
Heads: Bernhard Hofer (CEO), Lukas A. Huber (CSO) 
Systems biology researchers: Zlatko Trajanoski, Armin Graber, Matthias 
Dehmer, Reinhard Kofler 
Type: research company 
Disciplinary profile: bioinformatics, molecular biology data analysis 
Systems biology research groups: 
Area 5: Bioinformatics & Systems Biology 
Systems biology research projects: n/a 
Courses in systems biology: n/a 
Publications: 0 
                                                           
58 Source: http://www.oncotyrol.at/upload/file/Oncotyrol_Firmenprofil_2010_engl.pdf, 
accessed July 10th, 2011. 
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5.3.6 @ Department of Pathophysiology and Allergy 
Research/Medical University of Vienna 
Short description: The Department of Pathophysiology and Allergy Research 
at the Medical University was originally founded in 2000, but the website 
gives no information when it started to do research on systems biology. In to-
tal, the department has 21 research groups; one of them in the field of systems 
biology namely ‘Molecular Systems Biology and Pathophysiology’, headed 
by Diana Mechtcheriakova.  
Address: Währinger Gürtel 18-20, A-1090 Vienna 
Website: http://www.meduniVienna.ac.at/orgs/index.php?id=2461   
Founded: 2000 
Systems biology since: n/a 
Head: Erika Jensen-Jarolim 
Systems biology researchers: Diana Mechtcheriakova 
Type: university department – research, education 
Disciplinary profile: medical molecular biology 
Systems biology research groups: 
Diana Mechtcheriakova: Molecular Systems Biology and Pathophysiology 
Systems biology research projects: 
NUCSYS (FP6-MOBILITY) 
Courses in systems biology: n/a 
Publications: 0 
 
 
 
 6 Category II institutions 
6.1 Academic societies & networks 
6.1.1 Austrian Proteomics Platform (APP) I – III (1/2003 – 3/2012) 
Short description: The Austrian Proteomics Platform (APP) is a network 
funded by GEN-AU (FFG) and dedicated to research in the field of proteomics. 
In total, there are three funding periods. All three platform projects were co-
ordinated by Lukas A. Huber (Division of Cell Biology, Innsbruck Medical 
University). Only APP II and APP III include an explicit reference to systems 
biology; therefore APP I is not mentioned within the descriptions of the relat-
ing institutions. 
Austrian Proteomics Platform I (1/2003 – 3/2006; 1.977 310 €)59 
Subproject ‘Introducing New Proteomic Strategies in Veterinary Medicine’ 
(coordination: Ingrid Miller; Inst. for Medical Chemistry, University of 
Veterinary Medicine Vienna) 
Subproject ‘Novel Proteomics Tools’ (coordination: Karl Mechtler;  
IMP – Research Institute of Molecular Pathology) 
Subproject ‘Pharmaco-Proteomic Profiling of Chemokine/Co-Receptor 
Responses’ (coordination: Andreas Kungl; Inst. of Pharmaceutical Sciences, 
Univ. of Graz) 
Subproject ‘Phosphoproteomics of MAPK signaling’ (coordination: Christian 
Huck, Lukas Alfons Huber; Inst. of Analytical Chemistry and Radiochemistry, 
Univ. of Innsbruck) 
Austrian Proteomics Platform II (4/2006 – 5/2009; 2.250 000 €)60 
Subproject ‘Aufkonzentrierungs- und Trenntechnologien für den hohen 
Probendurchsatz in Proteomics, Metabolomics und Systembiologie’ 
(coordination: Günther Bonn, Christian Huck; Inst. of Analytical Chemistry 
and Radiochemistry, Univ. of Innsbruck) 
Subproject ‚Entwicklung selektiver Bioaffinitätsliganden und materialien zur 
qualitativen und quantitativen Untersuchung post-translationaler Modifikationen’ 
(coordination: Wolfgang Lindner; Inst. of Analytical Chemistry, Univ. of Vienna) 
Subproject ‚Entwicklung von Methoden zur Aufklärung des Proteoglykanoms’ 
(coordination: Andreas Kungl; Inst. of Pharmaceutical Sciences, Univ. of Graz) 
Subproject ‘Identifizierung und Quantifizierung von post-translationalen 
Modifikationen’ (coordination: Karl Mechtler; IMP – Research Institute of 
Molecular Pathology) 
Subproject ‘Medizinische Proteomics’ (coordination: Giulio Superti-Furga; 
CeMM – Research Centre for Molecular Medicine, Austrian Academy of 
Sciences) 
Subproject ‘Phosphoproteomics: Identifizierung neuer Substrate des 
Epidermalen Wachstumsfaktor/MAP Kinase Signalweges’ (coordination: 
Lukas Alfons Huber; Div. of Cell Biology, Med. Univ. of Innsbruck) 
                                                           
59 Source: http://www.gen-au.at/projekt.jsp?projektId=27&lang=en,  
accessed August 11th, 2011. 
60 Source: http://www.gen-au.at/projekt.jsp?projektId=52&lang=en,  
accessed August 11th, 2011. 
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Austrian Proteomics Platform III (4/2009-3/2012, 1.350 000 €)61 
Subproject ‘Chromatography, stationary phases, ESI-MS/MS, MALDI-TOF, 
MELDI, IR spectroscopy’ (coordination: Günther Bonn, Inst. of Analytical 
Chemistry and Radiochemistry, Univ. of Innsbruck) 
Subproject ‘Glyco-proteomics, protein complexes, biophysics, protein 
engineering, bioinformatics’ (coordination: Andreas Kungl; Inst. of 
Pharmaceutical Sciences, Univ. of Graz) 
Subproject ‘Interaction proteomics (TAP-tagging), drug proteomics, mass 
spectrometry, signal transduction, kinases’ (coordination: Giulio Superti-Furga; 
CeMM – Research Centre for Molecular Medicine, Austrian Academy of 
Sciences) 
Subproject ‘Qualitative and quantitative proteomics, top-down proteomics of 
intact proteins, multidimensional chromatography, mass spectrometry of 
biopolymers, bioinformatic tools for proteome analysis’ (coordination: 
Christian Huber; Dept. of Molecular Biology, Univ. of Salzburg) 
Subproject ‘Quantitative MS of post translational modifications, 
chromatography, mass spectrometry, interaction proteomics, top down 
proteomics’ (coordination: IMP – Research Institute of Molecular Pathology) 
Subproject ‘Signal transduction, mouse genetics, organelle- and phospho-
proteomics, protein complexes, 2D-DIGE, MALDI-TOF’ (coordination: Lukas 
Alfons Huber; Inst. of Analytical Chemistry and Radiochemistry, Univ. of 
Innsbruck) 
Subproject ‘Tagging chemistries and affinity materials for proteome analysis, 
chiral separations, capillary separation techniques and hyphenation of such 
techniques to mass spectrometry’ (coordination: Wolfgang Lindner; Inst. of 
Analytical Chemistry, Univ. of Vienna) 
 
6.1.2 Bioinformatics Integration Network (BIN) I – III 
Short description: The Bioinformatics Integration Network (BIN) is a net-
work funded by GEN-AU (FFG). It aims at integrating “the young Austrian 
bioinformatics research community” by “establishing bioinformatics services, 
research, networking, training for both researchers and industry”, an “Open 
Source platform of freely available source code” for an integrative research 
programme and “a national virtual laboratory”.62 In total, there are three fund-
ing periods. All three network projects were coordinated by Zlatko Trajanoski 
(2004-2010: Institute for Genomics and Bioinformatics, Graz University of 
Technology; 2010 – now: Section for Bioinformatics, Innsbruck Medical 
University). 
BIN I – III do not include an explicit reference to systems biology, although 
they are seen as a major contribution to the establishment of systems biology 
in Austria by some experts; therefore, they are presented here, but not men-
tioned within the descriptions of the relating institutions. 
 
 
 
                                                           
61 Source: http://www.gen-au.at/projekt.jsp?projektId=111&lang=en,  
accessed August 11th, 2011. 
62 http://www.gen-au.at/projekt.jsp?projektId=53&lang=en, accessed Feb. 4th, 2012. 
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Bioinformatics Integration Network I (1/2003 – 12/2005; 1.733 952 €)63 
“During this phase we established three thematic nodes with complementary 
expertise: (i) bioinformatics services and database integration, (ii) sequence 
annotation and (iii) structural genomics.” 64 
Subproject ‘Bioinformatics Services and Database Integration’ (coordination: 
Zlatko Trajanoski, Reinhard Kofler; Inst. for Genomics and Bioinformatics, 
TU Graz; Tyrolean Cancer Research Institute) 
Subproject ‘In Silico Target Identification and Function Prediction’ 
(coordination: Frank Eisenhaber; IMP – Research Institute of Molecular 
Pathology) 
Subproject ‘Rechnergestützte Strukturgenomik’ (coordination: Peter Schuster, 
Christoph Kratky; Inst. for Theoretical Chemistry, Univ. of Vienna; Inst. for 
Chemistry, Univ. of Graz) 
Bioinformatics Integration Network II (12/2005 – 11/2008; 2.542 380 €)65 
“During the second funding period we expanded and improved the backbone 
for bioinformatics services and broadened the scope of the thematic nodes by 
establishing proteomics informatics and evolutionary sequence analysis.” 66 
Subproject ‘Administration and Coordination’ (coordination: Zlatko 
Trajanoski; Inst. for Genomics and Bioinformatics, TU Graz) 
Subproject ‘Databases and Analytical Tools for Genomics and Proteomics’ 
(coordination: Zlatko Trajanoski; Inst. for Genomics and Bioinformatics,  
TU Graz) 
Subproject ‘Function Prediction with Biomolecular Sequence Analysis and 
Mass Spectrometry Data Interpretation’ (coordination: Frank Eisenhaber; 
IMP – Research Institute of Molecular Pathology) 
Subproject ‘Modeling and Inferring the Dynamics of Sequence Evolution’ 
(coordination: Arndt von Haeseler; Center for Integrative Bioinformatics, 
Max F. Perutz Laboratories) 
Subproject ‘RNA related Bioinformatics Tools’ (coordination: Ivo Hofacker, 
Peter Schuster; Inst. for Theoretical Chemistry, Univ. of Vienna) 
Subproject ‘Computational Structural Genomics’ (coordination: Kristina 
Djinovic-Carugo, Oliviero Carugo; Dept. of Biomolecular Structural 
Chemistry, Univ. of Vienna) 
Subproject ‘Data Mining in Proteomics’ (coordination: Bernhard Tilg, Armin 
Graber; Medical Informatics and Technology, UMIT) 
Subproject ‘Education and Training (International PhD Programme)’ 
(coordination: Zlatko Trajanoski; Inst. for Genomics and Bioinformatics,  
TU Graz) 
Bioinformatics Integration Network III (1/2009 – 12/2011; 1.840 000 €)67 
“The continuous development and application of novel technologies for gen-
erating high-throughput data requires the parallel development of computa-
tional methods and tools to manage, store, and analyze the data. The BIN III 
consortium therefore plans to maintain and enrich the computational labora-
tory and strengthen interactions with the experimental partners during the third 
                                                           
63 http://www.gen-au.at/projekt.jsp?projektId=26&lang=en, accessed Feb. 4th, 2012. 
64 http://bin.tugraz.at/, accessed Feb. 4th, 2012. 
65 http://www.gen-au.at/projekt.jsp?projektId=53&lang=en, accessed Feb. 4th, 2012. 
66 http://bin.tugraz.at/, accessed Feb. 4th, 2012. 
67 http://www.gen-au.at/projekt.jsp?projektId=53&lang=en, accessed Feb. 4th, 2012. 
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funding period. The goal of the BIN III project is to provide bioinformatics 
services and use computational methods to address biological questions aris-
ing from the GEN-AU projects.”68 
Subproject ‘Central infrastructure, administration, and coordination’ 
(coordination: Zlatko Trajanoski; Inst. for Genomics and Bioinformatics,  
TU Graz & Section for Bioinformatics, Innsbruck Medical University) 
Subproject ‘Biomolecular networks in cell differentiation and cancer’ 
(coordination: Zlatko Trajanoski; Inst. for Genomics and Bioinformatics,  
TU Graz & Section for Bioinformatics, Innsbruck Medical University) 
Subproject ‘Cis-acting regulatory motifs’ (coordination: Alexander Stark, 
Maria Novatchkova; IMP – Research Institute of Molecular Pathology) 
Subproject ‘Modeling and inferring the dynamics of sequence evolution’ 
(coordination: Arndt von Haeseler; Center for Integrative Bioinformatics, 
Max F. Perutz Laboratories) 
Subproject ‘RNA related bioinformatics tools’ (coordination: Ivo Hofacker; 
Inst. for Theoretical Chemistry, Univ. of Vienna) 
Subproject ‘Computational structural genomics’ (coordination: Kristina 
Djinovic-Carugo, Oliviero Carugo; Dept. of Biomolecular Structural 
Chemistry, Univ. of Vienna) 
Subproject ‘Data mining for cancer and cardiovascular diseases’ 
(coordination: Christian Baumgartner, Armin Graber; Medical Informatics 
and Technology, UMIT) 
Subproject ‘Integration and mining of drug-, protein-, and gene- interaction 
data’ (coordination: Jacques Colinge, Keiryn Lynn Bennett; CeMM – Research 
Centre for Molecular Medicine; Austrian Academy of Sciences) 
Subproject ‘Education und training’ (coordination: Zlatko Trajanoski; Inst. 
for Genomics and Bioinformatics, TU Graz & Section for Bioinformatics, 
Innsbruck Medical University) 
 
 
6.2 Institutions (centers, departments, institutes, companies) 
6.2.1 Department of Medicinal Chemistry/University Vienna 
Short description: At the Department of Medicinal Chemistry, research fo-
cuses on several areas of medical/pharmaceutical chemistry. The department 
in its current structure was founded in 2005 (the former Institute of Pharma-
ceutical Chemistry was split up into three departments) and is headed by 
Christian Noe. Noe is also an active promoter of systems biology and sys-
tems pharmacology at the international level (e.g. via IMI – The Innovative 
Medicines Initiative69). 
Address: Althanstraße 14, A-1090 Vienna 
                                                           
68 http://bin.tugraz.at/, accessed Feb. 4th, 2012. 
69 http://www.imi.europa.eu/, accessed April 4th, 2012. “IMI (2007), is a major joint 
effort planned by the European Commission and the European Pharmaceutical In-
dustry Association (EFPIA 2007). The objective of IMI is to support the faster dis-
covery and development of better medicines for patients and to enhance Europe’s 
competitiveness by ensuring that its biopharmaceutical sector remains a dynamic 
high-technology sector. IMI has been accepted as a Joint Technology Initiative by 
the European Council and European Parliament in 2008.” (Marcus 2007: 162) 
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Website: http://merian.pch.univie.ac.at/pch/medchem/ 
Founded: 2005 
Systems biology since: n/a 
Head: Christian R. Noe 
Systems biology researchers: Christian R. Noe, Johannes Winkler 
Type: university institute – research, education 
Systems biology research groups: 
Thematic research line ‘Systems Biology in Drug Research (Pharmaceutical 
Systems Biology)’: Christian R. Noe, Johannes Winkler 
Systems biology projects: n/a 
Courses in systems biology: n/a 
Systems biology publications: 1 
Westerhoff, H. V., Mosekilde, E., Noe, C. R. and Clemensen, A. M., 2008, 
Integrating systems approaches into pharmaceutical sciences, European  
Journal of Pharmaceutical Sciences 35(1-2), 1-4. 
 
6.2.2 Department of Genetics in Ecology/University Vienna 
Short description: Christa Schleper is head of the Department of Genetics in 
Ecology at the University Vienna. She was the main coordinator of the Euro-
pean project SulfoSYS (‘Silicon Cell Model for the central carbohydrate me-
tabolism of the archaeon Sulfolobus solfataricus under temperature variation’) 
within SysMO (Systems Biology of Microorganisms) from 2007 until 2010. 
Address: Althanstraße 14, A-1090 Vienna 
Website: http://genetics-ecology.univie.ac.at/index.html 
Founded: 2007 
Systems biology since: 2007* 
Head: Christa Schleper 
Systems biology researchers: Christa Schleper 
Type: university institute – research, education 
Disciplinary profile: medical molecular biology 
Systems biology projects: SulfoSYS (SysMO)70 
Courses in systems biology: n/a 
Systems biology publications: 0 
 
6.2.3 Department of Theoretical Biology/University Vienna 
Short description: Head of the Department of Theoretical Biology is Gerd 
B. Müller. Research at the department is dedicated to „(…) theoretical biol-
ogy of EvoDevo using developmental imaging, biometrics, and the integra-
tion of evolutionary theories.”71 Manfred Drack is a post-doc researcher at 
the department and has just started a project on systems biology (see below). 
Address: Althanstraße 14, A-1090 Vienna 
                                                           
70 Christa Schleper started coordination of this project from the University of Bergen, 
moving to the University of Vienna in 2007. 
71 Source: http://theoretical.univie.ac.at/home/, accessed Oct. 10th, 2011. 
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Website: http://theoretical.univie.ac.at/home/ 
Founded: 2005 
Systems biology since: 2011* 
Head: Gerd B. Müller 
Systems biology researchers: Manfred Drack 
Type: university institute – research, education 
Disciplinary profile: theoretical biology, philosophy of biology 
Systems biology projects: ‘Systeme in der Biologie’ (FWF) 
Courses in systems biology: n/a 
Systems biology publications: 1 
Drack, M., Apfalter, W. and Pouvreau, D., 2007, On the making of a system 
theory of life: Paul A. Weiss and Ludwig von Bertalanffy’s conceptual  
connection, Quarterly Review of Biology 82(4), 349-373. 
 
6.2.4 Institute for Theoretical Chemistry/University Vienna 
Short description: The Institute for Theoretical Chemistry was founded in 
1968 and is headed by Ivo Hofacker (professorships at the faculties of chemis-
try and computer science). Peter Schuster is emeritus professor and publishes 
papers on systems biology. Christoph Flamm gives courses in systems biology 
and was involved in a systems biology-related project funded by the WWTF.  
Address: Währinger Straße 17, A-1090 Vienna 
Website: http://www.itc.univie.ac.at/index.html  
Founded: 1968 
Systems biology since: n/a 
Head: Ivo Hofacker 
Systems biology researchers: Christoph Flamm, Peter Schuster, Bernd Mayer 
Type: university department – research & education 
Disciplinary profile: theoretical chemistry 
Systems biology relevant research groups 
Theoretical Biochemistry (TBI) research group 
Systems biology projects: n/a 
Courses in systems biology: VO Grundlagen der Systembiologie  
(English: Basics of systems biology) (Flamm), 2h 
Systems biology publications: 9 
Meisner, N. C., Hackermuller, J., Uhl, V., Aszodi, A., Jaritz, M. and Auer, M., 
2004, mRNA openers and closers: Modulating AU-rich element-controlled 
mRNA stability by a molecular switch in mRNA secondary structure, 
Chembiochem 5(10), 1432-1447. 
Engl, H. W., Flamm, C., Kugler, P., Lu, J., Muller, S. and Schuster, P., 2009, 
Inverse problems in systems biology, Inverse Problems 25, 123014. 
Schuster, P., 2008, Modeling in biological chemistry. From biochemical 
kinetics to systems biology, Monatshefte Fur Chemie 139(4), 427-446. 
Machne, R., Finney, A., Muller, S., Lu, J., Widder, S. and Flamm, C., 2006, 
The SBML ODE Solver Library: a native API for symbolic and fast numerical 
analysis of reaction networks, Bioinformatics 22(11), 1406-1407. 
Platzer, A., Perco, P., Lukas, A. and Mayer, B., 2007, Characterization of 
protein-interaction networks in tumors, Bmc Bioinformatics 8, 224. 
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Flamm, C., Endler, L., Muller, S., Widder, S. and Schuster, P., 2007, A 
minimal and self-consistent in silico cell model based on macromolecular 
interactions, Philosophical Transactions of the Royal Society B-Biological 
Sciences 362(1486), 1831-1839. 
Perco, P., Wilflingseder, J., Bernthaler, A., Wiesinger, M., Rudnicki, M., 
Wimmer, B., Mayer, B. and Oberbauer, R., 2008, Biomarker candidates for 
cardiovascular disease and bone metabolism disorders in chronic kidney 
disease: a systems biology perspective, Journal of Cellular and Molecular 
Medicine 12(4), 1177-1187. 
Perco, P., Muhlberger, I., Mayer, G., Oberbauer, R., Lukas, A. and Mayer, B., 
2010, Linking transcriptomic and proteomic data on the level of protein 
interaction networks, Electrophoresis 31(11), 1780-1789. 
Perco, P., Rapberger, R., Siehs, C., Lukas, A., Oberbauer, R., Mayer, G. and 
Mayer, B., 2006, Transforming omics data into context: Bioinformatics on 
genomics and proteomics raw data, Electrophoresis 27(13), 2659-2675. 
 
6.2.5 Max F. Perutz Laboratories (MFPL) 
Short description: In 2005, the Max F. Perutz Laboratories were founded by 
the University Vienna and the Medical University of Vienna as a joint ven-
ture. Graham Warren (Scientific Director) and Fabien Martins (Administrative 
Director) are the heads of about 50 research groups in the field of molecular 
biology. The groups led by Karl Kuchler and Heribert Hirt focus on systems 
biology research. 
Address: Dr. Bohr-Gasse 9, A-1030 Vienna 
Website: http://www.mfpl.ac.at/ 
Founded: 2005 
Systems biology since: 2005* 
Head: Graham Warren (Scientific Director),  
Fabien Martins (Administrative Director) 
Systems biology researchers: Karl Kuchler, Heribert Hirt, Walter Glaser, 
Martin Valachovic 
Type: research institute (joint venture University of Vienna & Medical 
University Vienna) 
Disciplinary profile: molecular biology 
Systems biology relevant research groups:  
Group Kuchler (with a link to the Kuchler laboratory at the Medical Univ. of 
Vienna) 
Group Hirt  
Systems biology projects72:  
UNICELLSYS (FP7-HEALTH) 
YSBN (FP6-LIFESCIHEALTH) 
EUSYSBIO (FP6-LIFESCIHEALTH) 
MOSES (SysMO) 
TRANSLUCENT (SysMO)73 
                                                           
72  Projects of both, Kuchler laboratory at the Medical Univ. of Vienna and Group 
Kuchler at the MFPL are mentioned here. 
73 Participation by Rudolf J. Schweyen, then affiliated with the Univ. of Vienna and 
MFPL. 
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Courses in systems biology: Karl Kuchler co-organises the biannual FEBS 
(Federation of the European Biochemical Societies) “Advanced Lecture Course 
on Systems Biology” 
Systems biology publications: 4 
van Bentem, S. D., Mentzen, W. I., de la Fuente, A. and Hirt, H., 2008, Towards 
functional phosphoproteomics by mapping differential phosphorylation events 
in signaling networks, Proteomics 8(21), 4453-65. 
Pflieger, D., Gonnet, F., van Bentem, S. D., Hirt, H. and de la Fuente, A., 2011, 
LINKING THE PROTEINS-ELUCIDATION OF PROTEOME-SCALE 
NETWORKS USING MASS SPECTROMETRY, Mass Spectrometry 
Reviews 30(2), 268-297. 
Pitzschke, A. and Hirt, H., 2010, Bioinformatic and Systems Biology Tools 
to Generate Testable Models of Signaling Pathways and Their Targets, Plant 
Physiology 152(2), 460-469. 
Pieroni, E., Van Bentem, S. D., Mancosu, G., Capobianco, E., Hirt, H. and de 
la Fuente, A., 2008, Protein networking: insights into global functional 
organization of proteomes, Proteomics 8(4), 799-816. 
 
6.2.6 Institute of Technology Assessment (ITA)/ 
Austrian Academy of Sciences 
Short description: The Institute of Technology Assessment (ITA) was founded 
in 1994 at the Austrian Academy of Sciences. It is an interdisciplinary re-
search institute focusing on the study of technological change and its societal 
conditions, options and impacts. Since 2006, Michael Nentwich is head of the 
institute. Currently, two projects on systems biology are conducted at the in-
stitute (‘Reflexive Systems Biology’, funded by the Norwegian Forskningsrådet 
and THCL, funded by the FFG).  
Address: Strohg. 45/5, A-1030 Vienna 
Website: http://www.oeaw.ac.at/ita/ 
Founded: 1994 
Systems biology since: 2009 
Head: Michael Nentwich 
Systems biology researchers: Karen Kastenhofer, Helge Torgerson 
Type: research institute 
Disciplinary profile: science and technology studies 
Systems biology projects: THCL (GEN-AU, FFG) 
Courses in systems biology: n/a 
Systems biology publications: 1 
Torgersen, H., 2009, Fuzzy Genes: Epistemic Tensions in Genomics,  
Science as Culture 18(1), 65-87. 
 
6.2.7 Institute for Bioinformatics and Translational Research/UMIT 
Short description: The Institute for Bioinformatics and Translational Research 
at the Health and Life Sciences University Hall/Tirol (UMIT) is headed by 
Matthias Dehmer. Armin Graber holds a chair in bioinformatics at the institute. 
Both researchers are also involved in Oncotyrol projects (see Oncotyrol). 
Address: Eduard Wallnöfer-Zentrum 1, A-6060 Hall in Tirol 
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Website: http://www.umit.at/page.cfm?vpath=departments/ 
technik/bioinf&expanddiv=subDeptItem343 
Founded: 2011 
Systems biology since: 2011 
Head: Mathias Dehmer 
Systems biology researchers: Mathias Dehmer, Armin Graber 
Systems biology research groups 
Research area ‘Systems Biology and Dynamical Systems’ 
Systems biology projects: n/a 
Courses in systems biology: n/a 
Systems biology publications: 5 
Modre-Osprian, R., Osprian, I., Tilg, B., Schreier, G., Weinberger, K. M.  
and Graber, A., 2009, Dynamic simulations on the mitochondrial fatty acid 
Beta-oxidation network, Bmc Systems Biology 3, 2. 
Emmert-Streib, F. and Dehmer, M., 2011, Networks for systems biology: 
conceptual connection of data and function, Iet Systems Biology 5(3), 185-207. 
Balasubramanian R, Mueller L, Kugler K, Hackl W, Pleyer L, Dehmer M, 
Graber A.: The impact of storage effects in biobanks on biomarker discovery 
in systems biology studies. Biomarkers. 15(8), 677-83. 
Molina, F., Dehmer, M., Perco, P., Graber, A., Girolami, M., Spasovski, G., 
Schanstra, J. P. and Vlahou, A., 2010, Systems biology: opening new avenues 
in clinical research, Nephrology Dialysis Transplantation 25(4), 1015-1018. 
Dominiczak AF, Herget-Rosenthal S, Delles C, Fliser D, Fournier I, Graber A, 
Girolami M, Holmes E, Lang F, Molina F, Nicholson J, Remuzzi G, Rossing 
P, Rudolph KL, Wolkenhauer O, Xenarios I, Zubarev R, Zubov D, Vlahou A, 
Schanstra JP.: Systems biology to battle vascular disease, Nephrol Dial 
Transplant. 25 (4), 1019-1022. 
 
6.2.8 Software Competence Center Hagenberg (SCCH) 
Short description: The Software Competence Center Hagenberg (SCCH) is 
an application orientated research company founded in 1999. The company is 
owned by the Johannes Kepler University Linz (1/3), the Upper Austrian Re-
search GmbH (1/3) and the ‘Verein der Partnerfirmen des SCCH’ (‘associa-
tion of SCCH associated companies’) (1/3). It empoys about 60 staff mem-
bers. In fiscal year 2009/2010, SCCH reached a performance of 5.1 million 
Euros. It cooperates with more than 28 international research institutes and 
reference customers like Siemens AG, Fronius International GmbH or the 
Upper Austrian Insurance Company. Since 2009, it is coordinator and partner 
of the project Cancermotisys with Julian Mattes as project leader and Matej 
Smid, Tomas Kazmar and Martina Schwendinger as project members. 
Address: Softwarepark 21, A-4232 Hagenberg 
Website: http://www.scch.at/en/home  
Founded: 1999 
Systems biology since: 2009 
Head: Klaus Pirklbauer (CEO) 
Systems biology researchers: Julian Mattes, Matej Smid, Tomas Kazmar, 
Martina Schwendinger 
Type: research centre (owned by Johannes Kepler University Linz, Upper 
Austrian research GmbH, Verein der Partnerfirmen des SCCH) 
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Disciplinary profile: computer science and mathematics (software-related 
research) 
Systems biology projects funded by the EU, ERASysBio, SysMO, FWF or FFG: 
CANCERMOTISYS (GEN-AU, FFG) 
Courses in systems biology: n/a 
Systems biology publications: Publications since 2000 with ‘systems 
biology’ in title, topic or keywords found in Web of Science74: 0 
 
6.2.9 Emergentec Biodevelopment GmbH 
Short description: The Emergentec Biodevelopment GmbH is a research com-
pany focusing on the development of new biotech and pharma products. The 
managing directors Arno Lukas and Bernd Mayer founded the company in 
2002. They are involved in the European Framework Programme 7 – ‘Syskid’-
project (see below). 
Address: Gersthofer Strasse 29-31, A-1180 Vienna 
Website: http://www.emergentec.com/en/index.php 
Founded: 2002 
Systems biology since: 2002* 
Heads: Arno Lukas, Bernd Mayer 
Systems biology researchers: Paul Perco, Martin Haiduk, Bernd Mayer, 
Irmgard Mühlberger, Raul Fachete, Martin Wiesinger 
Type: research company 
Disciplinary profile: microbial ecology, molecular biology 
Systems biology projects: SYSKID (FP7-HEALTH) 
Courses in systems biology: n/a 
Systems biology publications: 6 
Perco, P., Muhlberger, I., Mayer, G., Oberbauer, R., Lukas, A. and Mayer, B., 
2010, Linking transcriptomic and proteomic data on the level of protein 
interaction networks, Electrophoresis 31(11), 1780-1789. 
Perco, P., Rapberger, R., Siehs, C., Lukas, A., Oberbauer, R., Mayer, G. and 
Mayer, B., 2006, Transforming omics data into context: Bioinformatics on 
genomics and proteomics raw data, Electrophoresis 27(13), 2659-2675. 
Platzer, A., Perco, P., Lukas, A. and Mayer, B., 2007, Characterization of 
protein-interaction networks in tumors, Bmc Bioinformatics 8, 224. 
Molina, F., Dehmer, M., Perco, P., Graber, A., Girolami, M., Spasovski, G., 
Schanstra, J. P. and Vlahou, A., 2010, Systems biology: opening new avenues 
in clinical research, Nephrology Dialysis Transplantation 25(4), 1015-1018. 
Perco, P., Wilflingseder, J., Bernthaler, A., Wiesinger, M., Rudnicki, M., 
Wimmer, B., Mayer, B. and Oberbauer, R., 2008, Biomarker candidates for 
cardiovascular disease and bone metabolism disorders in chronic kidney 
disease: a systems biology perspective, Journal of Cellular and Molecular 
Medicine 12(4), 1177-1187. 
Rudnicki, M., Perco, P., Enrich, J., Eder, S., Heininger, D., Bernthaler, A., 
Wiesinger, M., Sarkozi, R., Noppert, S. J., Schramek, H., Mayer, B., 
Oberbauer, R. and Mayer, G., 2009, Hypoxia response and VEGF-A 
expression in human proximal tubular epithelial cells in stable and progressive 
renal disease, Laboratory Investigation 89(3), 337-346. 
                                                           
74 Source: http://wokinfo.com/, 19.7.2011 
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6.2.10 Biocrates Life Sciences AG 
Short description: The Biocrates Life Sciences AG is a company dedicated 
to research in the field of diagnostic biomarker research and was founded in 
2002. Elgar Schnegg (since 2008 at Biocrates, before he was working in phar-
maceutical industries, studied economics) is Chief Executive Officer, Klaus 
Weinberger (since 2003 at Biocrates, before he was research group leader at 
the Institute of Medical Microbiology and Hygiene at the University of Re-
gensburg, Germany, Ph.D. in medical microbiology) is Chief Scientific Offi-
cer, and Ralph Zahn (since 2010 at Biocrates, was managing director at Bio-
Safety Gmbh, Ph.D. in biology) is Chief Technology Officer.  
Address: Innrain 66/2, A-6020 Innsbruck 
Website: http://www.biocrates.com/  
Founded: 2002 
Systems biology since: 2002 
Heads: Elgar Schnegg (CEO), Klaus Weinberger (CSO), Ralph Zahn (CTO) 
Systems biology researchers: David P. Enot, Hans-Peter Deigner, Therese 
Koal, Ingrid Osprian, Klaus M. Weinberger 
Type: research company 
Disciplinary profile: metabolomics (diagnostic biomarker research) 
Systems biology projects:  
METAFLUX (FP7 people) 
SYSKID (FP7-HEALTH) 
COBRED (FP6-LIFESCIHEALTH) 
Courses in systems biology: n/a 
Systems biology publications: 3 
Griffiths, W. J., Koal, T., Wang, Y. Q., Kohl, M., Enot, D. P. and Deigner,  
H. P., 2010, Targeted Metabolomics for Biomarker Discovery, Angewandte 
Chemie-International Edition 49(32), 5426-5445. 
Koal, T. and Deigner, H. P., 2010, Challenges in Mass Spectrometry Based 
Targeted Metabolomics, Current Molecular Medicine 10(2), 216-226. 
Modre-Osprian, R., Osprian, I., Tilg, B., Schreier, G., Weinberger, K. M.  
and Graber, A., 2009, Dynamic simulations on the mitochondrial fatty acid 
Beta-oxidation network, Bmc Systems Biology 3, 2. 
 
6.2.11 Viscovery Software GmbH 
Short description: Viscovery Software GmbH is a data mining company and 
was founded in 1994 (formerly Eudaptics) by Gerhard Kranner. In 2007, the 
company was acquired by the Biomax Group, Germany. It offers data mining 
solutions using its developed software packages, for example the Viscovery® 
Suite for explorative data mining and predictive analytics with a focus on 
customer behavior modeling (CBM). Since 2009, Visocvery is a partner of 
the project Cancermotisys, with Swetlana Gaffron as project leader. 
Address: Kupelwiesergasse 27, A-1130 Vienna 
Website: http://www.viscovery.net/  
Founded: 1994 
Systems biology since: 2009 
Head: Gerhard Kranner (CEO) 
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Systems biology researchers: Swetlana Gaffron 
Type: company (part of the Biomax Group) 
Disciplinary profile: computer science and mathematics (data-mining) 
Systems biology projects funded by the EU, ERASysBio, SysMO, FWF or FFG: 
CANCERMOTISYS (GEN-AU, FFG) 
Courses in systems biology: n/a 
Systems biology publications: 0 
 
 
 7 Category III institutions 
7.1 Public research institutions: Vienna 
7.1.1 Department of Limnology/University of Vienna 
Address: A-1090 Vienna, 
http://www.univie.ac.at/deli/index.php/startseite.html  
Systems biology relevant experts: Tom J. Battin 
Systems biology publications: 1 
Battin, T. J., Sloan, W. T., Kjelleberg, S., Daims, H., Head, I. M., Curtis, T. P. 
and Eberl, L., 2007, Microbial landscapes: new paths to biofilm research,  
Nature Reviews Microbiology 5(1), 76-81. 
 
7.1.2 Department of Microbial Ecology/University of Vienna 
Address: A-1090 Vienna, http://www.microbial-ecology.net/default.asp  
Systems biology relevant experts: Holger Daims 
Systems biology publications: 1 
Battin, T. J., Sloan, W. T., Kjelleberg, S., Daims, H., Head, I. M., Curtis, T. P. 
and Eberl, L., 2007, Microbial landscapes: new paths to biofilm research,  
Nature Reviews Microbiology 5(1), 76-81. 
 
7.1.3 Department of Molecular Evolution and 
Development/University of Vienna 
Address: A-1090 Vienna, http://molevodevo.univie.ac.at/ 
Systems biology relevant experts: Ulrich Technau 
Systems biology projects: EVONET (FP7 people) 
 
7.1.4 Department of Applied Genetics and Cell Biology 
(DAGZ)/BOKU 
Address: A-1190 Vienna, http://www.dagz.boku.ac.at/dagz.html?&L=1 
Systems biology relevant experts: Andrea Pitzschke 
Systems biology publications: 1 
Pitzschke, A. and Hirt, H., 2010, Bioinformatic and Systems Biology Tools 
to Generate Testable Models of Signaling Pathways and Their Targets, Plant 
Physiology 152(2), 460-469. 
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7.1.5 Division of Biochemistry, Dpt. Of Chemistry/BOKU 
Address: A-1090 Vienna, http://www.chemie.boku.ac.at/366.html?&L=1  
Systems biology relevant experts: Johannes Stadlmann (currently: IMP) 
Systems biology publications: 1 
Baumann, K., Carnicer, M., Dragosits, M., Graf, A. B., Stadlmann, J., Jouhten, 
P., Maaheimo, H., Gasser, B., Albiol, J., Mattanovich, D. and Ferrer, P., 2010, 
A multi-level study of recombinant Pichia pastoris in different oxygen 
conditions, Bmc Systems Biology 4, 141. 
 
7.1.6 Institute of Applied Synthetic Chemistry/ 
Vienna University of Technology 
Address: A-1060 Vienna, http://www.ias.tuVienna.ac.at/ 
Systems biology relevant experts: Florian Rudroff 
Systems biology projects: ‘Biocatalytic Redox Cascades Using Baeyer-
Villiger Monooxygenase’ (DACH, FWF); Schrödinger Stipendium (FWF). 
 
7.1.7 Institute for Chemical Engineering/ 
Vienna University of Technology 
Address: A-1060 Vienna, http://www.vt.tuVienna.ac.at/index.php  
Systems biology relevant experts: Peter Christian Kubicek 
Systems biology publications: 1 
Andersen, M. R., Salazar, M. P., Schaap, P. J., van de Vondervoort, P. J. I., 
Culley, D., Thykaer, J., Frisvad, J. C., Nielsen, K. F., Albang, R., Albermann, 
K., Berka, R. M., Braus, G. H., Braus-Stromeyer, S. A., Corrochano, L. M., 
Dai, Z. Y., van Dijck, P. W. M., Hofmann, G., Lasure, L. L., Magnuson, J. K., 
Menke, H., Meijer, M., Meijer, S. L., Nielsen, J. B., Samson, R. A., Stam, H., 
Tsang, A., van den Brink, J. M., Atkins, A., Aerts, A., Shapiro, H., Pangilinan, 
J., Salamov, A., Lou, Y. G., Lindquist, E., Lucas, S., Grimwood, J., Grigoriev, 
I. V., Kubicek, C. P., Martinez, D., van Peij, N., Roubos, J. A., Nielsen, J. and 
Baker, S. E., 2011, Comparative genomics of citric-acid-producing Aspergillus 
niger ATCC 1015 versus enzyme-producing CBS 513.88, Genome Research 
21(6), 885-897. 
 
7.1.8 Institute for Mechanics of Materials and Structures/ 
Vienna University of Technology 
Address: A-1040 Vienna, http://www.imws.tuVienna.ac.at/en/home.html 
Systems biology relevant experts: Herbert Mang 
Systems biology projects: MICROBONE (FP7-IDEAS) 
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7.1.9 Institute of Cancer Research (ICR),  
Department of Medicine I/Medical University of Vienna 
Address: A-1090 Vienna, 
http://www.meduniVienna.ac.at/krebsforschung/en/ 
Systems biology relevant experts: Maria Sibilia, Robert Eferl 
Systems biology relevant research groups:  
Cellular and Molecular Tumorbiology Research Unit 
Applied and Experimental Oncology Research Unit 
Systems biology projects: Austrian Network for Functional Mouse  
Genomics II (GEN-AU, FFG) 
 
7.1.10 Institute for Hygiene and Applied Immunology,  
Centre for Pathophysiology, Infectiology and Immunology/ 
Medical University of Vienna 
Address: A-1090 Vienna,  
http://www.meduniVienna.ac.at/hp/en/ 
institute-for-hygiene-and-applied-immunology/ 
Systems biology relevant experts: Hannes Stockinger 
Systems biology relevant research groups: 
Molecular Immunology Unit 
Systems biology projects: MULTIFACETED CASR (FP7 people) 
 
7.1.11 Nephrology & Dialysis, Department of Internal Medicine III/ 
Medical University of Vienna 
Also: Laboratory Rainer Oberbauer, Academic Research in Genetic and 
Clinical Epidemiology of Kidney Disease 
Address: A-1090 Vienna, 
http://www.meduniVienna.ac.at/innere3/nephro/Nephro-abt-frameset.htm, 
http://www.meduniVienna.ac.at/nephrogene/ 
Systems biology relevant experts: Rainer Oberbauer, Paul Perco 
Systems biology relevant research groups:  
Academic Research in Genetic and Clinical Epidemiology of Kidney Disease 
Systems biology projects: SYSKID (FP7-HEALTH) 
Systems biology publications: 5 
Perco, P., Muhlberger, I., Mayer, G., Oberbauer, R., Lukas, A. and Mayer, 
B., 2010, Linking transcriptomic and proteomic data on the level of protein 
interaction networks, Electrophoresis 31(11), 1780-1789. 
Perco, P., Wilflingseder, J., Bernthaler, A., Wiesinger, M., Rudnicki, M., 
Wimmer, B., Mayer, B. and Oberbauer, R., 2008, Biomarker candidates for 
cardiovascular disease and bone metabolism disorders in chronic kidney 
disease: a systems biology perspective, Journal of Cellular and Molecular 
Medicine 12(4), 1177-1187. 
Rudnicki, M., Perco, P., Enrich, J., Eder, S., Heininger, D., Bernthaler, A., 
Wiesinger, M., Sarkozi, R., Noppert, S. J., Schramek, H., Mayer, B., Oberbauer, 
R. and Mayer, G., 2009, Hypoxia response and VEGF-A expression in human 
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proximal tubular epithelial cells in stable and progressive renal disease, 
Laboratory Investigation 89(3), 337-346. 
Molina, F., Dehmer, M., Perco, P., Graber, A., Girolami, M., Spasovski, G., 
Schanstra, J. P. and Vlahou, A., 2010, Systems biology: opening new avenues 
in clinical research, Nephrology Dialysis Transplantation 25(4), 1015-1018. 
Perco, P., Rapberger, R., Siehs, C., Lukas, A., Oberbauer, R., Mayer, G. and 
Mayer, B., 2006, Transforming omics data into context: Bioinformatics on 
genomics and proteomics raw data, Electrophoresis 27(13), 2659-2675. 
 
7.1.12 Experimental Oncology, Dpt. of Ear, Nose and Throat 
Dieseases/Medical University of Vienna 
Address: A-1090 Vienna, http://www.meduniVienna.ac.at/hno/ 
allgemeine-informationen/wissenschaft-forschung/experimentelle-onkologie/ 
Systems biology relevant experts: Dietmar Thurnher, B. M. Erovic 
Systems biology publications: 1 
Koehn, J., Krapfenbauer, K., Huber, S., Stein, E., Sutter, W., Watzinger, F., 
Erovic, B. M., Thurnher, D., Schindler, T., Fountoulakis, M. and Turhani, D., 
2008, Potential involvement of MYC- and p53-related pathways in 
tumorigenesis in human oral squamous cell carcinoma revealed by proteomic 
analysis, Journal of Proteome Research 7(9), 3818-3829. 
 
7.1.13 Department of Radiology/Medical University of Vienna 
Address: A-1090 Vienna,  
http://www.radiodiagnostik-akhVienna.at/index.aspx 
Systems biology relevant experts: Christian J. Herold 
Systems biology publications: 1 
Bradley, W. G., Golding, S. G., Herold, C. J., Hricak, H., Krestin, G. P., Lewin, 
J. S., Miller, J. C., Ringertz, H. G. and Thrall, J. H., 2011, Globalization of 
P4 Medicine: Predictive, Personalized, Preemptive, and Participatory-Summary 
of the Proceedings of the Eighth International Symposium of the International 
Society for Strategic Studies in Radiology, August 27-29, 2009, Radiology 
258(2), 571-582. 
 
7.1.14 Section for Science of Complex Systems,  
Center for Medical Statistics, Informatics, and Intelligent 
Systems/Medical University of Vienna  
Formerly Complex Systems Research Group (COSY) 
Address: A-1090 Vienna,  
http://www.complex-systems.meduniVienna.ac.at/about/  
Systems biology relevant experts: Stefan Thurner, Rudolf Hanel, Dejan Stokic 
Systems biology publications: 1 
Stokic, D., Hanel, R. and Thurner, S., 2009, A fast and efficient gene-network 
reconstruction method from multiple over-expression experiments, Bmc 
Bioinformatics 10, 253. 
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7.1.15 Department of Vascular Biology &  
Thrombosis Research, Center for Physiology and Pharmacology/ 
Medical University of Vienna 
Address: A-1090 Vienna, 
http://www.meduniVienna.ac.at/user/johannes.schmid/ 
Systems biology relevant experts: Johannes Schmid (research group) 
Systems biology projects: ‚Transkriptionsfaktoren bei Entzündung und 
Krebs’ (FWF) 
 
7.1.16 Children's Cancer Research Institute (CCRI)/ 
St. Anna Kinderkrebsforschung Association 
Address: 1090 Vienna, 
http://www.ccri.at/science/index.php?gr_id=40&k_id=238 
Systems biology relevant experts: Karla Maria Valdes Rodriguez 
Systems biology projects: ASSET (FP7-HEALTH) 
 
7.1.17 Institute for Medical Chemistry, Dpt. for Biomedical Sciences/ 
VU Vienna 
Address: A-1210 Vienna,  
http://www.vu-Vienna.ac.at/medchemie/content/index_ger.html 
Systems biology relevant experts: Ingrid Miller  
(working group ‘Peptid-, Protein- und Immunchemie’) 
Systems biology publications: 1 
Bendixen, E., Danielsen, M., Hollung, K., Gianazza, E. and Miller, I., 2011, 
Farm animal proteomics – A review, Journal of Proteomics 74(3), 282-293. 
 
7.1.18 Institute for Pharmacology and Toxicology,  
Dpt. for Biomedical Sciences/VU Vienna 
Address: A-1210 Vienna,  
http://vmutpp.vu-Vienna.ac.at/vuw/fodok/ 
suche.orgeinheit_mitarbeiter?sprache_in=de&menue_id_in=203&id_in=118 
Systems biology relevant experts: Katrin Staniek 
Systems biology publications: 1 
Ramzan, R., Staniek, K., Kadenbach, B. and Vogt, S., 2010, Mitochondrial 
respiration and membrane potential are regulated by the allosteric ATP-inhibition 
of cytochrome c oxidase, Biochimica Et Biophysica Acta-Bioenergetics 
1797(8), 1672-1680. 
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7.1.19 Institute of Animal Breeding and Genetics,  
Dpt. for Biomedical Sciences/VU Vienna 
Address: A-1210 Vienna, http://www.vu-
wien.ac.at/de/universitaet/departments/department1/tierzucht-und-genetik/ 
Systems biology relevant experts: Mathias Müller 
Systems biology projects:  
Austrian Network for Functional Mouse Genomics II (GEN-AU, FFG) 
 
7.1.20 dialog<>gentechnik 
Address: A-1030 Vienna, Campus Vienna Biocenter,  
http://www.dialog-gentechnik.at/ 
Short description: dialog<>gentechnik was established by concerned scien-
tists as ‘Plattform Gentechnik & Wir’ in 1997 in reaction to public controver-
sies about agri-biotechnology and a resulting popular petition. The independ-
ent, non-profit association aims at providing substantiated, well-balanced in-
formation in a comprehensible way and enhancing exchange between scien-
cists and lay people. It organises public events and contributes to the Vienna 
Open lab. It is funded exclusively by public sources. 
Systems biology projects: EUSYSBIO (FP6-LIFESCIHEALTH) 
 
 
7.2 Public research institutions: Lower Austria 
7.2.1 Konrad Lorenz Institute (KLI) 
Address: A-3422 Altenberg, http://www.kli.ac.at/institute-a.html 
Systems biology relevant experts: Matthias Samwald 
Short description: “Founded in 1990, the KLI is funded by a private trust 
and receives additional support from the Province of Lower Austria. The in-
stitute has close ties with many of the higher education institutions in Vienna 
and Lower Austria as well as with a number of international institutions with 
similar aims.”75 
Systems biology publications: 1 
Demir, E., Cary, M. P., Paley, S., Fukuda, K., Lemer, C., Vastrik, I., Wu, G. N., 
D'Eustachio, P., Schaefer, C., Luciano, J., Schacherer, F., Martinez-Flores, I., 
Hu, Z. J., Jimenez-Jacinto, V., Joshi-Tope, G., Kandasamy, K., Lopez-Fuentes, 
A. C., Mi, H. Y., Pichler, E., Rodchenkov, I., Splendiani, A., Tkachev, S., 
Zucker, J., Gopinath, G., Rajasimha, H., Ramakrishnan, R., Shah, I., Syed, M., 
Anwar, N., Babur, O., Blinov, M., Brauner, E., Corwin, D., Donaldson, S., 
Gibbons, F., Goldberg, R., Hornbeck, P., Luna, A., Murray-Rust, P., Neumann, 
E., Reubenacker, O., Samwald, M., van Iersel, M., Wimalaratne, S., Allen, K., 
Braun, B., Whirl-Carrillo, M., Cheung, K. H., Dahlquist, K., Finney, A., 
Gillespie, M., Glass, E., Gong, L., Haw, R., Honig, M., Hubaut, O., Kane, D., 
Krupa, S., Kutmon, M., Leonard, J., Marks, D., Merberg, D., Petri, V., Pico, A., 
Ravenscroft, D., Ren, L. Y., Shah, N., Sunshine, M., Tang, R., Whaley, R., 
                                                           
75 http://www.kli.ac.at/institute/introduction, accessed Feb. 4th, 2012. 
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Letovksy, S., Buetow, K. H., Rzhetsky, A., Schachter, V., Sobral, B. S., 
Dogrusoz, U., McWeeney, S., Aladjem, M., Birney, E., Collado-Vides, J., 
Goto, S., Hucka, M., Le Novere, N., Maltsev, N., Pandey, A., Thomas, P., 
Wingender, E., Karp, P. D., Sander, C. and Bader, G. D., 2010, The BioPAX 
community standard for pathway data sharing, Nature Biotechnology 28(9), 
935-942. 
 
 
7.3 Public research institutions: Upper Austria 
7.3.1 Biophysics Institute/Johannes Kepler University Linz 
Address: A-4040 Linz, http://www.jku.at/biophysics/content 
Systems biology relevant experts: Gerhard J Schütz 
Systems biology projects: LIPIDOMICNET (FP7-HEALTH) 
 
7.3.2 Research Institute for Symbolic Computation/ 
Johannes Kepler University Linz 
Address: A-4040 Linz, http://www.risc.jku.at/ 
Systems biology relevant experts: Franz Winkler 
Systems biology publications: 1 
Piazza, C., Antoniotti, M., Mysore, V., Policriti, A., Winkler, F. and Mishra, 
B., 2005, Algorithmic algebraic model checking I: Challenges from systems 
biology, in: Etessami, K. and Rajamani, S. K. (Eds): Computer Aided 
Verification< Proceedings, 5-19. 
 
 
7.4 Public research institutions: Styria 
7.4.1 Department of Pharmaceutical Chemistry,  
Institute of Pharmaceutical Sciences/University of Graz 
Address: A-8010 Graz, http://www.uni-graz.at/ipcwww/ 
Systems biology relevant experts: Andreas Kungl 
Systems biology projects: Austrian Proteomics Platform II (GEN-AU, 
FFG); Austrian Proteomics Platform III (GEN-AU, FFG) 
 
7.4.2 Institute of Molecular Biosciences/University of Graz 
Address: A-8010 Vienna, http://www.uni-graz.at/imbmwww.htm  
Systems biology relevant experts: Friedrich Spener, Klaus Natter, Christoph 
F. Kurat, Sepp D. Kohlwein, Gabriela Gogg-Fassolter; Frank Madeo 
Systems biology relevant research groups: 
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Yeast Genetics and Molecular Biology Group/lipid metabolism  
(Kohlwein, Kurat, Natter, Gogg-Fassolter) 
Yeast Genetics and Molecular Biology Group/cell death (Madeo) 
Systems biology projects:  
APO-SYS (FP7-HEALTH); LIPIDOMICNET (FP7-HEALTH) 
Systems biology publications: 2 
Fahy, E., Subramaniam, S., Brown, H. A., Glass, C. K., Merrill, A. H., Murphy, 
R. C., Raetz, C. R. H., Russell, D. W., Seyama, Y., Shaw, W., Shimizu, T., 
Spener, F., van Meer, G., VanNieuwenhze, M. S., White, S. H., Witztum, J. 
L. and Dennis, E. A., 2005, A comprehensive classification system for lipids, 
Journal of Lipid Research 46(5), 839-861. 
Zanghellini, J., Natter, K., Jungreuthmayer, C., Thalhammer, A., Kurat, C. F., 
Gogg-Fassolter, G., Kohlwein, S. D. and von Grunberg, H. H., 2008, 
Quantitative modeling of triacylglycerol homeostasis in yeast – metabolic 
requirement for lipolysis to promote membrane lipid synthesis and cellular 
growth, Febs Journal 275(22), 5552-5563. 
 
7.4.3 Institute of Pathology, Center for Theoretical-Clinical 
Medicine 1/Medical University of Graz 
Address: 8036 Graz, http://www.medunigraz.at/pathologie/1143 
Systems biology relevant experts: Kurt Zatloukal76 
Systems biology relevant research groups: 
Research laboratory for molecular pathology, experimental cell biology and 
oncology 
Systems biology projects:  
ESGI (FP7-INFRASTRUCTURES);  
ESBIC-D (FP6-LIFESCIHEALTH); livSYSiPS (ERASysBio) 
 
7.4.4 Division of Endocrinology and Metabolism, Internal Medicine/ 
Medical University of Graz 
Address: A-8036 Graz, http://forschung.meduni-graz.at/fodok/ 
suchen.orgeinheit_uebersicht?sprache_in=de&menue_id_in=201&id_in=4120, 
https://online.medunigraz.at/mug_online/ 
webnav.navigate_to?corg=15207&cperson_nr=51861 
Systems biology relevant experts: Thomas Wascher 
Systems biology publications: 1 
Maahs, D. M., Siwy, J., Argiles, A., Cerna, M., Delles, C., Dominiczak, A. F., 
Gayrard, N., Iphofer, A., Jansch, L., Jerums, G., Medek, K., Mischak, H., 
Navis, G. J., Roob, J. M., Rossing, K., Rossing, P., Rychlik, I., Schiffer, E., 
Schmieder, R. E., Wascher, T. C., Winklhofer-Roob, B. M., Zimmerli, L. U., 
Zurbig, P. and Snell-Bergeon, J. K., 2010, Urinary Collagen Fragments Are 
Significantly Altered in Diabetes: A Link to Pathophysiology, Plos One 5(9), 
e13051. 
 
                                                           
76 Kurt Zatloukal also took part in many preparatory EU panels on systems biology 
research funding and coordination as an Austrian systems biology expert. 
7.5   Public research institutions: Tyrol ________________________________________________________________________  69 
 
7.5 Public research institutions: Tyrol 
7.5.1 Department of Pharmacognosy, Institute of Pharmacy/ 
University of Innsbruck 
Address: A-6020 Innsbruck, 
http://www.uibk.ac.at/pharmazie/pharmakognosie/  
Systems biology relevant experts: Christoph Seger, Sonja Sturm 
Systems biology publications: 2 
Holmes, E., Tang, H. R., Wang, Y. L. and Seger, C., 2006, The assessment of 
plant metabolite profiles by NMR-based methodologies, Planta Medica 
72(9), 771-785. 
Seger, C. and Sturm, S., 2007, Analytical aspects of plant metabolite 
profiling platforms: Current standings and future aims, Journal of Proteome 
Research 6(2), 480-497. 
 
7.5.2 Institute of Analytical Chemistry and Radiochemistry/ 
University of Innsbruck 
Also: Horváth Laboratory of Bioseparation Sciences, with its main office at 
the Institute of Analytical Chemistry and Radiochemistry and a first full 
subsidiary at the Department of Medical Chemistry in University of Debrecen 
(Hungary). Günther Bonn and Barry L. Karger function as chairmen of the 
two advisory boards, András Guttmen as head of the laboratory 
(http://www.hlbs.org/, accessed 2.4.2012). 
Address: A-6020 Innsbruck, http://www.uibk.ac.at/acrc/ 
Systems biology relevant experts:  
Günther Bonn, Christian Huck, András Guttman 
 
Systems biology projects:  
COBRED (FP6-LIFESCIHEALTH);  
Austrian Proteomics Platform II (GEN-AU, FFG);  
Austrian Proteomics Platform III (GEN-AU, FFG) 
Systems biology publications: 2 
Csanky, E., Olivova, P., Rajnavolgyi, E., Hempel, W., Tardieu, N., Katalin, 
E. T., Jullien, A., Malderez-Bloes, C., Kuras, M., Duval, M. X., Nagy, L., 
Scholtz, B., Hancock, W., Karger, B., Guttman, A. and Takacs, L., 2007, 
Monoclonal antibody proteomics: Discovery and prevalidation of chronic 
obstructive pulmonary disease biomarkers in a single step, Electrophoresis 
28(23), 4401-4406. 
Szilagyi, A., Bonn, G. K. and Guttman, A., 2007, Capillary gel electrophoresis 
analysis of G-quartet forming oligonucleotides used in DNA-protein interaction 
studies, Journal of Chromatography A 1161(1-2), 15-21. 
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7.5.3 Division of Bioinformatics, Biocenter/ 
Innsbruck Medical University 
Address: A-6020 Innsbruck, Website: http://icbi.at/index.html 
Systems biology relevant experts: Zlatko Trajanoski, Hubert Hackl,  
Gernot Stocker, Pornpimol Charoentong, Stephan Pabinger 
Close links to: 
Institute for Genomics and Bioinformatics, Graz University of Technology 
Oncotyrol AREA5: Bioinformatics and Sytems Biology 
Bioinformatics Integration Network I – III 
Systems biology projects: 
Bioinformatics Integration Network III (GEN-AU, FFG) 
Systems biology publications: 2 
Hackl, H., Stocker, G., Charoentong, P., Mlecnik, B., Bindea, G., Galon, J. 
and Trajanoski, Z., 2010, Information technology solutions for integration of 
biomolecular and clinical data in the identification of new cancer biomarkers 
and targets for therapy, Pharmacology & Therapeutics 128(3), 488-498. 
Pabinger, S., Rader, R., Agren, R., Nielsen, J. and Trajanoski, Z., 2011, 
MEMOSys: Bioinformatics platform for genome-scale metabolic models, 
Bmc Systems Biology 5, 20. 
 
7.5.4 Division of Cell Biology, Biocenter/ 
Innsbruck Medical University 
Address: A-6020 Innsbruck, http://biocenter.i-med.ac.at/index.php/cellbiohome, 
http://www.i-med.ac.at/cellbio/  
Systems biology relevant experts: Lukas A. Huber 
Systems biology projects: 
Austrian Proteomics Platform III (GEN-AU, FFG) 
Systems biology publications: 1 
Morandell, S., Stasyk, T., Skvortsov, S., Ascher, S. and Huber, L. A., 2008, 
Quantitative proteomics and phosphoproteomics reveal novel insights into 
complexity and dynamics of the EGFR signaling network, Proteomics 8(21), 
4383-4401. 
 
7.5.5 Division of Physiology, Department of Physiology and Medical 
Physics/Innsbruck Medical University 
Address: A-6020 Innsbruck, http://physiologie.i-med.ac.at/ 
Systems biology relevant experts: Paul Jennings 
Systems biology projects:  
CARCINOGENOMICS (FP6-LIFESCIHEALTH) 
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7.5.6 Division of Human Genetics, Department of Medical Genetics, 
Molecular and Clinical Pharmacology/ 
Innsbruck Medical University 
Address: A- A-6020 Innsbruck, http://www.sfb021.at/baier/ 
Systems biology relevant experts: Gottfried Baier 
Systems biology projects: SYBILLA (FP7-HEALTH) 
 
7.5.7 Urology, Department Operative Medizin/ 
Innsbruck Medical University 
Address: A- 6020 Innsbruck, http://www.uro-innsbruck.at/ 
Systems biology relevant experts: Helmut Klocker 
Systems biology projects: CANCURE (FP6-MOBILITY) 
 
7.5.8 Cardiac Surgery, Department Operative Medizin/ 
Innsbruck Medical University 
Address: A-6020 Innsbruck, https://inside.i-med.ac.at/online/visitenkarte.show_ 
vcard?pPersonenId=FA341A4D9C70F236&pPersonenGruppe=3 
Systems biology relevant experts: Andrej Kuznetsov 
Systems biology publications: 4 
Guzun, R., Timohhina, N., Tepp, K., Gonzalez-Granillo, M., Shevchuk, I., 
Chekulayev, V., Kuznetsov, A. V., Kaambre, T. and Saks, V. A., 2011, 
Systems bioenergetics of creatine kinase networks: physiological roles of 
creatine and phosphocreatine in regulation of cardiac cell function, Amino 
Acids 40(5), 1333-1348. 
Saks, V., Guzun, R., Timohhina, N., Tepp, K., Varikmaa, M., Monge, C., 
Beraud, N., Kaambre, T., Kuznetsov, A., Kadaja, L., Eimre, M. and Seppet, 
E., 2010, Structure-function relationships in feedback regulation of energy 
fluxes in vivo in health and disease: Mitochondrial Interactosome, 
Biochimica Et Biophysica Acta-Bioenergetics 1797(6-7), 678-697. 
Guzun, R., Karu-Varikmaa, M., Gonzalez-Granillo, M., Kuznetsov, A. V., 
Michel, L., Cottet-Rousselle, C., Saaremae, M., Kaambre, T., Metsis, M., 
Grimm, M., Auffray, C. and Saks, V., 2011, Mitochondria-cytoskeleton 
interaction: Distribution of beta-tubulins in cardiomyocytes and HL-1 cells, 
Biochimica Et Biophysica Acta-Bioenergetics 1807(4), 458-469 . 
Saks, V., Guzun, R., Timohhina, N., Tepp, K., Varikmaa, M., Monge, C., 
Beraud, N., Kaambre, T., Kuznetsov, A., Kadaja, L., Margus, E. and Seppet, 
E., 2010, Systems biology and bioenergetics: Structure-function relationships 
in feedback regulation of energy fluxes in vivo Mitochondrial interactosome, 
Biochimica Et Biophysica Acta-Bioenergetics 1797, 138-138. 
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7.5.9 Nephrology and Hypertension, Internal Medicine IV/ 
Innsbruck Medical University 
Address: A-6020 Innsbruck, http://www.nephrologie-
innsbruck.at/index.php#, http://www.microarray.at/index.php 
Systems biology relevant experts: Gert Mayer, Susanna Eder,  
Dorothea Heininger, Michael Rudnicki, Susie-Jane Noppert, J. Enrich 
Systems biology relevant research groups:  
Functional Genomics and Biomarker Research group 
Systems biology projects: SYSKID (FP7-HEALTH) 
Systems biology publications: 4 
Rudnicki, M., Perco, P., Enrich, J., Eder, S., Heininger, D., Bernthaler, A., 
Wiesinger, M., Sarkozi, R., Noppert, S. J., Schramek, H., Mayer, B., 
Oberbauer, R. and Mayer, G., 2009, Hypoxia response and VEGF-A 
expression in human proximal tubular epithelial cells in stable and progressive 
renal disease, Laboratory Investigation 89(3), 337-346. 
Perco, P., Rapberger, R., Siehs, C., Lukas, A., Oberbauer, R., Mayer, G. and 
Mayer, B., 2006, Transforming omics data into context: Bioinformatics on 
genomics and proteomics raw data, Electrophoresis 27(13), 2659-2675. 
Perco, P., Muhlberger, I., Mayer, G., Oberbauer, R., Lukas, A. and Mayer, B., 
2010, Linking transcriptomic and proteomic data on the level of protein 
interaction networks, Electrophoresis 31(11), 1780-1789. 
Perco, P., Wilflingseder, J., Bernthaler, A., Wiesinger, M., Rudnicki, M., 
Wimmer, B., Mayer, B. and Oberbauer, R., 2008, Biomarker candidates for 
cardiovascular disease and bone metabolism disorders in chronic kidney 
disease: a systems biology perspective, Journal of Cellular and Molecular 
Medicine 12(4), 1177-1187.Institute for Biomedical Aging Research (IBA)/ 
Austrian Academy of Sciences. 
 
7.5.10 Institute for Biomedical Aging Research (IBA)/ 
Austrian Academy of Sciences 
Address: A-6020 Innsbruck, http://www.iba.oeaw.ac.at/index.php?id=9  
Systems biology relevant experts:  
Beatrix Grubeck-Loebenstein, Pidder Jansen-Dürr, Hermann Unterluggauer 
Systems biology relevant research groups:  
The Grubeck-Loebenstein Group (Immunology)  
The Jansen-Dürr Group (Molecular and Cell Biology) 
Systems biology projects: ADITEC (FP7-Health) 
Systems biology publications: 1 
Groebe, K., Klemm-Manns, M., Schwall, G. P., Hubenthal, H., Unterluggauer, 
H., Jansen-Durr, P., Tanguay, R. M., Morrow, G. and Schrattenholz, A., 
2010, Age-dependent posttranslational modifications of voltage-dependent 
anion channel 1, Experimental Gerontology 45(7-8), 632-637. 
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7.6 Public-private partnership institutions and companies 
7.6.1 Institute of Molecular Biotechnology GmbH (IMBA)/ 
Austrian Academy of Sciences 
Address: A-1030 Vienna, Campus Vienna Biocenter, 
http://www.imba.oeaw.ac.at/  
Short description: IMBA is a joint initiative of the Austrian Academy of 
Sciences and Boehringer Ingelheim; founded in 1999, the operative work at 
IMBA starts in 2003 and its new building ‘Life Sciences Center Vienna’ 
opened in 2006. It holds a Shared-Services agreement with IMP. 
Systems biology relevant researchers: Josef Penninger 
Systems biology projects:  
Austrian Network for Functional Mouse Genomics II (GEN-AU, FFG) 
Systems biology publications: 2 
Kocher, T., Pichler, P., Swart, R. and Mechtler, K., 2011, Quality control in 
LC-MS/MS, Proteomics 11(6), 1026-1030  
Leibbrandt, A. and Penninger, J. M., 2009, ESCI award lecture: from a little 
mouse to rationale medicine for bone loss, European Journal of Clinical 
Investigation 39(10), 842-850. 
 
7.6.2 Ludwig Boltzmann Institute for Cancer Research (LBI-CR) 
Address: A-1090 Vienna, http://lbicr.lbg.ac.at/en 
Short description: “The initiative to found a new Ludwig Boltzmann Insti-
tute for Cancer Research (LBI-CR) was started in 2004 and successfully ac-
complished in September 2005. Three scientists from the Institute of molecu-
lar Pathology (IMP), two scientists from the Medical University Vienna and a 
scientist from the Biocenter Basel formed a team in order to break new ground 
in cancer research. (…) The application was supported by 5 partner institu-
tions (the Medical University Vienna, the Institute of Molecular Pathology 
(IMP), the Research Institute of the St. Anna Kinderspital and the biotech 
companies TissueGnostics GmbH and Cell Danube AG) – and was accepted 
in December 2004 as one out of six new Ludwig Boltzmann Institutes.” 
Systems biology relevant experts: Robert Eferl, Emilio Casanova 
Systems biology projects:  
Austrian Network for Functional Mouse Genomics II (GEN-AU, FFG) 
 
7.6.3 Christian Doppler Laboratory for Allergy Research/ 
University of Vienna 
Address: A-1090 Vienna,  
http://www.meduniVienna.ac.at/allergy-research-christian-doppler/ 
Systems biology relevant experts: Rudolf Valenta 
Systems biology projects: MEDALL (FP7-HEALTH) 
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7.6.4 Christian Doppler Laboratory for Molecular Recognition 
Materials/University of Vienna 
Auch: Department of Analytical Chemistry and Food Chemistry, Institute of 
Analytical Chemistry, University of Vienna 
Short description: “The Christian Doppler (CD) Laboratory for Molecular 
Recognition Materials was founded at the beginning of 2002 at the Depart-
ment of Analytical Chemistry and Food Chemistry and is headed by Assoc. 
Prof. Dr. Michael Lämmerhofer and Prof. Dr. Wolfgang Lindner. It is fi-
nanced to 50% by the Austrian government (through the Christian-Doppler-
Society), with the second half of its budget being provided by the involved 
companies. Industrial partners are the Swedish pharmaceutical company As-
traZeneca, the German chemical-pharmaceutical company Merck KGaA, the 
pharmaceutical company Fresenius Kabi Austria and the Austrian start-up 
company piCHEM, which is active in the area of peptide chemistry.” 
Address: A-1090 Vienna, http://www.univie.ac.at/cdlformrm/index.html  
Systems biology relevant experts: Beatrix Preinerstorfer, Simone Schiesel, 
Michael Lämmerhofer, Wolfgang Lindner 
Systems biology projects: Austrian Proteomics Platform II (GEN-AU, 
FFG); Austrian Proteomics Platform III (GEN-AU, FFG) 
Systems biology publications: 1 
Preinerstorfer, B., Schiesel, S., Lammerhofer, M. L. and Lindner, W., 2010, 
Metabolic profiling of intracellular metabolites in fermentation broths from 
beta-lactam antibiotics production by liquid chromatography-tandem mass 
spectrometry methods, Journal of Chromatography A 1217(3), 312-328. 
 
7.6.5 Christian Doppler Laboratory for Proteome Analysis/ 
University of Vienna 
Address: A-1030 Vienna, Vienna Biocenter,  
http://cdl-proteome.at/?Christian_Doppler_Laboratory  
Systems biology relevant experts: Peter Pichler 
Systems biology publications: 1 
Kocher, T., Pichler, P., Swart, R. and Mechtler, K., 2011, Quality control in 
LC-MS/MS, Proteomics 11(6), 1026-1030. 
 
7.6.6 Christian Doppler Laboratory for Genomics and Bioinformatics/ 
Technical University Graz 
Address: A-8010 Graz, http://genome.tugraz.at/contact.shtml  
Systems biology relevant experts: R. Rader, S. Pabinger, Zlatko Trajanoski 
Systems biology publications: 1 
Pabinger, S., Rader, R., Agren, R., Nielsen, J. and Trajanoski, Z., 2011, 
MEMOSys: Bioinformatics platform for genome-scale metabolic models, 
Bmc Systems Biology 5, 20. 
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7.6.7 Biomarker Design Forschung GmbH (BDF) 
Address: A-1210 Vienna, http://www.biomarker-design.at/ 
Short description: “Biomarker Design Forschung GmbH (BDF) is a biotech 
R&D company incorporated in April 2009. The staff includes all the employees 
of the research department of Biomedica Medizinprodukte GmbH & Co Kg 
(Biomedica), who have successfully developed new innovative ELISA systems 
for clinical research on diseases of the cardiovascular system and bone me-
tabolism. We focus our work on finding new innovative biomarkers by coop-
eration with basic research at Universities or with small and medium Biotech 
companies and our own internal research efforts.” 
Systems biology projects: SYSKID (FP7-HEALTH) 
 
7.6.8 Biomodels Austria  
(Universitäres Zentrum für Biomodelle GmbH) 
Address: A-1210 Vienna, http://www.biomodels.at/ 
Short description: Established in 2002, the former ‘Österreichisches Zentrum 
für Biomodelle und Transgenetik’ (ÖZBT) was a joint venture of the Veteri-
nary University of Vienna, the Medical University of Vienna and the Depart-
ment for Agrobiotechnology (IFA) Tulln. In 2005, it was transformed into a 
limited liability company (GmbH) and renamed in 2006 as ‘Biomodels Austria, 
Universitäres Zentrum für Biomodelle GmbH’.  
Systems biology projects:  
Austrian Network for Functional Mouse Genomics II (GEN-AU, FFG) 
 
7.6.9 Biomay AG 
Address: A-1090 Vienna, http://www.biomay.com/  
Short description: “The Biomay Produktions- und Handels-Aktiengesellschaft, 
founded 17 years ago by Mag. Mayrhofer, today claims an important place 
among the young gene technology companies which are at the forefront of 
research in the pharmaceutical industry, thereby providing effective treatment 
possibilities for various diseases.”77 BIOMAY holds close contacts to four 
Christian-Doppler-Laboratories based at the Medical University of Vienna and 
the University of Salzburg (Allergy Research, Immunomodulation, Allergen 
Chips, Allergy Diagnosis and Therapy), representing an Austrian allergy re-
search cluster.  
Systems biology relevant experts: Ursula Baumgartner 
Systems biology projects: MEDALL (FP7-HEALTH) 
Systems biology publications: 1 
Bousquet, J., Anto, J., Auffray, C., Akdis, M., Cambon-Thomsen, A., Keil, T., 
Haahtela, T., Lambrecht, B. N., Postma, D. S., Sunyer, J., Valenta, R., Akdis, 
C. A., Annesi-Maesano, I., Arno, A., Bachert, C., Ballester, F., Basagana, X., 
Baumgartner, U., Bindslev-Jensen, C., Brunekreef, B., Carlsen, K. H., Chatzi, 
L., Crameri, R., Eveno, E., Forastiere, F., Garcia-Aymerich, J., Guerra, S., 
Hammad, H., Heinrich, J., Hirsch, D., Jacquemin, B., Kauffmann, F., Kerkhof, 
                                                           
77 http://www.biotechindustry.at/EN/biotechindustry.at/ 
Members/Biomay%20AG/Biomay+AG.aspx, accessed Feb. 4th, 2012. 
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M., Kogevinas, M., Koppelman, G. H., Kowalski, M. L., Lau, S., Lodrup-
Carlsen, K. C., Lopez-Botet, M., Lotvall, J., Lupinek, C., Maier, D., Makela, 
M. J., Martinez, F. D., Mestres, J., Momas, I., Nawijn, M. C., Neubauer, A., 
Oddie, S., Palkonen, S., Pin, I., Pison, C., Rance, F., Reitamo, S., Rial-Sebbag, 
E., Salapatas, M., Siroux, V., Smagghe, D., Torrent, M., Toskala, E., van 
Cauwenberge, P., van Oosterhout, A. J. M., Varraso, R., von Hertzen, L., 
Wickman, M., Wijmenga, C., Worm, M., Wright, J. and Zuberbier, T., 2011, 
MeDALL (Mechanisms of the Development of ALLergy): an integrated  
approach from phenotypes to systems medicine, Allergy 66(5), 596-604. 
 
7.6.10 Intercell AG 
Address: 1030 Vienna, http://www.intercell.com/ 
Short description: The Intercell AG was established as a Vienna BioCenter 
(University of Vienna) spin-of in 1998 by Alexander von Gabain (CEO), Max 
Birnstiel and three other high-ranking, international scientists, with a focus 
on the biotechnological development and production of vaccines against in-
fectious diseases. It was financed by venture capital and funding by the FFF 
and WWTF. In 2000, it was transformed into a company, going public in 2005. 
In 2010, Novartis held a share of 15.9 % (Resch and Hofer 2010: 263-265). 
Systems biology projects:  
ADITEC (FP7-HEALTH); PNEUMOPATH (FP7-HEALTH) 
 
7.6.11 TissueGnostics GmbH 
Address: A-1020 Vienna, http://www.tissuegnostics.com/EN/home.php 
Short description: established in 2003 by Katja Österreicher, Georg Steiner 
and Rupert Ecker with the aid of a dozen of development partners (Medical 
University Vienna, Memorial Sloan-Kettering Cancer Center New York, Lud-
wig Boltzmann Institute for Cancer Research, Vienna; Fred Hutchinson Cancer 
Center, Seattle; Brighamand Women`s Hospital, Boston; etc.), it purchased 
TissueGnostics Romania and founded TissueGnostics USA Inc. only four 
years later. For 2010, the company reported active sales in more than 30 
countries. Academic partners include the Ludwig Boltzmann Institute for Can-
cer Research (LBI-CR) Vienna, the Department of Pathophysiology and Al-
lergy Research and the Department of Urology at the Medical University of 
Vienna, the Urology Department at Innsbruck Medical University and Onco-
tyrol.  
Systems biology relevant experts: R.C. Ecker 
Systems biology publications: 1 
Ecker, R. C. and Tarnok, A., 2005, Cytomics: An entry to biomedical cell 
systems biology – Cytomics goes 3D: Toward tissomics, Cytometry Part A 
65A(1), 1-3 
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 Annexes 
A.1 Systems biology projects funded  
within the EU Sixth and Seventh Framework Programmes 
An ‘all fields search’ for ‘systems biology’ within the database for all FP 6 
and FP 7 projects78 results in the following lists of funded projects (details for 
these projects can be found in the same CORDIS database): 
 
A.1.1 Systems biology projects funded  
within the EU Sixth Seventh Framework Programmes 
(1) A bioinformatics and systems biology approach for the functional 
analysis of a growth-regulating MAP kinase pathway in Arabidopsis, 
ARA-MKK-D  
(2) A combined Cryo Electron Microscopy and mass Spectrometry 
approach for the structural and functional characterization of the URI-
complex, CRYO-EM URI-COMPLEX  
(3) A European model for bioinformatics research and community 
education, EMBRACE  
(4) A SNP and haplotype map for the rat, STAR  
(5) An integrative approach to cellular signalling and control processes: 
Bringing computational biology to the bench, COMBIO  
(6) AnEUploidy: understanding the importance of gene dosage imbalance 
in human health using genetics, functional genomics and systems 
biology, ANEUPLOIDY  
(7) Arabidopsis growth network integrating OMICS technologies, 
AGRON-OMICS  
(8) ASSESSMENT OF THE EUROPEAN TERRESTRIAL CARBON 
BALANCE, CARBOEUROPE-IP  
(9) Bacterial gene networks and the cell cycle, GENES AND GROWTH  
(10) Biological computation built on cell communication systems; 
CELLCOMPUT  
(11) Biosimulation – A New Tool in Drug Development, BIOSIM  
(12) CANcer CURe Early stage research training, CANCURE  
(13) Cellulose architecture systems biology for plant innovation creation; 
CASPIC  
(14) Chromosome substitution strains: a powerful tool to study the stress 
response in mouse, CSS-OMICS  
(15) Colon and breast cancer diagnostics, COBRED  
                                                           
78 http://cordis.europa.eu/search/index.cfm?fuseaction=proj.advSearch,  
accessed March 13th, 2012. 
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(16) Computational modeling of cell cycle activity and leaf development in 
Arabidopsis thaliana, LEAFMORPHOSIM  
(17) Computational systems biology of cell signalling, COSBICS  
(18) Corn Leaf Acclimation to Water Stress: Towards uncovering the molecular 
network that controls cell division and expansion in the growth zone 
with an emphasis on the role of Reactive Oxygen Species, CLAWS  
(19) Dedicated integration and modelling of novel data and prior knowledge 
to enable systems biology, DIAMONDS  
(20) Defects in the tricarboxylic acid (KREBS) cycle genes in 
tumorigenesis, TCAC IN CANCER  
(21) Design and Engineering of gene networks to respond to and correct 
alterations in signal transduction pathways, NETSENSOR  
(22) Development of a high throughput genomics-based test for assessing 
genotoxic and carcinogenic properties of chemical compounds in vitro; 
CARCINOGENOMICS  
(23) Development of metabolomics and fluxomics methods for metabolic 
drug target and toxicity elucidation using yeast, CHEMOFLUXOME  
(24) Dietary polyphenols, gut microbes and human health: A systems 
biology approach; GUTSYSTEM  
(25) DNA damage response and repair mechanisms, DNA REPAIR  
(26) Dynamics and complexity in synthetic protein networks, SYNPLEXITY  
(27) Empowering the micro-array-based European research area to take a 
lead in development and exploitation, EMERALD  
(28) ENFIN – an experimental network for functional integration, ENFIN  
(29) Engineered modular bacterial hydrogen photo-production of hydrogen; 
BIOMODULARH2  
(30) Entrainment of the circadian clock, EUCLOCK  
(31) European Conference on Mathematical and Theoretical Biology 2005; 
ECMTB05  
(32) European systems biology initiative for combating complex diseases, 
ESBIC-D  
(33) Evolution of the Protein-Interaction Networks: the SH3 network in 
Yeast, PENELOPE  
(34) From gene regulatory networks to drug prediction, NET2DRUG  
(35) Function and regulation of the type 2 vasopressin receptor and 'V2R' in 
body fluid homeostasis, AVP-V2R  
(36) Functional analysis of plant metacaspases type II, PLANT 
METACASPASES  
(37) Generating an integrative plant science, GIPS  
(38) HYperspectral REmote Sensing in Europe – specific Support Actions; 
HYRESSA  
(39) IMPACTS AND RISKS FROM ANTHROPOGENIC 
DISTURBANCES ON SOILS, CARBON DYNAMICS AND 
VEGETATION IN PODZOLIC ECOSYSTEMS, OMRISK  
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(40) IMPROVING THE YIELD STABILITY OF DURUM WHEAT 
UNDER MEDITERRANEAN CONDITIONS, OPTIWHEAT  
(41) Interdisciplinary training in systems biology, SYSTEMS BIOLOGY  
(42) Investigation of the transcriptional regulation of the antioxidant network 
in bundle sheath cells of Arabidopsis using a novel immunocapture 
technique for bundle sheath specific polysomes, ANTIOXARAB  
(43) Metabolomics of salicylate induced plants, MESAIP  
(44) Million frame per second, time-correlated single photon camera; 
MEGAFRAME  
(45) Modeling signaling pathways in cartilage degeneration, MOSPAIC  
(46) Novel computational and informatics approaches for the quantitative 
studies of proteins, COMPROT  
(47) Novel molecular tools for the analysis of the cell membrane proteome 
and interactome, MOLTOOL/INTERACTOM  
(48) Reconstructing regulatory networks from high-throughput post –
genomic data, REGULOMICS  
(49) Scalable modelling and analysis techniques to study emergent cell 
behaviour – understanding the E. coli stress response, EC-MOAN  
(50) Shaping new directions in Mathematics for Science and Society, 
MATHFSS  
(51) Simulation modelling of the MAP kinase pathway, SIMAP  
(52) Synthesis and nanotechnologial application of tethered silicates, SANTS  
(53) Synthetic biomimetic nanoengines: A modular platform for engineering 
of nanomechanical actuator building blocks, NANOMOT  
(54) Systematic functional analysis of intracellular parasitism as a model of 
genomes conflict, SYSCO  
(55) Systems biology for medical applications, SYSBIOMED  
(56) Systems Biology of Gulcose Repression in Yeast, SYBGRY  
(57) Systems biology of nuclear receptors: A nutrigenomics approach to 
aging-related diseases, NUCSYS  
(58) Systems biology of RNA metabolism in yeast, RIBOSYS  
(59) SYSTEMS BIOLOGY OF STEM CELL FUNCTION IN 
ARABIDOPSIS THALIANA, SY-STEM  
(60) Systems biology of the AMP-activated protein kinase pathway, AMPKIN  
(61) Systems biology strategies and metabolome engineering for the enhanced 
production of recombinant proteins in streptomyces, STREPTOMICS  
(62) Systems Sciences; ERASYSBIO  
(63) System-wide analysis and modelling of protein modification, SYSPROT  
(64) Temporal Genomics for tailored chronotherapeutics, TEMPO  
(65) The Take-off of European Systems Biology, EUSYSBIO  
(66) The technologies of biological membranes, MEMPROT  
(67) Towards an understanding of dynamic transcriptional regulation at 
global scale in bacteria: a systems biology approach, BASYSBIO  
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(68) Towards European Neuromal Cell Simulation: a European consortium to 
integrate the scientific activities for the creation of a European Alliance 
devoted to the complete in-silico model of Neuronal Cell, SYMBIONIC  
(69) Training in plant systems biology, PLANT SYSTEMS BIOLOG  
(70) Wnt signalling and adipose tissue plasticity, WNT ADIPOSE TISSUE  
(71) Workshop on ‘Systems biology of DNA-damage-induced stress 
responses’, EU-US WORKSHOP  
(72) Yeast Systems Biology Network, YSBN  
 
 
A.1.2 Systems biology projects funded  
within the EU Seventh Framework Programmes 
(1) 4C technology: uncovering the multi-dimensional structure of the 
genome, 4C  
(2) A combined experimental and computational approach for quantitative 
and mechanistic understanding of transcriptional regulation, 
TRANSCRIPTION_REG  
(3) A combined post-genomics, biochemical and biophysical investigation 
to model the systems biology of embryo cell expansion and seed 
germination in Arabidopsis thaliana, EXPANSION  
(4) A comparative genomic analysis into the origin of metazoan 
multicellularity, MULTICELLGENOME  
(5) A comprehensive dissection of pneumococcal-host interactions, 
PNEUMOPATH  
(6) A Computational Systems Biology Approach to Reveal the Molecular 
Basis of Complex Diseases, EYLCOMPDISSYSBIO  
(7) A cross-species neurogenomics approach to anxiety, GENANX  
(8) A novel mode of TGF-beta signalling through Smad1/Smad5 
phosphorylation: mechanism and functional role in cancer, SMAD1/5 
AND CANCER  
(9) a Study of the Epigenetic Alterations that Result in Cardiac 
Hypertrophy, SEARCH  
(10) A system view on the differential activities of human type I interferons, 
IFNACTION  
(11) A systems approach to defining membrane protein networks and 
applications, TRANSYS  
(12) A Systems Biology Approach to controlling Nematode Infections of 
Livestock ,NEMATODESYSTEMHEALTH  
(13) A Systems Biology approach to disclose auxin synthesis in plants, 
SYSBIOAUX  
(14) A systems biology approach to dissect cilia function and its disruption 
in human genetic disease ,SYSCILIA  
(15) A systems biology approach to elucidate the yeast metabolic network, 
MRM-YEAST METABOLISM  
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(16) A systems BIOlogy Study to TAilored Treatment in Chronic Heart 
Failure, BIOSTAT-CHF  
(17) Accelerating the transition to a toxicity pathway-based paradigm for 
chemical safety assessment through internationally coordinated research 
and technology development, AXLR8  
(18) Actin-membrane interaction in biomimetic and living cellular systems 
studied with a novel, high precision optical method,  
BIOMIMETIC-CORTEX  
(19) Advanced bioanalytical technologies for systems biology studies, 
ADVANCED BIOANALYSIS  
(20) Advanced Immunization Technologies, ADITEC  
(21) Airway Disease PRedicting Outcomes through Patient Specific 
Computational Modelling, AIRPROM  
(22) An integrated study on three novel regulatory hubs in megakaryocytes 
and platelets, discovered as risk genes for myocardial infarction by a 
genome-wide association and platelet systems biology study, NETSIM  
(23) Apoptosis systems biology applied to cancer and AIDS. An integrated 
approach of experimental biology, data mining, mathematical modelling, 
biostatistics, systems engineering and molecular medicine, APO-SYS  
(24) Assembly and maintenance of a co-regulated chromosomal 
compartment, ACCOMPLI  
(25) ASSET: Analysing and Striking the Sensitivities of Embryonal 
Tumours, ASSET  
(26) BIO knowLEDGe Extractor and Modeller for Protein Production, 
BIOLEDGE  
(27) Biology of liver and pancreatic development and disease, BOLD  
(28) Bioproduction of pharmaceutically important iridoids: systems biology 
based approach, SYSBIOPRO  
(29) Breaking the code of RNA sequence-structure-function relationships: 
New strategies and tools for modelling and engineering of RNA and 
RNA-protein complexes, RNA+P=123D  
(30) Cancerbiome: Characterization of the cancer-associated microbiome, 
CANCERBIOME  
(31) Canine models of human psychiatric disease: identifying novel anxiety 
genes with the help of man's best friend, DOGPSYCH  
(32) Cell Growth and Size Homeostasis in Proliferating Mammalian Cells, 
CELLCYCLEGROWTHSIZE  
(33) Characterization and modelling of dietary effects mediated by gut 
microbiota on lipid metabolism, ETHERPATHS  
(34) Characterization and quantitative modeling of DNA mismatch repair 
and its role in the maintenance of genomic stability and cancer 
avoidance, MISMATCH2MODEL  
(35) Charting the landscape of brain development by large-scale single-cell 
transcriptomics and phylogenetic lineage reconstruction, BRAINCELL  
(36) Chemogenomic profiling of drug-protein binding by shape, 
enthalpy/entropy and interaction kinetics, DRUGPROFILBIND  
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(37) Chromatin and transcription in ES cells: from single cells to genome 
wide views, EXPRES  
(38) Cis-regulatory logic of the transcriptional control in neural stem cells, 
CISSTEM  
(39) Communication Motifs: Principles of bacterial communication in  
non-genetically diversified populations, COMMOTS  
(40) Comparative Genomics and Next Generation Sequencing, COGANGS  
(41) Compartmentalization and dynamics of nuclear functions, CDNF  
(42) Connecting the animal genome, gastrointestinal microbiomes and 
nutrition to improve digestion efficiency and the environmental 
impacts of ruminant livestock production, RUMINOMICS  
(43) Conservation and divergence of tissue-specific transcriptional regulation, 
CONSERVREGCIRCUITRY  
(44) Conserved Non-Coding Sequences; function, variability and phenotypic 
consequences, HUCNC  
(45) Control of light use efficiency in plants and algae – from light to harvest, 
HARVEST  
(46) Controlling stochastic gene expression during development and stem 
cell differentiation, GENENOISECONTROL  
(47) Coordination of oxidative stress signalling with forkhead-regulated 
transcription during the fission yeast cell cycle, OXICELLCYCLE  
(48) Coordination of resources for conditional expression of mutated mouse 
alleles, CREATE  
(49) Decoding genetic switches in T helper cell differentiation, THSWITCH  
(50) Decoding the complexity of quantitative natural variation in 
Arabidopsis thaliana, DECODE  
(51) Decomposition and Discovery of Complex Networks, DEDINET  
(52) Derived and Ancestral RNAs: Comparative Genomics and Evolution of 
ncRNAs, DARCGENS  
(53) Design principles and controllability of protein circuits, DEPICT  
(54) Detection and interpretation of de novo mutations and structural 
genomic variations in mental retardation, DENOVO  
(55) Determinants of mammalian transcription start site selection and core 
promoter usage, DTSSCP  
(56) Determining the roles of the nuclear periphery in mammalian genome 
function, FUNCTIONALEDGE  
(57) Developing maximum-resolution genotype-phenotype maps using 
whole-genome polymorphism data, MAXMAP  
(58) Developing single cell technologies for systems biology, ISOLATE  
(59) Development of microRNA Medicines for Cardiac Metabolic Diseases; 
A Targeted European Exchange Programme, CARDIOMIR  
(60) Development of novel treatment strategies based on knowledge of 
cellular dysfunction in diabetes, BETABAT  
(61) Development of systems for high content screening of live cells, 
HICONTCELLSCREEN  
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(62) Developmental and genetic analysis of DNA double-strand break repair, 
DSBREPAIR  
(63) Developmental effects of environment on reproductive health, DEER  
(64) DISSECTING GENETIC DEPENDENCIES IN CANCER, 
FUNCTIONAL GENOMICS  
(65) Dissecting the transcriptional mechanisms controlling growth during 
normal development and cancer, GROWTHCONTROL  
(66) Dissection of environmentally-mediated epigenetic silencing, ENVGENE  
(67) DNA Repair in Individual BActerial Cells, DRIBAC  
(68) Doxorubicin-induced impairment of metabolic and stress signaling:  
A culprit of cardiotoxic action of the drug?, ANTHRAPLUS  
(69) Dynamic Interplay between Eukaryotic Chromosomes: Impact on 
Genome Stability, DICIG  
(70) Dynamic protein-DNA interactomes and circadian transcription 
regulatory networks in mammals, DYNACLOCK  
(71) Dynamics and stability of covalent protein modifications, PROTMOD  
(72) Dynamics of local transcriptomes and proteomes in neurons, 
NEURONAL DYNAMICS  
(73) e-Laboratory for interdisciplinary collaborative research in data mining 
and data-intensive sciences, E-LICO  
(74) Elucidation of the molecular and functional basis of disease phenotypes 
in the rat model, ELABORATE  
(75) Engineering zinc fingers to target cancer hub genes, ZINC-HUBS  
(76) Enhancing access and services to east European users towards an efficient 
and coordinated panEuropean pool of NMR capacities to enable global 
collaborative research & boost technological advancements, EAST-NMR  
(77) Epigenetic and genome stability: Non coding RNA-mediated chromatin 
modifications in S. cerevisiae, EPINCRNA  
(78) Epigenetic determinants of the genome that govern cellular plasticity, 
EPIGEPLAS  
(79) Epigenetic regulation and monoallelic gene expression:  
the X-inactivation paradigm and beyond, EPIGENETIX  
(80) Epigenetic regulation of the adaptative response of C.reinhardtii to 
development and environmental stresses:Characterization of.Histone 
PTMS,gene regulation and pathways employing a Systems Biology., 
EPISYSBIOL  
(81) Epigenetics towards systems biology, EPIGENESYS  
(82) Eukaryotic unicellular organism biology systems biology of the control 
of cell growth and proliferation, UNICELLSYS  
(83) European consortium on synaptic protein networks in Neurological and 
Psychiatric diseases, EUROSPIN  
(84) European multidisciplinary ALS network identification to cure motor 
neuron degeneration, EURO-MOTOR  
(85) European Sequencing and Genotyping Infrastructure, ESGI  
(86) Events, Causality and Symmetry-the next-generation semantics, ECSYM  
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(87) Evolution and Development of Bacterial Communication, 
EVODEVOQUORUM  
(88) Evolution of gene regulatory networks in animal development, EVONET  
(89) Exploitation of actinomycetes genomics using synthetic and system 
biology approaches, EXPLOGEN  
(90) Exploring cellular dynamics at nanoscale, EXCELL  
(91) Expression regulatory networks: beyond promoters and transcription 
control, ERNBPTC  
(92) Fighting osteoporosis by blocking nucleotides: purinergic signalling in 
bone formation and homeostasis, ATPBONE  
(93) Finding biomarkers of anti-microbial drug resistance via a systems 
biology analysis of fungal pathogen interactions with the human immune 
system, SYBARIS  
(94) From Data to Models: New Bioinformatics Methods and Tools for 
Data-Driven Predictive Dynamic Modelling in Biotechnological 
Applications, BIOPREDYN  
(95) Functional and evolutionary studies of the glutamatergic synapse;  
a proteomic and genetic approach, PSIEMBL  
(96) Functional and regulatory protein networks of chromatin modifying 
enzymes, CHROMATINMODWEB  
(97) Functional genomics of fatty acid desaturases in caenorhabditis elegans, 
FUNGENCEL  
(98) Fungi in the setting of inflammation, allergy and autoimmune diseases: 
Translating basic science into clinical practices, ALLFUN  
(99) GENE REGULATORY NETWORK CONTROLLING THE ROOT 
STEM CELL NICHE IN ARABIDOPSIS THALIANA, STEM CELL 
REGULATION  
(100) Genetic and epigenetic determinants of allele-specific gene expression 
in the human Major Histocompatibility Complex, REGVARMHC  
(101) Genetic and Epigenetic Networks in Cognitive Dysfunction, GENCODYS  
(102) Genetic interaction networks: From C. elegans to human disease, 2-HIT  
(103) Genetics of Resistance to Malaria Parasites in the Mosquito Anopheles 
gambiae, MALARES  
(104) Genome Evolution in the Animal Kingdom, GENEVA  
(105) Genomic determinants of inflammation: from physical measurements 
to system perturbation and mathematical modeling, MODEL-IN  
(106) Genomics biomarkers of environmental health, 
ENVIROGENOMARKERS  
(107) Harnessing systems immunology to unravel dendritic cell subset 
biology, SYSTEMSDENDRITIC  
(108) High Throughput Systematic Single Cell Genomics using Micro/ 
Nano-Fluidic Chips for Extracting, Pre-analysing, Selecting and 
Preparing Sequence-ready DNA, CELL-O-MATIC  
(109) How biochemical networks encode biological specificity: Modulation of 
cell migration by isoform specific ERK and Akt signaling, BIOSPEC  
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(110) How does the X chromosome regulate DNA methylation in pluripotent 
stem cells?, XXDNAM  
(111) Human Evolutionary Immunogenomics: population genetic variation 
in immune responses, EVOIMMUNOPOP  
(112) Human Genetics of Tuberculosis, GENTB  
(113) Identification and characterization of primate structural variation and 
an assessment of intra-specific patterns of selection and copy-number 
variation, PRIMATESVS  
(114) Identifying network control elements in breast cancer oncogenic 
transformation via whole transcriptome analysis, 
CONTROLNETONCTRANS  
(115) Improving the resistance of legume crops to combined abiotic and 
biotic stress, ABSTRESS  
(116) In-depth quantification and characterisation of PI 3-kinase signalling 
networks at a System Biology level, PI3K SYSTEMS BIOLOGY  
(117) Industrial Systems Biology of Yeast and A. oryzae, INSYSBIO  
(118) Inferring DNA binding specificities through in silico folding of 
natively unstructured protein regions, PROTDNABINDSPEC  
(119) Initiating and interfering with silencing of transposons, I2ST  
(120) INtegral BIOmathics Support Action, INBIOSA  
(121) Integrated evolutionary analyses of genetic and drug interaction 
networks in yeast, NETWORK EVOLUTION  
(122) Integrating modeling into plant systems biology: Applications to 
auxin-driven plant morphogenesis, PLANTSYSMODEL  
(123) INTEGRATION OF THE SYSTEM MODELS OF INSULIN 
SIGNALLING AND OF MITOCHONDRIAL FUNCTION AND ITS 
APPLICATION IN THE STUDY OF COMPLEX DISEASES, MITIN  
(124) Interferon-focused Innate Immunity Interactome and Inhibitome, I-FIVE  
(125) International Data Exchange and Data Representation Standards for 
Proteomics, PROTEOMEXCHANGE  
(126) KRAB zinc finger gene biology in evolution and disease, KRAB-ZNF  
(127) Linking the clock to metabolism, TIMET  
(128) Lipid droplets as dynamic organelles of fat deposition and release: 
Translational research towards human disease, LIPIDOMICNET  
(129) Macrophage systems biology applied to disease control, MACROSYS  
(130) Mammalian Origin of replication Genome-wide Mapping and 
Regulation, ORIGINOME  
(131) Mapping the cell, MAPPING THE CELL  
(132) Mechanisms of Epigenetic regulation in Development, Evolution and 
Adaptation, MEDEA  
(133) Mechanisms of microRNA biogenesis and turnover, MIRTURN  
(134) Mechanisms of the Development of ALLergy, MEDALL  
(135) MEIOtic inSIGHT: Deciphering the engine of heredity, MEIOSIGHT  
(136) Metabolic Flux Analysis and Cancer, METAFLUX  
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(137) Metabolomics of fungal diseases: a systems biology approach for 
biomarkers discovery and therapy, FUNMETA  
(138) Metabolomics of single eukaryotic cells, MESEL  
(139) Methods for high-throughput (HTP) analysis of protein glycosylation, 
HIGHGLYCAN  
(140) Microbes in Allergy and Autoimmunity Related to the Skin, MAARS  
(141) Microsystems and Bioanalysis Platforms for Health Care 
MICROCARE, MICROCARE  
(142) Modelling and simulation environment for systems medicine  
(Chronic obstructive pulmonary disease -COPD- as a use case), 
SYNERGY-COPD  
(143) Modelling latent causes in molecular networks, LATENTCAUSES  
(144) Models of genome evolution, phylogenomics and the tree of life, 
PHYGENOM  
(145) Modulating cellular clearance to cure human disease, CLEAR  
(146) Molecular mechanisms controlling X chromosome inactivation, 
ACTIVATION OF XCI  
(147) Molecular mechanisms underlying plant miRNA action, MICROMECCA  
(148) Molecular signatures: a systems biology tool to understand how leaf 
development is constrained by drought, MOLSIG  
(149) Multi-layer network modules to identify markers for personalized 
medication in complex diseases, MULTIMOD  
(150) Multilevel Modelling for Predictive Toxicology, COMPTOX  
(151) Multiscale Applications on European e-Infrastructures, MAPPER  
(152) Multiscale poro-micromechanics of bone materials, with links to 
biology and medicine, MICROBONE  
(153) New Algorithms for Host Pathogen Systems Biology, SYSPATHO  
(154) Optimization and inference algorithms from the theory of disordered 
systems: theoretical challenges and applications to large-scale inverse 
problems in systems biology, OPTINF  
(155) Pathogenomics and systems biology of fungal infections an integrative 
approach, FINSYSB  
(156) Physical principles in host-pathogen interactions, PPHPI  
(157) Polycomb in development, genome regulation and cancer, 
FLYINGPOLYCOMB  
(158) Population transcriptional genomics in humans using high throughput 
sequencing, POPRNASEQ  
(159) Practical statistical approaches for addressing replicability problems in 
life sciences, PSARPS  
(160) Predicting long-term toxic effects using computer models based on 
systems characterization of organotypic cultures, NOTOX  
(161) Principles of Chromatin Organization, CHROMATINPRINCIPLES  
(162) Programmed and unprogrammed genomic rearrangements during the 
evolution of yeast species, CHROMARRANGE  
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(163) Prokaryotic RNomics: Unravelling the RNA-mediated regulatory 
layers, PROKRNA  
(164) Protease Systems Biology in Tumorigenesis and Neurodegeneration, 
PROTEASYS  
(165) Proteomics facility at the institute of molecular biology and 
biotechnology, PROFI  
(166) Proteomics specification in time and space, PROSPECTS  
(167) Proteomics standards international molecular exchange – Systematic 
capture of published molecular interaction data, PSIMEX  
(168) Proteomics v3.0: development, implementation and dissemination of  
a third generation proteomics technology, PROTEOMICS V3.0  
(169) Quantitative Analysis of the Hourglass Model of Evolution of 
Development., HOURGLASS  
(170) Quantitative Reactive Modeling, QUAREM  
(171) Quantitative understanding of a living system and its engineering as  
a cellular organelle, CELLDOCTOR  
(172) Rational design of plant systems for sustainable generation of  
value-added industrial products, SMARTCELL  
(173) Real-time non-invasive characterization and selection of oil-producing 
microalgae at the single-cell level, FUEL MAKING ALGAE  
(174) Regulating recombination in mitotic and meiotic cells, RECMITMEI  
(175) Regulation and function of non-coding RNAs in epigenetic processes: 
the paradigm of X-chromosome inactivation, NCRNAX  
(176) Regulation of Polycomb Complex (PRC2) during development and in 
diseases, REPODDID  
(177) Regulatory genomics in Drosophila, REGULATORY GENOMICS  
(178) Relevance of double strand break repair pathway choice in human 
disease and cancer, DSBRECA  
(179) Reproductive Biology Early Research Training, REPRO-TRAIN  
(180) RNA and epigenetics: RNAi-driven chromatin modifications, 
RNAIEPIMOD  
(181) RNA silencing in regulation and evolution, REVOLUTION  
(182) RNAi-mediated genome regulation, RNAIGENREG  
(183) Role of bone morphogenic protein 8b (BMP8b) in thermogenesis,  
BMP 8B THERMOGENESIS  
(184) Sex-biased genome and transcriptome evolution in mammals, 
SEXGENTRANSEVOLUTION  
(185) Signaling circuitry controlling fungal virulence: identification and 
characterization of conserved and specific fungal virulence genes as 
common antifungal targets, ARIADNE  
(186) Signaling Networks of Ovarian Cancer Metastates, Stem Cells and 
Maturation Phenotypes, SIGNALING METASTATES  
(187) Single cell imaging of gene activation during oxidative neuron death: 
towards quantitative systems approaches, SIM-ON  
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(188) Single-cell gene regulation in differentiation and pluripotency, 
SINGLE-CELL GENOMICS  
(189) Small RNA mediated Epigenetics in vertebrates, EPIRNAS  
(190) Social interactions in microbes, INTERACTINGMICROBES  
(191) Sphingolipid homeostasis: from basic biology to applications, 
SPHINGONET  
(192) sRNA regulatory networks, MIRNET  
(193) Strengthening the University of Plovdiv research potential in plant 
systems biology and food biotechnology, BIOSUPPORT  
(194) Sustainable approaches to reduce Oomycete (Saprolegnia) infections in 
aquaculture, SAPRO  
(195) Synaptic Systems: dissecting brain function in health and disease, 
SYNSYS  
(196) Synthetic metabolic pathways for carbon fixation, SYMPAC  
(197) System biology of nitrogen-carbon-signal integration in the overall 
Arabidopsis signaling network, ATSYSTM-BIOL  
(198) Systematic analysis of factors controlling meiotic recombination in 
higher plants, MEIOSYS  
(199) Systematic chemical genetic interrogation of biological networks, SCG  
(200) Systems analysis of plant metabolism through the integration of 
heterogeneous data from genetics, informatics and metabolomics, SAMIT  
(201) Systems and Signals Tools for Estimation and Analysis of 
Mathematical Models in Endocrinology and Neurology, SYSTEAM  
(202) Systems biology approaches to novel Tumour Suppressors, SYSTUMS  
(203) Systems biology approaches to understand cell pluripotency Acronym: 
PluriSys, PLURISYS  
(204) Systems Biology as a Driver for Industrial Biotechnology, SYSINBIO  
(205) Systems Biology of Cancer Kinome, CANCER KINOME  
(206) Systems Biology of Colorectal Cancer, SYSCOL  
(207) Systems biology of human metabolism, SYSTEM_US  
(208) Systems Biology of Lipids Metabolism, SBLIME  
(209) Systems biology of liver cancer: an integrative genomic-epigenomic 
approach, MODHEP  
(210) Systems Biology of Mitosis, MITOSYS  
(211) Systems biology of Mycobacterium tuberculosis, SYSTEMTB  
(212) Systems biology of phagosome formation and maturation, modulation 
by intracellular pathogens, PHAGOSYS  
(213) Systems Biology Of Pseudomonas Aeruginosa In Biofilms, SYSBIOFILM  
(214) Systems Biology of Stem Cells and Reprogramming, SYBOSS  
(215) Systems biology of T-cell activation in health and disease, SYBILLA  
(216) Systems biology of the heterobasidion-spruce interaction: application of 
metabolomics and genomics to understanding host resistance, SYBHES  
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(217) Systems biology to understand plant architecture, SYSARC  
(218) Systems biology towards novel chronic kidney disease diagnosis and 
treatment, SYSKID  
(219) Systems Chemical Biology – Chemical Biological Perturbation and 
Dissection of Dynamic Biological Systems, SYSCHEMBIOL  
(220) Systems Chemistry from Bottom Up: Switching, Gating and Oscillations 
in Non Enzymatic Peptide Networks, BOTTOM-UP_SYSCHEM  
(221) Systems Genetics of Heritable variaTions, SIGHT  
(222) Systems Genetics of Obesity and Related Metabolic Traits in Pig Model 
to Improve Human Health, SYSGEN OF OBESITY  
(223) Systems microscopy ? a key enabling methodology for next-generation 
systems biology, SYSTEMS MICROSCOPY  
(224) 'Systems' study of cellular growth, shape and polarity, SYSGRO  
(225) Systems-level, multi-layer understanding of cellular responses to 
ionizing radiation, TRIREME  
(226) System-wide analysis of regulatory processes that mediate at the 
boarder of metabolome and proteome, METABOLICREGULATORS  
(227) Tackling the future challenges in systems biology, FUTURESYSBIO  
(228) Targeting endothelial metabolism: a novel anti-angiogenic therapy, 
ECMETABOLISM  
(229) Targeting glucocorticoid resistance in T-ALL: a Systems Biology 
approach, TIGRE  
(230) Targeting the reproductive biology of the malaria mosquito Anopheles 
gambiae: from laboratory studies to field applications, ANOREP  
(231) Telomere function in meiosis, TELOMERES IN MEIOSIS  
(232) The Application of Modern Proteomic and Metabolomic 
Methodologies to the Assessment of FOOd SAFety, FOOSAF  
(233) The biological role of tandem repeats as hypervariable modules in 
genomes, REPEATSASMUTATORS  
(234) The consolidation of systems biology research stimulating the 
widespread adoption of systems approaches in biomedicine, 
biotechnology, and agri-food, ERASYSBIO+  
(235) The evolution of antibiotic resistance: integrating molecular 
mechanisms of resistance and evolutionary context, RESISTEVO  
(236) The evolution of genetic robustness, 2B-ROBUST  
(237) The international data coordination centre, I-DCC  
(238) THE ROLE OF BACTERIAL MULTIGENE FAMILIES IN 
INFECTION: IDENTIFICATION OF HOST TARGET NETWORKS 
BY HIGH-THROUGHPUT PROTEIN INTERACTOMICS, 
INFBIOSYS  
(239) The role of heterochromatin enzymes on the biology of their targets, 
PICHV2.0  
(240) The role of noncoding RNA in sense and antisense or orientation in 
epigenetic control of rRNA genes, RIBOGENES  
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(241) The role of the Calcium Sensing Receptor (CaSR) in health and disease, 
implications for translational medicine., MULTIFACETED CASR  
(242) The tympanal ears of insects: structural solutions to acoustic signal 
analysis., INSECT EARS  
(243) Towards the establishment of a permanent European Virtual Institute 
dedicated to Malaria Research (EVIMalaR), EVIMALAR  
(244) Traditional Chinese medicine in the post-genomic era: identifying lead 
therapeutic compounds against cancer, TCMCANCER  
(245) Training in systems biology applied to flowering, SYSFLO  
(246) Transcription factor dynamics in living cells at the single molecule 
level, TF DYNAMICS IN VIVO  
(247) Transcriptomics in cancer epidemiology, TICE  
(248) Transport and signalling in Polarized Cells, TRANSPOL  
(249) Uncovering and understanding RNA through Massively Parallel 
Sequencing, RNA-MAPS  
(250) Uncultivated microbes in situ – a computational biology approach to 
determine molecular capabilities and ecological roles, UMICIS  
(251) Understanding the axon-glial functional unit in myelination and 
remyelination, AXOGLIA  
(252) Understanding the cytotoxicity of aberrantly folded proteins in 
neurodegeneration, FOLDTOX  
(253) United Europeans for the development of pharmacogenomics in multiple 
sclerosis, UEPHA-MS  
(254) Unveiling the Roles of Chromatin Insulators in Higher-order Chromatin 
Architecture and Transcription Regulation one molecule at a time., 
SMINSULATOR  
(255) Variability and robustness in bio-molecular systems, VARB  
(256) VIB International Postdoctoral Program to boost '-omics' technologies 
throughout the institute., OMICS@VIB  
(257) Virtual multidisciplinary EnviroNments USing Cloud infrastructures, 
VENUS-C  
(258) Word Wide NMR, WW-NMR  
(259) Zebrafish Regulomics for Human Health, ZF-HEALTH  
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A.2 Co-authorship networks of  
systems biology researchers in Austria and internationally 
Systems biology researchers based in Austria with publications on  
topic ‘systems biology’ in Web of KnowledgeTM database since 2000  
(as of August 2011) 
(1) Bollenbach, Tobias 
(2) Dehmer, Matthias 
(3) Deigner, Hans-Peter 
(4) Drack, Manfred 
(5) Engl, Heinz W. 
(6) Enot, David P. 
(7) Flamm, Christoph 
(8) Graber, Armin 
(9) Grabherr, Reingard 
(10) Guet, Calin 
(11) Henzinger, Thomas A. 
(12) Hirt, Heribert 
(13) Hofacker, Ivo L. 
(14) Koal, Therese 
(15) Kreil, David P. 
(16) Kuchler, Karl 
(17) Kugler, Philipp 
(18) Lu, James 
(19) Mayer, Bernd 
(20) Mechtcheriakova, Diana 
(21) Mechtler, Karl 
(22) Mühlberger, Irmgard 
(23) Noe, Christian 
(24) Osprian, Ingrid 
(25) Perco, Paul 
(26) Rattei, Thomas 
(27) Schleper, Christa 
(28) Schmeiser, Christian 
(29) Schuster, Peter 
(30) Stark, Alexander 
(31) Superti-Furga, Giulio 
(32) Torgersen, Helge 
(33) Trajanoski, Zlatko 
(34) Weckwerth, Wolfram 
(35) Weinberger, Klaus M. 
(36) Widder, Stefanie 
(37) Wienkoop, Stefanie 
(38) Wiesinger, Martin 
(39) Zacherl, Nikolaus 
(40) Zatloukal, Kurt 
 
Top 100 systems biology researchers with publications on topic ‘systems 
biology’ in Web of KnowledgeTM database since 2000 (as of August 2011)  
The list of authors has been scanned for inconsistencies in names. Additionally, 
following names were excluded because they are shared by several authors: 
Anonymous, Zhang J, Chen X, Kim S, Yang Jy, Li J, Brown M, Wang Y. 
(1) Aderem, Alan 
(2) Aebersold, Ruedi 
(3) Alberghina, Lilia 
(4) Allgöwer Frank 
(5) Alon, Uri 
(6) An, Gary 
(7) Andersen, Melvin E. 
(8) Androulakis, Ioannis, P. 
(9) Auffray, Charles 
(10) Bader, Gary D. 
(11) Bakker, Barbara M. 
(12) Baliga, Nitin S. 
(13) Banga, Julio R. 
(14) Bolouri, Hamid 
(15) Breitling, Rainer 
(16) Bruggeman, Frank J. 
(17) Burgess, Shane C. 
(18) Califano, Andrea 
(19) Cascanta, Marta 
(20) Chen, Bor-Sen 
(21) Chen Luonan 
(22) Cho, Kwang Hyun 
(23) Clermont, Gilles 
(24) Collins, James J. 
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(25) Deutsch, Eric W. 
(26) Doyle, Francis J. III 
(27) Dunn, Warwick B. 
(28) Fages, Francois 
(29) Fernie, Alisdair R. 
(30) Ghosh, Samik 
(31) Gilles, Ernst Dieter 
(32) Goodacre, Royston 
(33) Hankemeier, Thomas 
(34) Heinemann, Matthias 
(35) Hogenesch, John B. 
(36) Holmes, Elaine 
(37) Hood, Leroy E. 
(38) Hucka, Michael 
(39) Hunt, C. Anthony 
(40) Iyengar, Ravi 
(41) Kell, Douglas B. 
(42) Khammash, Mustafa 
(43) Kim, Tae Yong 
(44) Kitano, Hiroaki 
(45) Klamt, Steffen 
(46) Klingmüller, Ursula 
(47) Klipp, Edda 
(48) Kochhar, Sunil 
(49) Kolch, Walter 
(50) Kopka, Joachim 
(51) Lauffenburger, Douglas A. 
(52) Le Novere Nicholas 
(53) Lee, Sang Yup 
(54) Liao, James C. 
(55) Lindon, John C. 
(56) Lu, Xin 
(57) Ma’ayan, Avi 
(58) Matsuoka, Yukiko 
(59) Mendes, Pedro 
(60) Miyano, Satoru 
(61) Murphy, Robert F. 
(62) Nicholson, Jeremy K. 
(63) Nielsen, Jens 
(64) Noble, Denis 
(65) Oliver, Stephen G. 
(66) Oresic, Matej 
(67) Palsson, Bernhard O. 
(68) Pandey, Akhilesh 
(69) Popel, Aleksander S. 
(70) Priami, Corrado 
(71) Roukos, Dimitrios H. 
(72) Saez-Rodriguez, Julio 
(73) Saito, Kazuki 
(74) Sander, Chris 
(75) Sauer, Uwe 
(76) Sauro, Herbert M 
(77) Schadt, Eric E. 
(78) Selbig, Joachim 
(79) Snoep, Jacky L. 
(80) Soliman, Sylvain 
(81) Spasic, Irena 
(82) Subramaniam, Shankar 
(83) Tarnok, Attila 
(84) Terzic, Andre 
(85) Timmer, Jens 
(86) Tomita, Masaru 
(87) Ueda, Hiroki R. 
(88) Van der Greef, Jan 
(89) Van Ommen, Ben 
(90) Vera, Julio 
(91) Vidal, Marc 
(92) Vodovotz, Yoram 
(93) Voit, Eberhard O. 
(94) Weckwerth, Wolfram 
(95) Westerhoff, Hans V. 
(96) Wiechert, Wolfgang 
(97) Willmitzer, Lothar 
(98) Wolkenhauer, Olaf 
(99) Xu, Guowang 
(100) Zhang, Xiang-S 
 
 
 
